Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,A1BG,Alpha-1B-glycoprotein,23695,41,2.20 [0.39-12.43],0.3723087468745141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AAMDC,Mth938 domain-containing protein,23041,41,0.82 [0.47-1.44],0.4917046303237069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AARSD1,Alanyl-tRNA editing protein Aarsd1,27009,48,1.03 [0.66-1.62],0.8910543454314799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ABCA2,ATP-binding cassette sub-family A member 2,22889,39,1.72 [0.88-3.38],0.1150562730656286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ABHD14B,Protein ABHD14B,26864,48,0.82 [0.53-1.28],0.381238142702322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ABL1,Tyrosine-protein kinase ABL1,27009,48,0.71 [0.47-1.07],0.1063929454365929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ABO,Histo-blood group ABO system transferase,23663,40,0.99 [0.81-1.22],0.955288354319423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ABRAXAS2,BRISC complex subunit Abraxas 2,22889,39,0.87 [0.54-1.39],0.561073463712249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",26496,46,1.20 [0.90-1.62],0.2170221618288728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",23202,40,0.83 [0.50-1.38],0.4824976534342847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",23652,40,0.82 [0.58-1.17],0.2792434447672101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACAN,Aggrecan core protein,26891,49,1.86 [0.76-4.58],0.1759207833442725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACE,Angiotensin-converting enzyme,23663,40,2.36 [0.85-6.55],0.0983369340140225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACE2,Angiotensin-converting enzyme 2,26637,46,1.78 [1.20-2.64],0.0042898527166701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACHE,Acetylcholinesterase,23153,40,1.55 [0.65-3.69],0.321480674623406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACOT13,Acyl-coenzyme A thioesterase 13,23528,40,0.92 [0.71-1.19],0.5225885781795905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,27132,49,0.91 [0.55-1.53],0.7299161215241583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACP1,Low molecular weight phosphotyrosine protein phosphatase,22978,40,1.22 [0.64-2.33],0.5448076886417821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACP5,Tartrate-resistant acid phosphatase type 5,27255,46,0.77 [0.33-1.81],0.5505053204984611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACP6,Lysophosphatidic acid phosphatase type 6,27315,49,0.74 [0.55-1.00],0.0471063540151653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACRBP,Acrosin-binding protein,23514,40,0.77 [0.34-1.74],0.5284708916976473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACRV1,Acrosomal protein SP-10,22978,40,1.25 [0.55-2.81],0.595661601928108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACSL1,Long-chain-fatty-acid--CoA ligase 1,22889,39,1.59 [0.94-2.69],0.0843552680537228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACTA2,"Actin, aortic smooth muscle",26637,46,1.52 [0.99-2.32],0.0535934805433068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACTN2,Alpha-actinin-2,22889,39,1.17 [0.69-1.99],0.5572976564101866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACTN4,Alpha-actinin-4,26592,46,0.96 [0.42-2.22],0.9255736047284908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACVRL1,Serine/threonine-protein kinase receptor R3,26908,48,1.59 [0.57-4.39],0.3740083864461202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACY1,Aminoacylase-1,27132,49,1.35 [0.91-2.00],0.1355983692775673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,22889,39,1.70 [1.06-2.71],0.0275031866498154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACYP1,Acylphosphatase-1,23057,40,0.94 [0.59-1.49],0.7920962589409882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADA,Adenosine deaminase,27414,49,1.32 [0.66-2.64],0.4267006477489828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADA2,Adenosine deaminase 2,26960,49,1.87 [1.08-3.26],0.0263199339772027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,22978,40,1.87 [1.04-3.38],0.0366587889995108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,26637,46,1.74 [0.74-4.07],0.2035482501576824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,26950,48,1.10 [0.53-2.26],0.8058576188569953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,27414,49,1.05 [0.51-2.19],0.8861419930796097
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,27324,49,0.87 [0.36-2.11],0.7535936834723314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,23528,40,1.39 [0.53-3.66],0.5013276887964502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,22978,40,0.68 [0.24-1.90],0.45741761091971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,27462,47,0.39 [0.14-1.10],0.0764283465069912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,27009,48,1.02 [0.58-1.80],0.9406678767492054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,26637,46,1.01 [0.42-2.43],0.9800911006368228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,22978,40,0.74 [0.30-1.85],0.521917149059621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,27225,47,0.98 [0.55-1.75],0.9532759249429535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTSL2,ADAMTS-like protein 2,23649,41,1.67 [0.69-4.01],0.2555399023934289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTSL4,ADAMTS-like protein 4,23041,41,2.55 [0.76-8.54],0.1288906512672909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTSL5,ADAMTS-like protein 5,23652,40,0.54 [0.25-1.15],0.1091036621590973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,26496,46,0.62 [0.23-1.71],0.3597478266919928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADD1,Alpha-adducin,23153,40,0.96 [0.62-1.47],0.8384444751828803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRB3,Adhesion G protein-coupled receptor B3,26908,48,0.75 [0.34-1.63],0.466602229560797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRD1,Adhesion G-protein coupled receptor D1,23153,40,1.40 [0.62-3.14],0.4134151107042016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRE1,Adhesion G protein-coupled receptor E1,23528,40,1.47 [0.88-2.45],0.1402991938656873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRE2,Adhesion G protein-coupled receptor E2,27269,49,0.96 [0.39-2.39],0.9324324453516584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRE5,Adhesion G protein-coupled receptor E5,27328,47,1.30 [0.56-3.03],0.5424725824013228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRF5,Adhesion G protein-coupled receptor F5,23652,40,0.83 [0.31-2.25],0.7199088357516201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRG1,Adhesion G-protein coupled receptor G1,27009,48,0.96 [0.62-1.47],0.8359191999756825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRG2,Adhesion G-protein coupled receptor G2,27132,49,0.58 [0.23-1.45],0.2418404807010138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRV1,Adhesion G-protein coupled receptor V1,22880,37,1.16 [0.78-1.72],0.4673791888394084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADH1B,All-trans-retinol dehydrogenase,23153,40,1.28 [0.89-1.84],0.1858501370805894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,26637,46,1.16 [0.86-1.57],0.3204831202728542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADIPOQ,Adiponectin,23695,41,1.69 [1.08-2.63],0.020782285827692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADM,Pro-adrenomedullin,27363,49,1.26 [0.49-3.25],0.638480936488987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADRA2A,Alpha-2A adrenergic receptor,22889,39,0.72 [0.41-1.28],0.2632833284129096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AFAP1,Actin filament-associated protein 1,23153,40,0.98 [0.68-1.42],0.9296686835266066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AFM,Afamin,23695,41,0.98 [0.20-4.69],0.9794578310231092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AFP,Alpha-fetoprotein,26869,48,1.07 [0.74-1.56],0.7059437092867652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGBL2,Cytosolic carboxypeptidase 2,22880,37,1.02 [0.71-1.47],0.9035459521078488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGER,Advanced glycosylation end product-specific receptor,27091,49,0.89 [0.49-1.63],0.7051377798215543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGR2,Anterior gradient protein 2 homolog,26234,44,0.98 [0.76-1.28],0.9017560001852089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGR3,Anterior gradient protein 3,26449,45,1.10 [0.72-1.70],0.6561495415074131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGRN,Agrin,27269,49,1.00 [0.47-2.11],0.9926690596277458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGRP,Agouti-related protein,27414,49,1.47 [0.92-2.35],0.1083021056202052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGT,Angiotensinogen,23663,40,2.02 [0.84-4.85],0.1140582477816266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGXT,Serine--pyruvate aminotransferase,27132,49,1.29 [0.96-1.74],0.0883974656815837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AHCY,Adenosylhomocysteinase,27132,49,1.06 [0.73-1.52],0.7690958213598473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AHNAK,Neuroblast differentiation-associated protein AHNAK,23041,41,0.57 [0.21-1.56],0.2715617966339628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AHNAK2,Protein AHNAK2,23041,41,0.77 [0.26-2.30],0.6355716611036144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,23514,40,1.12 [0.75-1.67],0.5759685053954144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AHSG,Alpha-2-HS-glycoprotein,23663,40,0.91 [0.31-2.74],0.8728661607971073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AHSP,Alpha-hemoglobin-stabilizing protein,27096,49,1.04 [0.78-1.37],0.7967319245429543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AIDA,"Axin interactor, dorsalization-associated protein",22992,41,1.06 [0.76-1.49],0.7311698814851706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AIF1,Allograft inflammatory factor 1,26496,46,0.91 [0.55-1.51],0.7094227019633739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AIF1L,Allograft inflammatory factor 1-like,23041,41,1.06 [0.64-1.77],0.8167934196073707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",26958,48,1.00 [0.79-1.28],0.9692333077602208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AK1,Adenylate kinase isoenzyme 1,27132,49,1.20 [0.83-1.74],0.3432488488056162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AK2,"Adenylate kinase 2, mitochondrial",23597,41,0.90 [0.68-1.19],0.465547676213335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKAP12,A-kinase anchor protein 12,23153,40,1.51 [0.51-4.44],0.4578348119975135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKR1B1,Aldo-keto reductase family 1 member B1,26496,46,0.88 [0.62-1.24],0.4638364530830428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKR1B10,Aldo-keto reductase family 1 member B10,22992,41,1.13 [0.71-1.81],0.6018987214848619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKR1C4,Aldo-keto reductase family 1 member C4,26637,46,1.08 [0.69-1.69],0.7246965355305743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKR7L,Aflatoxin B1 aldehyde reductase member 4,22978,40,1.04 [0.67-1.60],0.8744338969035255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKT1S1,Proline-rich AKT1 substrate 1,26470,44,0.95 [0.64-1.42],0.8127809269556705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKT2,RAC-beta serine/threonine-protein kinase,23614,39,0.91 [0.71-1.15],0.4168148295939703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKT3,RAC-gamma serine/threonine-protein kinase,26369,46,0.87 [0.55-1.39],0.5672290241027182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALCAM,CD166 antigen,27462,47,0.54 [0.14-2.03],0.3627380574731361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALDH1A1,Retinal dehydrogenase 1,27137,49,1.34 [0.88-2.04],0.1660517938839549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALDH2,"Aldehyde dehydrogenase, mitochondrial",23514,40,1.14 [0.69-1.89],0.5990279183322744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",27043,49,1.07 [0.75-1.53],0.7018650148362605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",23614,39,1.23 [0.67-2.24],0.5018907985826803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALMS1,Alstrom syndrome protein 1,23202,40,1.06 [0.57-1.94],0.8606767103957398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALPI,Intestinal-type alkaline phosphatase,22978,40,1.09 [0.85-1.39],0.4959459690476563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALPP,"Alkaline phosphatase, placental type",27009,48,0.96 [0.76-1.23],0.7640824615882553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMBN,Ameloblastin,26592,46,0.65 [0.22-1.90],0.4316807731296351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMBP,Protein AMBP,27326,49,0.60 [0.17-2.10],0.4215560557105084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,23649,41,1.55 [0.48-4.98],0.4585586792080655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMFR,E3 ubiquitin-protein ligase AMFR,26470,44,1.05 [0.69-1.58],0.8265413054837176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMIGO1,Amphoterin-induced protein 1,22992,41,1.31 [0.82-2.07],0.255909525972844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMIGO2,Amphoterin-induced protein 2,27009,48,3.87 [1.28-11.70],0.0165264568673778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMN,Protein amnionless,26592,46,0.81 [0.46-1.44],0.4776916748248186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMOT,Angiomotin,23153,40,1.41 [0.68-2.93],0.3622356226892285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMOTL2,Angiomotin-like protein 2,23436,40,0.84 [0.42-1.69],0.6312274230568728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMPD3,AMP deaminase 3,23597,41,1.44 [0.98-2.11],0.0647059560399191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,22143,36,0.77 [0.39-1.51],0.4448310972046176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMY2A,Pancreatic alpha-amylase,26060,45,0.70 [0.40-1.23],0.2140772353615867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMY2B,Alpha-amylase 2B,25278,45,0.68 [0.39-1.18],0.1719161058055501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANG,Angiogenin,27044,49,0.68 [0.31-1.46],0.3226372393019534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPT1,Angiopoietin-1,27041,49,0.77 [0.58-1.02],0.0672251618502412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPT2,Angiopoietin-2,27363,49,1.97 [1.06-3.68],0.0332793657410649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPTL1,Angiopoietin-related protein 1,26762,46,1.16 [0.47-2.87],0.7415391259290404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPTL2,Angiopoietin-related protein 2,27184,49,1.33 [0.72-2.47],0.3623790783173899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPTL3,Angiopoietin-related protein 3,27133,49,1.12 [0.56-2.22],0.7527677821133516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPTL4,Angiopoietin-related protein 4,27224,49,2.55 [1.48-4.39],0.0007519106983217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPTL7,Angiopoietin-related protein 7,27363,49,0.98 [0.48-1.96],0.9446160144089292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANK2,Ankyrin-2,22889,39,1.19 [0.85-1.68],0.3125847120080348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,22978,40,0.89 [0.61-1.31],0.567630938461664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANKRA2,Ankyrin repeat family A protein 2,22790,39,1.03 [0.60-1.76],0.9136447835361567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANKRD54,Ankyrin repeat domain-containing protein 54,26496,46,1.00 [0.64-1.57],0.9922321788297226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,23041,41,1.61 [1.04-2.51],0.032839423326292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANPEP,Aminopeptidase N,27178,49,2.76 [1.36-5.63],0.0051535307451156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA1,Annexin A1,23011,40,0.63 [0.29-1.37],0.2422755628954714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA10,Annexin A10,26470,44,1.22 [0.93-1.60],0.145562609303454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA11,Annexin A11,27047,48,0.94 [0.65-1.37],0.7637541413681278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA2,Annexin A2,22688,41,0.94 [0.61-1.45],0.7914318049320339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA3,Annexin A3,27324,49,0.91 [0.63-1.30],0.5867988862809421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA4,Annexin A4,26993,49,0.80 [0.56-1.15],0.233509268948711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA5,Annexin A5,26389,44,1.42 [0.60-3.35],0.4268878230681128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AOC1,Amiloride-sensitive amine oxidase [copper-containing],26592,46,0.79 [0.46-1.37],0.4013215276869425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AOC3,Membrane primary amine oxidase,27224,49,1.33 [0.58-3.04],0.498449430298305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AP1G2,AP-1 complex subunit gamma-like 2,23514,40,0.86 [0.58-1.26],0.4273634625388701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AP2B1,AP-2 complex subunit beta,22992,41,0.59 [0.29-1.20],0.1479910785604181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AP3B1,AP-3 complex subunit beta-1,23528,40,0.77 [0.51-1.15],0.2044615327220851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AP3S2,AP-3 complex subunit sigma-2,23597,41,0.82 [0.42-1.57],0.5429249599882959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,27009,48,0.70 [0.36-1.33],0.2761524123061296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APCS,Serum amyloid P-component,23483,41,0.48 [0.23-1.01],0.0520589311319071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,27268,49,1.18 [0.79-1.78],0.4207542352439543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APLP1,Amyloid-like protein 1,27132,49,0.78 [0.48-1.28],0.3235049502460191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOA1,Apolipoprotein A-I,23695,41,0.48 [0.14-1.73],0.2641778101368879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOA2,Apolipoprotein A-II,23663,40,1.47 [0.80-2.71],0.2123512053198747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOA4,Apolipoprotein A-IV,23695,41,1.14 [0.52-2.50],0.7505797502925242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOB,Apolipoprotein B-100,23663,40,1.76 [0.45-6.88],0.418011548719711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOBR,Apolipoprotein B receptor,23041,41,1.16 [0.56-2.40],0.697994572877521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOC1,Apolipoprotein C-I,23645,41,0.92 [0.39-2.20],0.8564986900070578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOD,Apolipoprotein D,22607,40,0.89 [0.40-1.96],0.7686626868400506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOE,Apolipoprotein E,23695,41,1.14 [0.82-1.58],0.4311287958989902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOF,Apolipoprotein F,23663,40,3.36 [0.79-14.31],0.1005712567407757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOH,Beta-2-glycoprotein 1,27137,49,0.65 [0.31-1.37],0.260163873050712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOL1,Apolipoprotein L1,23663,40,0.54 [0.30-0.96],0.0351976070531848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOM,Apolipoprotein M,27177,49,0.48 [0.19-1.17],0.107080753245634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APP,Amyloid-beta precursor protein,27097,49,0.71 [0.49-1.05],0.0881593178966654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APPL2,DCC-interacting protein 13-beta,23153,40,0.91 [0.69-1.18],0.4643968786397776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APRT,Adenine phosphoribosyltransferase,26911,48,1.12 [0.65-1.90],0.6891936718470721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARAF,Serine/threonine-protein kinase A-Raf,23202,40,1.14 [0.75-1.72],0.5432695034486521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AREG,Amphiregulin,27009,48,1.39 [0.84-2.30],0.2018329254711749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARF6,ADP-ribosylation factor 6,23528,40,0.91 [0.69-1.20],0.4838042955796263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARFIP1,Arfaptin-1,23614,39,0.87 [0.55-1.35],0.5300888407655374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARG1,Arginase-1,26989,48,1.06 [0.66-1.70],0.8073141172258445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARG2,"Arginase-2, mitochondrial",23514,40,1.29 [0.72-2.31],0.3832739462885983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGAP1,Rho GTPase-activating protein 1,26496,46,0.71 [0.40-1.26],0.2412777742937826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGAP25,Rho GTPase-activating protein 25,26496,46,1.01 [0.65-1.59],0.9494460150635816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGAP30,Rho GTPase-activating protein 30,23202,40,0.76 [0.29-2.01],0.5793761337394671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGAP45,Rho GTPase-activating protein 45,23153,40,0.87 [0.60-1.27],0.4824265246120488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGAP5,Rho GTPase-activating protein 5,22790,39,1.16 [0.81-1.64],0.419732111763896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGEF1,Rho guanine nucleotide exchange factor 1,23597,41,0.97 [0.70-1.34],0.840305198693786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGEF10,Rho guanine nucleotide exchange factor 10,23614,39,1.00 [0.72-1.38],0.9823845175617436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGEF12,Rho guanine nucleotide exchange factor 12,27084,49,0.90 [0.71-1.15],0.4185601624458174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGEF5,Rho guanine nucleotide exchange factor 5,22880,37,1.33 [0.94-1.88],0.1121479523595958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARID3A,AT-rich interactive domain-containing protein 3A,22880,37,0.70 [0.30-1.66],0.4195485967228923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARID4B,AT-rich interactive domain-containing protein 4B,26470,44,0.74 [0.35-1.59],0.4421357158270855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARL13B,ADP-ribosylation factor-like protein 13B,22889,39,0.99 [0.63-1.54],0.9562957775384444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,22889,39,0.67 [0.30-1.49],0.3255242833857817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARMCX2,Armadillo repeat-containing X-linked protein 2,22880,37,1.19 [0.78-1.80],0.4199064258611901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARNT,Aryl hydrocarbon receptor nuclear translocator,26592,46,0.82 [0.38-1.78],0.6146260666748012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,22889,39,1.08 [0.64-1.83],0.77800809126622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARSA,Arylsulfatase A,27137,49,1.39 [0.83-2.32],0.211474540271351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARSB,Arylsulfatase B,27009,48,0.80 [0.50-1.29],0.356530751018052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ART3,Ecto-ADP-ribosyltransferase 3,27224,49,0.56 [0.27-1.19],0.1342590233310113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ART5,Ecto-ADP-ribosyltransferase 5,22880,37,0.84 [0.45-1.54],0.5672098590530825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARTN,Artemin,26592,46,0.90 [0.48-1.70],0.7390078147497161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASAH1,Acid ceramidase,23427,41,0.96 [0.50-1.86],0.905214316882068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASAH2,Neutral ceramidase,26950,48,0.98 [0.60-1.59],0.9297303290876874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASGR1,Asialoglycoprotein receptor 1,26950,48,1.31 [0.56-3.07],0.532837907940664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASGR2,Asialoglycoprotein receptor 2,23663,40,2.08 [0.70-6.19],0.187261596038291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASPN,Asporin,23652,40,0.99 [0.33-3.00],0.9858323568270164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASPSCR1,Tether containing UBX domain for GLUT4,23614,39,0.99 [0.63-1.55],0.9723650060088556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASRGL1,Isoaspartyl peptidase/L-asparaginase,23041,41,0.90 [0.67-1.22],0.5054570467741597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASS1,Argininosuccinate synthase,22889,39,0.91 [0.61-1.35],0.6327720097217435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATF2,Cyclic AMP-dependent transcription factor ATF-2,26470,44,1.10 [0.79-1.54],0.5612770733971034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATF4,Cyclic AMP-dependent transcription factor ATF-4,22790,39,0.60 [0.22-1.66],0.323712541901406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATG16L1,Autophagy-related protein 16-1,23528,40,0.94 [0.66-1.34],0.7273208513743484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATG4A,Cysteine protease ATG4A,26496,46,1.22 [0.81-1.86],0.3416149734925881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATOX1,Copper transport protein ATOX1,27225,47,0.96 [0.67-1.39],0.84487077075923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,22889,39,1.31 [0.81-2.10],0.26732559344886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,22889,39,0.81 [0.30-2.24],0.6908451581726041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,22889,39,0.74 [0.30-1.84],0.5153356007189753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP1B4,Protein ATP1B4,22790,39,1.26 [0.66-2.41],0.490772012664423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP2B4,Plasma membrane calcium-transporting ATPase 4,22889,39,1.12 [0.71-1.75],0.6231087426246447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP5F1D,"ATP synthase subunit delta, mitochondrial",22889,39,1.14 [0.70-1.85],0.5907766988920035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP5IF1,"ATPase inhibitor, mitochondrial",27269,49,0.84 [0.67-1.05],0.131220598716642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP5PO,"ATP synthase subunit O, mitochondrial",26470,44,0.83 [0.42-1.64],0.6012643104008961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP6AP2,Renin receptor,26496,46,0.68 [0.32-1.46],0.3268892336428609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP6V1D,V-type proton ATPase subunit D,27009,48,0.64 [0.22-1.82],0.3983413170608555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP6V1F,V-type proton ATPase subunit F,26420,44,0.85 [0.56-1.29],0.4428851487847975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP6V1G1,V-type proton ATPase subunit G 1,23041,41,0.92 [0.61-1.41],0.709163207063317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP6V1G2,V-type proton ATPase subunit G 2,22889,39,0.86 [0.61-1.20],0.3654641222701031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATRAID,All-trans retinoic acid-induced differentiation factor,23528,40,1.72 [1.09-2.70],0.0200660929033536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATRN,"Attractin, Isoform 2",23695,41,1.41 [0.23-8.52],0.7095383764727639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATXN10,Ataxin-10,26470,44,0.95 [0.66-1.38],0.7902921492902094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATXN2,Ataxin-2,22880,37,1.26 [1.04-1.54],0.0191375712352019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATXN2L,Ataxin-2-like protein,23614,39,0.94 [0.49-1.82],0.862190428267815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATXN3,Ataxin-3,23597,41,1.05 [0.66-1.68],0.8292853396343275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AXIN1,Axin-1,27084,49,0.90 [0.69-1.18],0.4483052377020809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AXL,Tyrosine-protein kinase receptor UFO,27224,49,1.79 [0.75-4.28],0.1877085735365956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AZI2,5-azacytidine-induced protein 2,23614,39,0.82 [0.46-1.45],0.4949768518469148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AZU1,Azurocidin,26259,45,1.10 [0.81-1.51],0.5386569081464458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,B2M,Beta-2-microglobulin,23695,41,1.42 [0.84-2.41],0.1883385989522867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,22889,39,0.53 [0.10-2.76],0.4487679869957174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",23041,41,1.49 [0.65-3.40],0.3433676335979723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,B4GALT1,"Beta-1,4-galactosyltransferase 1",27269,49,1.78 [0.74-4.33],0.2000321759240865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,B4GAT1,"Beta-1,4-glucuronyltransferase 1",27137,49,0.58 [0.20-1.67],0.3112604441020652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BABAM1,BRISC and BRCA1-A complex member 1,22978,40,1.31 [0.51-3.37],0.5784526053507402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BACH1,Transcription regulator protein BACH1,27084,49,1.04 [0.73-1.47],0.8324708540553781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BAG3,BAG family molecular chaperone regulator 3,26908,48,0.79 [0.43-1.45],0.4454153426311638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BAG4,BAG family molecular chaperone regulator 4,22978,40,0.51 [0.25-1.05],0.0671996880673501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BAG6,Large proline-rich protein BAG6,26637,46,0.94 [0.45-1.98],0.8768843822517564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,26496,46,1.42 [0.99-2.04],0.0536847197522244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BAMBI,BMP and activin membrane-bound inhibitor homolog,26496,46,1.56 [0.69-3.51],0.2859278269304324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BANK1,B-cell scaffold protein with ankyrin repeats,27084,49,0.90 [0.71-1.13],0.3608505423646394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BAP18,Chromatin complexes subunit BAP18,23597,41,1.11 [0.74-1.68],0.6145952890838737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BATF,Basic leucine zipper transcriptional factor ATF-like,22992,41,1.22 [0.94-1.58],0.1397442396342145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BAX,Apoptosis regulator BAX,26428,44,0.86 [0.63-1.17],0.3437434377332167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCAM,Basal cell adhesion molecule,27137,49,1.56 [0.56-4.33],0.390965362463158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCAN,Brevican core protein,26950,48,0.82 [0.39-1.74],0.6048459352289512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",23652,40,1.46 [0.62-3.44],0.3840312754275878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",22880,37,1.13 [0.68-1.89],0.6350884468028006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCHE,Cholinesterase,23228,39,0.71 [0.27-1.86],0.4881652557010284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCL2,Apoptosis regulator Bcl-2,23528,40,0.90 [0.50-1.62],0.7173813283411006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCL2L1,Bcl-2-like protein 1,23597,41,0.87 [0.65-1.18],0.3763754181704881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",27084,49,1.00 [0.57-1.76],0.9977566734875282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCL2L15,Bcl-2-like protein 15,22978,40,0.78 [0.43-1.40],0.4013555696218509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCL7A,B-cell CLL/lymphoma 7 protein family member A,22790,39,1.04 [0.67-1.63],0.8481983046715601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCL7B,B-cell CLL/lymphoma 7 protein family member B,23514,40,0.52 [0.21-1.25],0.1411194222118398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCR,Breakpoint cluster region protein,27084,49,0.94 [0.71-1.25],0.6840618798149809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BDNF,Brain-derived neurotrophic factor,23649,41,0.88 [0.62-1.24],0.457723917741777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BECN1,Beclin-1,23041,41,0.69 [0.41-1.18],0.1748163068081605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BEX3,Protein BEX3,22790,39,0.77 [0.36-1.63],0.4898542151001549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BGLAP,Osteocalcin,23649,41,1.12 [0.81-1.54],0.4850543113231973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BGN,Biglycan,26450,46,1.13 [0.92-1.39],0.255028840598223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BHLHE40,Class E basic helix-loop-helix protein 40,22880,37,0.93 [0.58-1.48],0.7583768447155811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,22889,39,1.08 [0.32-3.70],0.8994881058094081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BID,BH3-interacting domain death agonist,27084,49,0.71 [0.48-1.06],0.0949821019151577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BIN2,Bridging integrator 2,27137,49,0.86 [0.65-1.14],0.3072143822816427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BIRC2,Baculoviral IAP repeat-containing protein 2,26496,46,0.97 [0.64-1.48],0.8953873707524423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BLMH,Bleomycin hydrolase,27462,47,1.67 [0.86-3.22],0.1274682876093126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BLNK,B-cell linker protein,22978,40,0.64 [0.26-1.57],0.3267382327816377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,22880,37,0.88 [0.54-1.43],0.6038876455029398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,23597,41,0.63 [0.28-1.42],0.2659548465756125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BLVRB,Flavin reductase,27137,49,1.21 [0.86-1.70],0.2810188798914574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BMP10,Bone morphogenetic protein 10,23153,40,1.54 [0.52-4.57],0.4335624970921222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BMP4,Bone morphogenetic protein 4,26908,48,0.91 [0.51-1.59],0.7309854143294734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BMP6,Bone morphogenetic protein 6,26593,46,1.22 [0.65-2.30],0.5332539956169658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BMPER,BMP-binding endothelial regulator protein,23153,40,2.02 [0.72-5.70],0.1832032881500257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,23652,40,0.85 [0.34-2.13],0.7229569875034407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,22978,40,0.92 [0.46-1.85],0.8091506124422022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BOC,Brother of CDO,26637,46,1.51 [0.50-4.59],0.466976254586338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BOLA1,BolA-like protein 1,22880,37,1.00 [0.56-1.78],0.9932162171205516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BOLA2_BOLA2B,BolA-like protein 2,23041,41,0.89 [0.52-1.53],0.6809446773942786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BPIFA2,BPI fold-containing family A member 2,22193,39,0.90 [0.68-1.19],0.4720828837986899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BPIFB1,BPI fold-containing family B member 1,27058,47,0.87 [0.57-1.33],0.5322373536637155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BPIFB2,BPI fold-containing family B member 2,23605,40,1.05 [0.69-1.58],0.8335752857761807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRAP,BRCA1-associated protein,23321,40,0.91 [0.69-1.20],0.5159230572632509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRD1,Bromodomain-containing protein 1,23202,40,0.57 [0.18-1.79],0.3383707627952954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRD2,Bromodomain-containing protein 2,22880,37,0.92 [0.35-2.46],0.8703524167390726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRD3,Bromodomain-containing protein 3,22889,39,0.43 [0.18-1.03],0.0585290387706246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRDT,Bromodomain testis-specific protein,22889,39,0.66 [0.27-1.59],0.3504418452399092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRK1,Protein BRICK1,26470,44,0.89 [0.48-1.63],0.6979024381324442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRME1,Break repair meiotic recombinase recruitment factor 1,22880,37,1.04 [0.49-2.18],0.9246860567568116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRSK2,Serine/threonine-protein kinase BRSK2,23614,39,0.57 [0.24-1.38],0.2167402540136181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BSG,Basigin,27369,48,1.01 [0.30-3.36],0.9866056422766238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BSND,Barttin,22790,39,0.68 [0.24-1.93],0.4694692296920761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,27371,49,0.86 [0.53-1.38],0.529772117379538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BST2,Bone marrow stromal antigen 2,27371,49,1.90 [1.43-2.54],1.1187588010867716e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTC,Probetacellulin,26496,46,0.90 [0.62-1.30],0.5797579799689485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTD,Biotinidase,23695,41,1.88 [0.43-8.24],0.4005820558999492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTLA,B- and T-lymphocyte attenuator,22790,39,1.27 [1.02-1.59],0.0344627086576433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTN1A1,Butyrophilin subfamily 1 member A1,23468,40,1.25 [0.72-2.16],0.4219161831588254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTN2A1,Butyrophilin subfamily 2 member A1,27269,49,0.77 [0.29-2.06],0.605961714178729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTN3A2,Butyrophilin subfamily 3 member A2,27084,49,1.21 [0.64-2.29],0.5615660664188353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTNL10,Butyrophilin-like protein 10,22790,39,0.33 [0.11-1.00],0.0499781523389453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C19orf12,Protein C19orf12,26470,44,1.17 [0.82-1.67],0.3880738051811496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1GALT1C1,C1GALT1-specific chaperone 1,22889,39,1.05 [0.40-2.75],0.9154388237377078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QA,Complement C1q subcomponent subunit A,27274,48,2.96 [0.97-9.03],0.0567420090402986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",23614,39,0.70 [0.37-1.32],0.2684766029895983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QL2,Complement C1q-like protein 2,22978,40,1.03 [0.52-2.02],0.9332289929615796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,27224,49,1.94 [1.17-3.24],0.0107599814131081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,23153,40,2.50 [1.13-5.52],0.0235233213305124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,23614,39,1.73 [0.83-3.59],0.145322700927129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,23107,40,0.70 [0.39-1.23],0.2155373078894703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1R,Complement C1r subcomponent,23695,41,1.19 [0.28-5.03],0.8087518847179216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1RL,Complement C1r subcomponent-like protein,23657,41,1.14 [0.25-5.14],0.8685160288241183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1S,Complement C1s subcomponent,23695,41,1.65 [0.40-6.76],0.4894491624922428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C2,Complement C2,27177,49,0.97 [0.34-2.79],0.9610658172299944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C2CD2L,Phospholipid transfer protein C2CD2L,26420,44,1.09 [0.63-1.89],0.7677864339766307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C2orf69,UPF0565 protein C2orf69,22992,41,1.06 [0.67-1.69],0.7905717190758845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C3,Complement C3,22472,38,0.77 [0.36-1.64],0.4943098435628814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C4BPB,C4b-binding protein beta chain,27225,47,0.90 [0.48-1.68],0.7412469398867909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C5,Complement C5,23695,41,1.46 [0.24-8.83],0.6779542703994494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C7,Complement component C7,23136,39,1.62 [0.60-4.41],0.3432197218424351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C7orf50,Uncharacterized protein C7orf50,23597,41,1.33 [0.44-4.07],0.6151849144182463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C8B,Complement component C8 beta chain,23695,41,1.39 [0.52-3.72],0.5108961254352468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C9,Complement component C9,23663,40,1.78 [0.95-3.34],0.0731583108110752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C9orf40,Uncharacterized protein C9orf40,23528,40,1.19 [0.84-1.68],0.3252567664563306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA1,Carbonic anhydrase 1,26503,48,1.09 [0.73-1.62],0.6790567967740413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA11,Carbonic anhydrase-related protein 11,26496,46,0.66 [0.24-1.81],0.4147520160033549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA12,Carbonic anhydrase 12,27009,48,0.79 [0.34-1.80],0.568316495627589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA13,Carbonic anhydrase 13,26843,47,0.90 [0.71-1.15],0.4009256869116514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA14,Carbonic anhydrase 14,27363,49,0.53 [0.26-1.10],0.0888173632915817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA2,Carbonic anhydrase 2,27047,49,1.18 [0.84-1.65],0.3452910638886678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA3,Carbonic anhydrase 3,27412,47,1.14 [0.76-1.70],0.5291807409136068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA4,Carbonic anhydrase 4,27462,47,0.42 [0.14-1.21],0.1067125693562517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA5A,"Carbonic anhydrase 5A, mitochondrial",26637,46,1.08 [0.82-1.42],0.5804474768518482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA6,Carbonic anhydrase 6,27051,49,0.92 [0.62-1.38],0.6962292837860588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA7,Carbonic anhydrase 7,23202,40,0.87 [0.35-2.17],0.7647939570448531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA8,Carbonic anhydrase-related protein,22978,40,1.07 [0.36-3.15],0.9068530332398774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA9,Carbonic anhydrase 9,27363,49,1.83 [1.17-2.88],0.0083800442051001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CABP2,Calcium-binding protein 2,22992,41,0.84 [0.50-1.40],0.4960457066358574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,22880,37,1.00 [0.39-2.60],0.99827484398261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,22889,39,0.98 [0.59-1.64],0.953627249959332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,22880,37,0.68 [0.36-1.27],0.2223350985179763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,23614,39,0.90 [0.63-1.28],0.5497420421734072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CACYBP,Calcyclin-binding protein,23105,40,0.87 [0.65-1.16],0.3479567089136254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CADPS,Calcium-dependent secretion activator 1,22992,41,0.74 [0.32-1.67],0.4611793320548525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CALB1,Calbindin,27009,48,0.69 [0.42-1.13],0.139058663479924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CALB2,Calretinin,26470,44,0.38 [0.15-0.97],0.0433303514071408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CALCA,Calcitonin,26900,48,1.27 [0.86-1.90],0.2310122959490865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CALCB,Calcitonin gene-related peptide 2,23597,41,0.83 [0.36-1.92],0.6656231895262672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,27273,49,0.91 [0.72-1.16],0.4583077341548823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,23041,41,0.89 [0.60-1.32],0.5576432272399012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CALY,Neuron-specific vesicular protein calcyon,22889,39,0.87 [0.36-2.09],0.7504649097525935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,26496,46,1.10 [0.61-1.99],0.7437691872774856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,22992,41,0.74 [0.40-1.37],0.3376504993562002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,23614,39,0.93 [0.70-1.24],0.6320568280274781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CANT1,Soluble calcium-activated nucleotidase 1,27056,49,1.00 [0.29-3.43],0.9969363373975808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CAPG,Macrophage-capping protein,26925,48,1.20 [0.78-1.82],0.4046539369052802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CAPN3,Calpain-3,23514,40,0.89 [0.38-2.09],0.7857815248169081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CAPS,Calcyphosin,23597,41,0.88 [0.60-1.27],0.487529744190296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CARHSP1,Calcium-regulated heat-stable protein 1,26470,44,1.07 [0.65-1.75],0.8019166892812606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASC3,Protein CASC3,22992,41,0.57 [0.25-1.26],0.1649949557134828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP1,Caspase-1,26470,44,0.92 [0.62-1.38],0.6891688399885804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP10,Caspase-10,26470,44,1.01 [0.69-1.48],0.939803950245782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP2,Caspase-2,27084,49,0.86 [0.59-1.27],0.4546249578777938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP3,Caspase-3,27462,47,0.99 [0.74-1.33],0.9622023965116816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP4,Caspase-4,23202,40,1.06 [0.90-1.25],0.4752732882201409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP7,Caspase-7,23597,41,0.86 [0.60-1.23],0.4131375189524312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP8,Caspase-8,27278,49,0.92 [0.61-1.38],0.6799174499526266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP9,Caspase-9,22978,40,0.77 [0.46-1.29],0.325815057331666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASQ2,Calsequestrin-2,22889,39,0.94 [0.48-1.85],0.8628799913353309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CAT,Catalase,23301,40,1.20 [0.72-2.02],0.4860577213448293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CBLIF,Cobalamin binding intrinsic factor,27087,49,1.34 [0.96-1.86],0.0829277843575789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CBLN1,Cerebellin-1,22880,37,1.13 [0.86-1.48],0.3920867298396723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CBLN4,Cerebellin-4,27363,49,0.54 [0.25-1.18],0.1207404654841841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CBS,Cystathionine beta-synthase,23041,41,1.27 [0.75-2.13],0.3729148117440188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CBX2,Chromobox protein homolog 2,22889,39,0.87 [0.38-2.02],0.7495189016501813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,26950,48,0.92 [0.65-1.30],0.6392463842082992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCAR2,Cell cycle and apoptosis regulator protein 2,23597,41,0.73 [0.35-1.50],0.3915442014014345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCDC134,Coiled-coil domain-containing protein 134,23514,40,0.62 [0.32-1.20],0.1529332184663177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCDC28A,Coiled-coil domain-containing protein 28A,22992,41,0.72 [0.25-2.02],0.5282540290092308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCDC50,Coiled-coil domain-containing protein 50,23614,39,1.15 [0.82-1.62],0.41486007087839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCDC80,Coiled-coil domain-containing protein 80,27132,49,1.22 [0.63-2.36],0.5620766703579849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,23041,41,0.55 [0.33-0.92],0.0220130616547767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL11,Eotaxin,27414,49,0.75 [0.38-1.49],0.4172670401131869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL13,C-C motif chemokine 13,27363,49,0.86 [0.60-1.25],0.4337542143268142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL14,C-C motif chemokine 14,27044,49,0.72 [0.37-1.39],0.3264424559276114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL15,C-C motif chemokine 15,27462,47,1.14 [0.64-2.00],0.6600865821976879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL16,C-C motif chemokine 16,27462,47,0.78 [0.50-1.21],0.2671219218271261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL17,C-C motif chemokine 17,27098,49,0.82 [0.62-1.08],0.1597115312663532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL18,C-C motif chemokine 18,26739,49,0.97 [0.66-1.41],0.8701798013443112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL19,C-C motif chemokine 19,27371,49,0.94 [0.77-1.15],0.5399328368950709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL2,C-C motif chemokine 2,26908,48,0.90 [0.56-1.46],0.6762451105328071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL20,C-C motif chemokine 20,27414,49,0.88 [0.65-1.19],0.4058803983911898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL21,C-C motif chemokine 21,27269,49,0.90 [0.50-1.62],0.7153387605524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL22,C-C motif chemokine 22,26880,48,1.05 [0.64-1.71],0.8537217254790057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL23,C-C motif chemokine 23,27269,49,1.31 [0.73-2.37],0.369024780777814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL24,C-C motif chemokine 24,27224,49,0.86 [0.63-1.17],0.3304996398674866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL25,C-C motif chemokine 25,27414,49,1.35 [0.80-2.27],0.260932702210111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL26,C-C motif chemokine 26,27084,49,0.82 [0.60-1.12],0.2042548911322558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL27,C-C motif chemokine 27,27132,49,0.92 [0.60-1.42],0.7132175897484947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL28,C-C motif chemokine 28,26997,48,1.25 [0.83-1.87],0.2807408386355375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL3,C-C motif chemokine 3,27084,49,0.84 [0.52-1.36],0.484339973703388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL4,C-C motif chemokine 4,27180,49,0.45 [0.27-0.76],0.002557450746392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL5,C-C motif chemokine 5,27224,49,0.86 [0.67-1.10],0.2365517125921235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL7,C-C motif chemokine 7,27084,49,0.94 [0.61-1.46],0.7983173564582383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL8,C-C motif chemokine 8,27326,49,0.73 [0.49-1.09],0.1208190131623202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCN1,CCN family member 1,26962,48,1.12 [0.80-1.58],0.5027366288426072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCN2,CCN family member 2,27134,49,0.82 [0.53-1.28],0.3906401453579474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCN3,CCN family member 3,27422,46,2.04 [1.04-3.99],0.0368023237875111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCN4,CCN family member 4,27363,49,1.07 [0.58-1.95],0.8320813724753533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCN5,CCN family member 5,27137,49,0.89 [0.46-1.71],0.7165607698126895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCND2,G1/S-specific cyclin-D2,23202,40,0.80 [0.37-1.74],0.5758762133227305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCNE1,G1/S-specific cyclin-E1,22978,40,0.93 [0.63-1.39],0.7371754987802215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCS,Copper chaperone for superoxide dismutase,26950,48,0.96 [0.56-1.62],0.8663565076175093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCT5,T-complex protein 1 subunit epsilon,26496,46,1.07 [0.61-1.86],0.8125487710616054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD101,Immunoglobulin superfamily member 2,23528,40,1.05 [0.51-2.17],0.885248526779634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD109,CD109 antigen,27137,49,1.67 [0.78-3.60],0.1876743103039448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD14,Monocyte differentiation antigen CD14,26548,48,1.62 [0.92-2.86],0.0940811605407355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD160,CD160 antigen,27414,49,1.19 [0.70-2.01],0.5275450294384296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD163,Scavenger receptor cysteine-rich type 1 protein M130,27224,49,1.30 [0.73-2.31],0.3724333832300444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD164,Sialomucin core protein 24,27137,49,1.05 [0.46-2.44],0.9011709575230278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD164L2,CD164 sialomucin-like 2 protein,22992,41,0.93 [0.40-2.13],0.8559516509823706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD177,CD177 antigen,27094,49,1.15 [0.93-1.43],0.2003942816338849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD1C,T-cell surface glycoprotein CD1c,27225,47,0.67 [0.40-1.14],0.1429036514658196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD2,T-cell surface antigen CD2,22889,39,1.29 [0.68-2.42],0.4348963262578038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD200,OX-2 membrane glycoprotein,27084,49,0.97 [0.37-2.56],0.957528290843544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD200R1,Cell surface glycoprotein CD200 receptor 1,26996,49,0.95 [0.46-1.96],0.8892065720733402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD207,C-type lectin domain family 4 member K,26554,46,0.54 [0.28-1.06],0.0734063742692921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD209,CD209 antigen,27198,46,0.53 [0.27-1.04],0.0635240477394903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD22,B-cell receptor CD22,27414,49,0.65 [0.35-1.21],0.173352240767741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD226,CD226 antigen,22978,40,0.66 [0.32-1.37],0.2654362984645225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD244,Natural killer cell receptor 2B4,27414,49,1.18 [0.46-3.02],0.7354769736628621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD248,Endosialin,23649,41,2.47 [1.20-5.09],0.0143026524084722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD27,CD27 antigen,27225,47,1.17 [0.64-2.15],0.6087802650430367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD274,Programmed cell death 1 ligand 1,26950,48,1.62 [0.84-3.13],0.1503424683079205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD276,CD276 antigen,27139,49,2.44 [1.21-4.91],0.0127433708313602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD28,T-cell-specific surface glycoprotein CD28,26496,46,1.16 [0.58-2.30],0.678260555280341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD2AP,CD2-associated protein,27132,49,0.92 [0.62-1.36],0.6786684137161662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD300A,CMRF35-like molecule 8,23153,40,2.00 [0.75-5.31],0.1663985410539489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD300C,CMRF35-like molecule 6,27371,49,1.01 [0.49-2.06],0.9821948587736408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD300E,CMRF35-like molecule 2,27261,49,1.22 [0.66-2.24],0.5203782885953165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD300LF,CMRF35-like molecule 1,27363,49,1.10 [0.73-1.66],0.6445094932071722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD300LG,CMRF35-like molecule 9,27137,49,0.76 [0.39-1.48],0.4214704442607242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD302,CD302 antigen,27009,48,1.92 [0.88-4.16],0.0996175471284306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD33,Myeloid cell surface antigen CD33,27225,47,0.99 [0.72-1.36],0.9423005445040824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD34,Hematopoietic progenitor cell antigen CD34,27281,49,0.43 [0.15-1.22],0.1121716361048606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD36,Platelet glycoprotein 4,22978,40,0.59 [0.29-1.20],0.1445351500064993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,27009,48,2.09 [0.96-4.53],0.0620647354466371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD3D,T-cell surface glycoprotein CD3 delta chain,22880,37,0.52 [0.16-1.69],0.2769507805593635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD3E,T-cell surface glycoprotein CD3 epsilon chain,23202,40,0.84 [0.33-2.14],0.7193720722389781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD3G,T-cell surface glycoprotein CD3 gamma chain,22978,40,0.67 [0.39-1.15],0.1456723301062196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD4,T-cell surface glycoprotein CD4,27038,48,1.06 [0.48-2.38],0.8801639026208573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD40,Tumor necrosis factor receptor superfamily member 5,27135,49,0.86 [0.51-1.46],0.5836253386120207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD40LG,CD40 ligand,27414,49,0.75 [0.54-1.03],0.0753040783518643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD46,Membrane cofactor protein,26951,49,0.80 [0.32-2.01],0.637389360946681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD48,CD48 antigen,27224,49,1.37 [0.59-3.16],0.4679260148726585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD5,T-cell surface glycoprotein CD5,27326,49,0.79 [0.37-1.70],0.5470593904213565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD55,Complement decay-accelerating factor,26162,46,0.59 [0.20-1.70],0.3277748341375266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD58,Lymphocyte function-associated antigen 3,27099,49,0.68 [0.17-2.76],0.5858713083649343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD59,CD59 glycoprotein,26126,46,0.67 [0.19-2.28],0.5189014584505591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD5L,CD5 antigen-like,23555,41,1.74 [0.94-3.23],0.078429847889602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD6,T-cell differentiation antigen CD6,27369,48,0.74 [0.46-1.19],0.207738416610627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD63,CD63 antigen,26908,48,0.61 [0.38-0.98],0.0424190200751908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD69,Early activation antigen CD69,27003,49,0.84 [0.63-1.11],0.2129284472337063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD7,T-cell antigen CD7,22930,40,0.59 [0.28-1.27],0.180548612715249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD70,CD70 antigen,27084,49,0.85 [0.46-1.56],0.6006866390463359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD72,B-cell differentiation antigen CD72,23153,40,1.25 [0.63-2.49],0.5221648099888077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD74,HLA class II histocompatibility antigen gamma chain,27371,49,1.36 [0.68-2.73],0.3864644354043839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD79B,B-cell antigen receptor complex-associated protein beta chain,27414,49,1.34 [0.78-2.28],0.2849164434851959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD80,T-lymphocyte activation antigen CD80,23652,40,1.43 [0.61-3.33],0.4116143150329844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD82,CD82 antigen,23202,40,0.76 [0.33-1.78],0.5307392065160511
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD83,CD83 antigen,27084,49,0.80 [0.38-1.70],0.5616996938892589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD84,SLAM family member 5,27084,49,0.76 [0.34-1.69],0.4953374047513762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD86,T-lymphocyte activation antigen CD86,23528,40,1.87 [0.68-5.14],0.2254845354737077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD8A,T-cell surface glycoprotein CD8 alpha chain,27371,49,1.00 [0.60-1.65],0.9885319891245824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD93,Complement component C1q receptor,26094,47,1.49 [0.67-3.31],0.3277438090265375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD99,CD99 antigen,27137,49,0.47 [0.12-1.77],0.2653126204816772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD99L2,CD99 antigen-like protein 2,27137,49,0.85 [0.29-2.47],0.7598225928868781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDA,Cytidine deaminase,23603,40,1.73 [1.03-2.91],0.0380252341830118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDAN1,Codanin-1,23597,41,1.31 [0.44-3.87],0.6296655530285591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDC123,Cell division cycle protein 123 homolog,22790,39,1.07 [0.70-1.64],0.748029952958774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDC25A,M-phase inducer phosphatase 1,22790,39,1.33 [0.76-2.31],0.3133201777748341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDC26,Anaphase-promoting complex subunit CDC26,23487,40,0.82 [0.53-1.29],0.3908349675489825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDC27,Cell division cycle protein 27 homolog,26496,46,0.81 [0.51-1.29],0.3758902592320353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDC37,Hsp90 co-chaperone Cdc37,27225,47,0.95 [0.70-1.30],0.7609590585282819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDC42BPB,Serine/threonine-protein kinase MRCK beta,23528,40,0.91 [0.68-1.22],0.5261834609445553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDCP1,CUB domain-containing protein 1,26950,48,1.35 [0.83-2.17],0.2232461647113244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH1,Cadherin-1,26208,48,1.05 [0.55-2.03],0.8781007283774825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH15,Cadherin-15,27321,49,0.80 [0.45-1.43],0.4495119018102268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH17,Cadherin-17,27132,49,1.01 [0.70-1.46],0.9432345887109762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH2,Cadherin-2,27132,49,1.72 [0.86-3.46],0.1282848330211706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH22,Cadherin-22,23202,40,0.71 [0.23-2.19],0.5558186888458337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH23,Cadherin-23,23597,41,0.55 [0.16-1.85],0.3353738869857813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH3,Cadherin-3,27371,49,1.10 [0.54-2.21],0.7961097021141573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH4,Cadherin-4,22880,37,1.52 [0.97-2.39],0.0702377405557998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH5,Cadherin-5,27462,47,1.61 [0.73-3.57],0.2396107161839158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH6,Cadherin-6,27132,49,1.97 [1.04-3.74],0.037947268523118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDHR1,Cadherin-related family member 1,26470,44,1.21 [0.70-2.08],0.4976194996948712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDHR2,Cadherin-related family member 2,27009,48,1.08 [0.77-1.51],0.6535555461401967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDHR5,Cadherin-related family member 5,27132,49,0.91 [0.48-1.72],0.7808160941378135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDK1,Cyclin-dependent kinase 1,22790,39,0.76 [0.33-1.75],0.5150648438920544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,23614,39,0.75 [0.41-1.34],0.3289387536068437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDKL5,Cyclin-dependent kinase-like 5,22880,37,1.14 [0.68-1.91],0.61441620951258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDKN1A,Cyclin-dependent kinase inhibitor 1,27009,48,0.89 [0.70-1.13],0.3295386612955816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,27009,48,0.91 [0.70-1.19],0.4949842562773113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDNF,Cerebral dopamine neurotrophic factor,27009,48,0.69 [0.31-1.55],0.3660780768178391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,27187,49,0.79 [0.31-2.05],0.6327844766260526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDSN,Corneodesmosin,27323,49,0.85 [0.48-1.52],0.584557228281582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,27181,47,3.52 [1.14-10.90],0.029097967862223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,23528,40,0.94 [0.64-1.38],0.7516699869687924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,23202,40,0.93 [0.58-1.49],0.7640454193741777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,23528,40,0.60 [0.28-1.30],0.1947616281764342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,23202,40,1.68 [1.09-2.58],0.0190949370478756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,27084,49,1.10 [0.83-1.46],0.4897283031603587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,26496,46,1.19 [0.73-1.95],0.4822146329119899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,26141,45,0.84 [0.56-1.28],0.4188141341267243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,23649,41,1.31 [0.63-2.71],0.4636418201317825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,26637,46,1.06 [0.64-1.77],0.8164302919968145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEBPA,CCAAT/enhancer-binding protein alpha,22978,40,1.19 [0.58-2.42],0.6314516263121274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEBPB,CCAAT/enhancer-binding protein beta,26637,46,1.26 [0.67-2.40],0.4749125598943309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CELA2A,Chymotrypsin-like elastase family member 2A,23649,41,0.67 [0.42-1.06],0.0879226845589393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CELA3A,Chymotrypsin-like elastase family member 3A,27415,47,0.76 [0.49-1.19],0.2258856322290291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,23153,40,0.70 [0.25-1.97],0.4969009099178941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEMIP2,Cell surface hyaluronidase,22978,40,0.55 [0.18-1.69],0.2977208000358928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEND1,Cell cycle exit and neuronal differentiation protein 1,22880,37,0.93 [0.51-1.70],0.8128779275769378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CENPF,Centromere protein F,23202,40,1.03 [0.60-1.78],0.9038014129025864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CENPJ,Centromere protein J,23202,40,0.90 [0.56-1.43],0.6464379300935179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP112,Centrosomal protein of 112 kDa,22889,39,1.37 [0.79-2.37],0.2645406295864589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP152,Centrosomal protein of 152 kDa,22790,39,0.57 [0.25-1.33],0.1922062303317936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP164,Centrosomal protein of 164 kDa,26592,46,1.15 [0.82-1.59],0.4217210637266161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP170,Centrosomal protein of 170 kDa,23041,41,0.81 [0.54-1.23],0.3202230928782258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP20,Centrosomal protein 20,26496,46,0.96 [0.68-1.38],0.8400014673655758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP290,Centrosomal protein of 290 kDa,23202,40,1.43 [0.99-2.08],0.0594387898833096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP350,Centrosome-associated protein 350,22790,39,1.35 [0.66-2.77],0.4163588497134159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP43,Centrosomal protein 43,26424,45,0.92 [0.63-1.37],0.6925257022465479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP85,Centrosomal protein of 85 kDa,26496,46,0.96 [0.63-1.45],0.8398449636627225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CERT,Ceramide transfer protein,26470,44,0.82 [0.53-1.27],0.3781945553413774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CES1,Liver carboxylesterase 1,27191,47,1.27 [0.94-1.72],0.1121264900713061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CES2,Cocaine esterase,27009,48,0.94 [0.58-1.51],0.7859776544056444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CES3,Carboxylesterase 3,27009,48,1.08 [0.76-1.52],0.6705155050746612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CETN2,Centrin-2,26470,44,0.76 [0.50-1.17],0.214401527320425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CETN3,Centrin-3,23528,40,0.89 [0.60-1.32],0.5619118651956339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFB,Complement factor B,23242,40,1.05 [0.41-2.68],0.9243641877587516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFC1,Cryptic protein,26496,46,1.10 [0.62-1.96],0.7373469477948319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFD,Complement factor D,23695,41,1.59 [0.39-6.53],0.5181572755841999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFH,Complement factor H,22286,39,0.70 [0.18-2.72],0.6077291512751246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFHR2,Complement factor H-related protein 2,23513,41,0.77 [0.48-1.25],0.2935228572164297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFHR4,Complement factor H-related protein 4,23654,41,0.91 [0.61-1.34],0.627680275964172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFHR5,Complement factor H-related protein 5,23345,39,0.81 [0.41-1.59],0.5357318893666208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFI,Complement factor I,23695,41,1.92 [0.44-8.46],0.387095013395785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFP,Properdin,23695,41,0.69 [0.16-2.94],0.6149344916593191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CGA,Glycoprotein hormones alpha chain,27137,49,0.76 [0.54-1.05],0.0950628735835401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,23663,40,1.42 [0.87-2.30],0.159016640078153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CGN,Cingulin,22992,41,1.41 [0.83-2.41],0.2054736435944447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CGREF1,Cell growth regulator with EF hand domain protein 1,27132,49,0.95 [0.52-1.72],0.8600198448062163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,26496,46,1.25 [0.86-1.82],0.2479073760003884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHAD,Chondroadherin,23153,40,1.18 [0.67-2.06],0.5674148524681146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",23597,41,1.55 [0.78-3.04],0.2086233640334175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHCHD6,MICOS complex subunit MIC25,23514,40,1.39 [0.59-3.30],0.4528266972735265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHEK2,Serine/threonine-protein kinase Chk2,26637,46,1.23 [0.57-2.63],0.6029387891108433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHGA,Chromogranin-A,23649,41,1.23 [0.94-1.60],0.1308332670200672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHGB,Secretogranin-1,27272,49,0.85 [0.45-1.60],0.6204695177875648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHI3L1,Chitinase-3-like protein 1,26509,47,0.87 [0.61-1.24],0.4388265497137646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHIT1,Chitotriosidase-1,27236,47,1.21 [0.95-1.54],0.117545699598045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHL1,Neural cell adhesion molecule L1-like protein,27182,49,0.49 [0.21-1.17],0.1066197976557312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHM,Rab proteins geranylgeranyltransferase component A 1,22992,41,0.64 [0.37-1.08],0.093093626129384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHMP1A,Charged multivesicular body protein 1a,26950,48,0.84 [0.61-1.15],0.2738186071647059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHMP6,Charged multivesicular body protein 6,23652,40,0.69 [0.40-1.20],0.1841819241358163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHP1,Calcineurin B homologous protein 1,22880,37,0.86 [0.53-1.39],0.5341642875909043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHRDL1,Chordin-like protein 1,27224,49,1.49 [0.66-3.37],0.3337078329214265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHRDL2,Chordin-like protein 2,27132,49,0.82 [0.50-1.33],0.4231402024322171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHRM1,Muscarinic acetylcholine receptor M1,22992,41,0.77 [0.31-1.90],0.5714425980834961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CIAPIN1,Anamorsin,27225,47,0.91 [0.61-1.37],0.6588707608459843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CILP,Cartilage intermediate layer protein 1,23649,41,1.46 [0.82-2.60],0.1996347455246205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CINP,Cyclin-dependent kinase 2-interacting protein,23202,40,0.79 [0.36-1.72],0.5460746782962158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CIRBP,Cold-inducible RNA-binding protein,23528,40,0.90 [0.65-1.23],0.4899804424412901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CIT,Citron Rho-interacting kinase,22992,41,1.07 [0.57-2.01],0.8297826419957992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CKAP4,Cytoskeleton-associated protein 4,27281,48,1.69 [0.71-4.06],0.237062292967769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CKB,Creatine kinase B-type,23649,41,1.35 [0.83-2.21],0.229532799694281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",27047,49,1.73 [1.18-2.52],0.0045936030029649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLASP1,CLIP-associating protein 1,22790,39,0.87 [0.54-1.41],0.5709450168561286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLC,Galectin-10,27091,49,0.56 [0.36-0.87],0.0097105096297679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC10A,C-type lectin domain family 10 member A,26950,48,0.63 [0.32-1.25],0.1852310961406232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC11A,C-type lectin domain family 11 member A,27087,49,1.41 [0.83-2.39],0.2013915811265504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC12A,C-type lectin domain family 12 member A,22978,40,0.45 [0.10-1.93],0.2814305045932328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC14A,C-type lectin domain family 14 member A,27137,49,1.23 [0.56-2.69],0.605039361206464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC1A,C-type lectin domain family 1 member A,26637,46,1.14 [0.52-2.51],0.7382093597842299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC1B,C-type lectin domain family 1 member B,27371,49,0.89 [0.68-1.15],0.3738880935938067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC2L,C-type lectin domain family 2 member L,22992,41,0.94 [0.50-1.77],0.8440408228208425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC3B,Tetranectin,23117,40,0.62 [0.14-2.62],0.5108412012490391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC4A,C-type lectin domain family 4 member A,27084,49,0.44 [0.24-0.81],0.0082239397478681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC4C,C-type lectin domain family 4 member C,27084,49,1.01 [0.58-1.73],0.981716776844374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC4D,C-type lectin domain family 4 member D,27084,49,0.80 [0.53-1.19],0.2680796932664303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC4G,C-type lectin domain family 4 member G,27084,49,1.26 [0.59-2.70],0.5566442330610843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC4M,C-type lectin domain family 4 member M,23603,41,0.76 [0.41-1.41],0.3897885751622996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC5A,C-type lectin domain family 5 member A,27044,49,0.60 [0.25-1.46],0.261239461678687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC6A,C-type lectin domain family 6 member A,26496,46,1.51 [0.90-2.51],0.1159394095262201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC7A,C-type lectin domain family 7 member A,27414,49,0.98 [0.65-1.47],0.9033468445832328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLGN,Calmegin,22992,41,1.02 [0.52-1.98],0.9637212682481128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLIC5,Chloride intracellular channel protein 5,22992,41,0.94 [0.36-2.42],0.8959130009221463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLINT1,Clathrin interactor 1,22790,39,0.71 [0.33-1.57],0.4004293100003073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLIP2,CAP-Gly domain-containing linker protein 2,27084,49,0.94 [0.75-1.17],0.5667239220732293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLMP,CXADR-like membrane protein,27363,49,0.49 [0.14-1.68],0.259046082327826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLNS1A,Methylosome subunit pICln,22992,41,0.97 [0.39-2.40],0.9444362142978022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",26900,48,0.96 [0.73-1.25],0.7430730453231444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLPS,Colipase,27096,49,0.77 [0.54-1.10],0.1514014059143939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLSPN,Claspin,26420,44,1.12 [0.53-2.36],0.7684456854302848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLSTN1,Calsyntenin-1,26470,44,1.31 [0.89-1.94],0.1746684873818417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLSTN2,Calsyntenin-2,27414,49,1.29 [0.70-2.39],0.4093490935612044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLSTN3,Calsyntenin-3,23597,41,1.66 [0.69-3.98],0.253434516675823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLTA,Clathrin light chain A,26637,46,1.18 [0.72-1.93],0.501190959763125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLU,Clusterin,23695,41,0.87 [0.54-1.40],0.556169023087818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLUL1,Clusterin-like protein 1,27092,49,0.81 [0.46-1.41],0.4483691365466102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CMC1,COX assembly mitochondrial protein homolog,23652,40,0.81 [0.58-1.13],0.2155719746588984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CMIP,C-Maf-inducing protein,23514,40,0.85 [0.59-1.23],0.3930085544849757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNDP1,Beta-Ala-His dipeptidase,27224,49,0.68 [0.43-1.09],0.1092293585010337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNGB3,Cyclic nucleotide-gated cation channel beta-3,22880,37,1.18 [0.74-1.90],0.4810834335816608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",22996,41,0.93 [0.64-1.36],0.7162273977778475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNPY2,Protein canopy homolog 2,26637,46,1.05 [0.70-1.57],0.8240374403705134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNPY4,Protein canopy homolog 4,27009,48,0.89 [0.63-1.25],0.50644012029695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNST,Consortin,27132,49,0.86 [0.68-1.09],0.2155213952224046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTF,Ciliary neurotrophic factor,22880,37,1.65 [0.72-3.80],0.2369909843758443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTN1,Contactin-1,27462,47,0.56 [0.25-1.29],0.1733509210094238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTN2,Contactin-2,27363,49,0.94 [0.54-1.65],0.8371920964211207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTN3,Contactin-3,27137,49,0.53 [0.26-1.06],0.0715350302836219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTN4,Contactin-4,27137,49,1.06 [0.37-3.03],0.9113508403634693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTN5,Contactin-5,27199,49,0.65 [0.33-1.28],0.20776805966806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTNAP2,Contactin-associated protein-like 2,27084,49,1.03 [0.55-1.93],0.926150617439965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTNAP4,Contactin-associated protein-like 4,22992,41,0.90 [0.64-1.26],0.5441985509845372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COCH,Cochlin,23652,40,0.73 [0.38-1.41],0.3491420739395591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL15A1,Collagen alpha-1(XV) chain,23649,41,1.18 [0.39-3.58],0.7718221987721937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL18A1,Collagen alpha-1(XVIII) chain,27244,46,1.27 [0.42-3.83],0.6761519888759079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL1A1,Collagen alpha-1(I) chain,27462,47,1.89 [0.73-4.92],0.1917528882302629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL24A1,Collagen alpha-1(XXIV) chain,23528,40,1.25 [0.71-2.19],0.4383920715788391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL28A1,Collagen alpha-1(XXVIII) chain,22992,41,1.02 [0.67-1.53],0.9371799742623602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL2A1,Collagen alpha-1(II) chain,23041,41,0.93 [0.64-1.36],0.7112180202122449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL3A1,Collagen alpha-1(III) chain,23649,41,3.35 [1.34-8.36],0.0094913620824903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL4A1,Collagen alpha-1(IV) chain,27132,49,1.56 [0.84-2.90],0.1567813325046893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL4A4,Collagen alpha-4(IV) chain,23162,40,0.84 [0.50-1.42],0.5193607870323227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL5A1,Collagen alpha-1(V) chain,23153,40,1.97 [1.04-3.75],0.037963946694924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL6A3,Collagen alpha-3(VI) chain,27462,47,1.19 [0.57-2.45],0.6429401861344176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL9A1,Collagen alpha-1(IX) chain,27084,49,1.39 [0.87-2.23],0.1671537799279833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL9A2,Collagen alpha-2(IX) chain,23202,40,0.61 [0.26-1.41],0.2478181619397094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COLEC12,Collectin-12,27139,49,1.14 [0.43-3.03],0.79910061119727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COMMD1,COMM domain-containing protein 1,23041,41,0.79 [0.47-1.30],0.3506754882561219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COMMD9,COMM domain-containing protein 9,23514,40,0.58 [0.24-1.41],0.2299538265018829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COMP,Cartilage oligomeric matrix protein,26825,49,1.48 [0.70-3.16],0.3060765306380791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COMT,Catechol O-methyltransferase,26358,46,0.90 [0.66-1.23],0.5093990663780348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COPB2,Coatomer subunit beta',22889,39,0.88 [0.41-1.86],0.7293918825603253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COPE,Coatomer subunit epsilon,26470,44,0.85 [0.44-1.62],0.6178238079352529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",23041,41,1.55 [0.92-2.60],0.1008992267622267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CORO1A,Coronin-1A,26551,46,0.91 [0.68-1.23],0.5340849844173543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CORO6,Coronin-6,22880,37,1.11 [0.47-2.61],0.8195954286806225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",27009,48,1.08 [0.76-1.55],0.6533333835436865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COX6B1,Cytochrome c oxidase subunit 6B1,23652,40,0.62 [0.24-1.64],0.3363601792686109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPA1,Carboxypeptidase A1,27462,47,0.79 [0.51-1.23],0.2921902249730628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPA2,Carboxypeptidase A2,27273,48,0.80 [0.53-1.19],0.2709821840741616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPA4,Carboxypeptidase A4,22681,40,0.98 [0.49-1.97],0.9515671606391763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPB1,Carboxypeptidase B,27462,47,0.83 [0.53-1.30],0.4102454812693369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPB2,Carboxypeptidase B2,23645,41,0.80 [0.42-1.53],0.4968628753891133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPE,Carboxypeptidase E,27161,49,0.71 [0.39-1.29],0.2613802457201068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPLX2,Complexin-2,22790,39,0.55 [0.18-1.65],0.2831898494447313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPM,Carboxypeptidase M,27242,49,0.93 [0.45-1.93],0.8504152932365401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",22978,40,1.49 [0.57-3.90],0.4123188617030774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPPED1,Serine/threonine-protein phosphatase CPPED1,27371,49,0.86 [0.58-1.26],0.438089885318308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPQ,Carboxypeptidase Q,23603,41,0.80 [0.39-1.67],0.5569520194511126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPTP,Ceramide-1-phosphate transfer protein,22889,39,0.48 [0.18-1.30],0.1492127273645783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPVL,Probable serine carboxypeptidase CPVL,27326,49,1.58 [0.82-3.03],0.1676807641594195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPXM1,Probable carboxypeptidase X1,27225,47,0.92 [0.63-1.32],0.6397252361530166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPXM2,Inactive carboxypeptidase-like protein X2,23652,40,1.24 [0.40-3.85],0.7132030721097304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CR1,Complement receptor type 1,23571,40,1.57 [0.69-3.56],0.2789542185543853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CR2,Complement receptor type 2,27224,49,1.03 [0.60-1.76],0.9160204775065612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,26496,46,0.96 [0.70-1.30],0.7676934500220378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRADD,Death domain-containing protein CRADD,26900,48,0.84 [0.60-1.18],0.3125059084340799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CREB3,Cyclic AMP-responsive element-binding protein 3,22790,39,1.47 [1.00-2.14],0.0483887643672621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CREBZF,CREB/ATF bZIP transcription factor,22790,39,1.89 [0.74-4.83],0.1861834868941496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CREG1,Protein CREG1,26782,47,0.88 [0.43-1.81],0.7232364235854893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRELD1,Protein disulfide isomerase CRELD1,23153,40,0.95 [0.42-2.11],0.8912953640650906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRELD2,Protein disulfide isomerase CRELD2,27224,49,1.07 [0.66-1.73],0.7770057773885448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRH,Corticoliberin,26449,46,0.75 [0.55-1.03],0.0757533636705683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRHBP,Corticotropin-releasing factor-binding protein,27139,49,1.36 [0.56-3.32],0.5012528529258629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRHR1,Corticotropin-releasing factor receptor 1,26637,46,0.64 [0.38-1.07],0.0871685491078067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRIM1,Cysteine-rich motor neuron 1 protein,27269,49,3.92 [1.31-11.79],0.0148141271330205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRIP2,Cysteine-rich protein 2,26950,48,1.21 [0.63-2.35],0.5689476585303637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRISP2,Cysteine-rich secretory protein 2,27363,49,0.92 [0.62-1.36],0.6750359411212072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRISP3,Cysteine-rich secretory protein 3,23442,39,0.89 [0.29-2.72],0.8366328662066729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRKL,Crk-like protein,27184,49,0.90 [0.71-1.14],0.3758074871278769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRLF1,Cytokine receptor-like factor 1,27269,49,2.34 [0.88-6.24],0.0883313670071535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRNN,Cornulin,26342,48,0.74 [0.52-1.05],0.0954870220937028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRTAC1,Cartilage acidic protein 1,27462,47,0.63 [0.27-1.46],0.2800977957074482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRTAM,Cytotoxic and regulatory T-cell molecule,26950,48,1.57 [0.96-2.58],0.0723910386237263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRTAP,Cartilage-associated protein,22992,41,0.40 [0.16-0.96],0.0412017681923748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRX,Cone-rod homeobox protein,26637,46,0.97 [0.75-1.25],0.811725676802618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRYBB1,Beta-crystallin B1,23652,40,0.70 [0.43-1.14],0.1518835418448701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRYBB2,Beta-crystallin B2,23597,41,1.05 [0.75-1.48],0.7627377703312422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRYGD,Gamma-crystallin D,23597,41,0.77 [0.57-1.05],0.1017911723522932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRYM,Ketimine reductase mu-crystallin,22880,37,0.58 [0.34-1.00],0.048701451314905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRYZL1,Quinone oxidoreductase-like protein 1,23041,41,0.86 [0.62-1.19],0.3552865645514025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSDE1,Cold shock domain-containing protein E1,22889,39,0.91 [0.68-1.22],0.5216992513654561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF1,Macrophage colony-stimulating factor 1,27269,49,1.31 [0.53-3.23],0.5639671471603362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF1R,Macrophage colony-stimulating factor 1 receptor,23663,40,2.43 [1.23-4.80],0.0107521127712467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF2,Granulocyte-macrophage colony-stimulating factor,22889,39,1.06 [0.44-2.57],0.8989076471426779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,26950,48,1.20 [0.82-1.77],0.348234664001668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF2RB,Cytokine receptor common subunit beta,22978,40,0.66 [0.33-1.30],0.2318591452469497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF3,Granulocyte colony-stimulating factor,26592,46,1.27 [0.75-2.13],0.3718199416766266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF3R,Granulocyte colony-stimulating factor receptor,22978,40,0.96 [0.36-2.60],0.9384648864180664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSH1,Chorionic somatomammotropin hormone 1,23663,40,0.56 [0.20-1.62],0.2862426025246581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSNK1D,Casein kinase I isoform delta,22978,40,0.93 [0.56-1.55],0.7841253073853648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSNK2A1,Casein kinase II subunit alpha,23614,39,0.66 [0.33-1.32],0.2398536057551107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSPG4,Chondroitin sulfate proteoglycan 4,23649,41,4.22 [1.77-10.03],0.0011331038298737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSPG5,Chondroitin sulfate proteoglycan 5,22880,37,0.92 [0.47-1.79],0.7957931288876043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSRP3,Cysteine and glycine-rich protein 3,22889,39,1.17 [0.89-1.55],0.2607295366696847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CST1,Cystatin-SN,20509,34,0.98 [0.70-1.37],0.9089264598889089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CST3,Cystatin-C,27183,49,1.20 [0.50-2.89],0.6874761649768013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CST5,Cystatin-D,26680,47,0.91 [0.57-1.45],0.6808331539806576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CST6,Cystatin-M,26412,46,0.61 [0.35-1.04],0.0689509495587058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CST7,Cystatin-F,27180,49,0.87 [0.64-1.18],0.3768357698347291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSTB,Cystatin-B,26749,45,1.36 [0.74-2.51],0.3201609790364852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTAG1A_CTAG1B,Cancer/testis antigen 1,23155,40,0.87 [0.46-1.65],0.6782088937677275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTBS,Di-N-acetylchitobiase,23309,39,0.60 [0.22-1.61],0.3113724675682182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTF1,Cardiotrophin-1,26637,46,0.96 [0.70-1.32],0.8075921644287489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTHRC1,Collagen triple helix repeat-containing protein 1,23649,41,1.77 [0.69-4.54],0.23511153693172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTLA4,Cytotoxic T-lymphocyte protein 4,23649,41,1.32 [0.55-3.17],0.5384014586817429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTNNA1,Catenin alpha-1,22880,37,1.10 [0.53-2.28],0.8035782894596238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTRB1,Chymotrypsinogen B,27137,49,0.78 [0.49-1.25],0.3001022960468242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTRC,Chymotrypsin-C,27141,49,0.91 [0.62-1.35],0.638633100066899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTRL,Chymotrypsin-like protease CTRL-1,23597,41,1.02 [0.66-1.59],0.912691671740806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSB,Cathepsin B,27158,46,1.12 [0.70-1.80],0.6304265421786048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSC,Dipeptidyl peptidase 1,27099,49,1.25 [0.71-2.21],0.4408478663209403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSD,Cathepsin D,25322,44,1.31 [0.71-2.41],0.3846422001724432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSE,Cathepsin E,23153,40,1.08 [0.60-1.93],0.7984647967132821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSF,Cathepsin F,27225,47,0.56 [0.29-1.07],0.079426082546845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSH,Pro-cathepsin H,26560,45,0.94 [0.66-1.35],0.7384644901563965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSL,Cathepsin L1,27132,49,1.56 [0.57-4.28],0.3853231286555049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSO,Cathepsin O,27414,49,2.29 [1.07-4.91],0.0326918727027608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSS,Cathepsin S,21295,40,0.57 [0.16-2.10],0.4008918466267324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSV,Cathepsin L2,27284,49,0.58 [0.31-1.07],0.0788456943501817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSZ,Cathepsin Z,27133,49,1.53 [0.69-3.35],0.2933842989038678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CUZD1,CUB and zona pellucida-like domain-containing protein 1,22992,41,1.07 [0.51-2.25],0.8548612452241465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CWC15,Spliceosome-associated protein CWC15 homolog,23395,40,0.82 [0.44-1.50],0.5143331491845955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CX3CL1,Fractalkine,26950,48,1.26 [0.60-2.63],0.5443939754403395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXADR,Coxsackievirus and adenovirus receptor,27084,49,1.48 [0.98-2.22],0.0608984588169023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL1,Growth-regulated alpha protein,27091,49,1.00 [0.77-1.29],0.9970310272236848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL10,C-X-C motif chemokine 10,27269,49,1.22 [0.87-1.71],0.2396423571607671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL11,C-X-C motif chemokine 11,27371,49,1.16 [0.87-1.54],0.3127429976498758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL12,Stromal cell-derived factor 1,26592,46,0.99 [0.52-1.88],0.9663018374911468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL13,C-X-C motif chemokine 13,27371,49,1.30 [0.97-1.73],0.0767418463945451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL14,C-X-C motif chemokine 14,26592,46,0.92 [0.58-1.48],0.7433073022618855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL16,C-X-C motif chemokine 16,27415,47,0.41 [0.14-1.21],0.106644016177539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL17,C-X-C motif chemokine 17,27414,49,1.79 [1.05-3.04],0.0323385289153829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL3,C-X-C motif chemokine 3,27135,49,0.89 [0.68-1.15],0.3677307052102262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL5,C-X-C motif chemokine 5,27044,49,0.96 [0.78-1.19],0.7396671365579649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL6,C-X-C motif chemokine 6,27414,49,1.06 [0.77-1.46],0.7225548515585247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL8,Interleukin-8,26906,48,1.10 [0.79-1.54],0.5745205975519924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL9,C-X-C motif chemokine 9,27269,49,1.14 [0.80-1.62],0.4635849110644287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CYB5A,Cytochrome b5,22790,39,1.29 [0.94-1.77],0.1129863287012077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CYB5R2,NADH-cytochrome b5 reductase 2,23248,40,0.80 [0.46-1.39],0.4235319281818328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",22889,39,1.11 [0.81-1.52],0.525279825369162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CYTH3,Cytohesin-3,22790,39,0.89 [0.56-1.43],0.6287466551143295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CYTL1,Cytokine-like protein 1,23649,41,0.47 [0.14-1.63],0.2372396852056631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DAAM1,Disheveled-associated activator of morphogenesis 1,23153,40,0.76 [0.53-1.10],0.1501766343292327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DAB2,Disabled homolog 2,27363,49,0.96 [0.77-1.20],0.7241963982407256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DAG1,Dystroglycan,27269,49,0.73 [0.42-1.27],0.2702316912045907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DAND5,DAN domain family member 5,22978,40,0.71 [0.41-1.23],0.2234980473509821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DAPK2,Death-associated protein kinase 2,22978,40,0.56 [0.29-1.08],0.0831471426187632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,27084,49,0.91 [0.75-1.11],0.3497684104377961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DARS1,"Aspartate--tRNA ligase, cytoplasmic",26900,48,0.92 [0.65-1.29],0.6182704035905149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DBH,Dopamine beta-hydroxylase,23614,40,1.14 [0.83-1.57],0.4111645980237931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DBI,Acyl-CoA-binding protein,27008,49,0.82 [0.59-1.15],0.2510258369639077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DBN1,Drebrin,22978,40,0.71 [0.37-1.34],0.2873850460220842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DBNL,Drebrin-like protein,27269,49,0.90 [0.69-1.18],0.45298043743975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",27225,47,1.51 [0.72-3.15],0.2743534790381692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCC,Netrin receptor DCC,22992,41,0.69 [0.34-1.39],0.297544600983281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCDC2C,Doublecortin domain-containing protein 2C,22790,39,1.27 [0.89-1.82],0.1844088455729896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCLRE1C,Protein artemis,22790,39,0.58 [0.20-1.69],0.3231829191660425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCN,Decorin,26637,46,1.22 [0.40-3.69],0.7260348900758204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCTD,Deoxycytidylate deaminase,23153,40,0.85 [0.62-1.16],0.3014935617216561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCTN1,Dynactin subunit 1,27363,49,1.06 [0.73-1.55],0.7546560791310087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCTN2,Dynactin subunit 2,27009,48,0.89 [0.68-1.17],0.4124735530916893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCTN6,Dynactin subunit 6,26470,44,0.91 [0.61-1.35],0.6310369355532357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCTPP1,dCTP pyrophosphatase 1,27132,49,1.45 [0.65-3.22],0.3608977464908106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCUN1D1,DCN1-like protein 1,22880,37,1.01 [0.66-1.53],0.9707042744076247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCUN1D2,DCN1-like protein 2,22790,39,1.02 [0.70-1.48],0.919527022547104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCXR,L-xylulose reductase,27225,47,1.18 [0.73-1.92],0.4902357513887619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDA1,DET1- and DDB1-associated protein 1,22889,39,0.56 [0.22-1.46],0.2374435138532886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",27009,48,0.93 [0.52-1.65],0.8005471903720984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDC,Aromatic-L-amino-acid decarboxylase,27087,49,1.17 [0.70-1.94],0.5552734184154898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDHD2,Phospholipase DDHD2,23614,39,0.74 [0.46-1.18],0.2071177984784795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDI2,Protein DDI1 homolog 2,23153,40,1.20 [0.84-1.72],0.3181121641406157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDR1,Epithelial discoidin domain-containing receptor 1,27371,49,1.13 [0.37-3.49],0.8263889486204122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDT,D-dopachrome decarboxylase,23649,41,1.19 [0.61-2.32],0.6158319923968206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDX1,ATP-dependent RNA helicase DDX1,23528,40,0.82 [0.42-1.60],0.5570190156931731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDX25,ATP-dependent RNA helicase DDX25,22992,41,0.85 [0.37-1.96],0.705200560110389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDX39A,ATP-dependent RNA helicase DDX39A,22978,40,0.70 [0.35-1.41],0.322543081095582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDX4,Probable ATP-dependent RNA helicase DDX4,22978,40,1.00 [0.56-1.76],0.9932665433622836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDX53,Probable ATP-dependent RNA helicase DDX53,22992,41,0.44 [0.18-1.05],0.0629427031656131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDX58,Antiviral innate immune response receptor RIG-I,26496,46,1.20 [0.82-1.78],0.3502537515519752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",27084,49,0.84 [0.65-1.10],0.2046985390864835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DEFA1_DEFA1B,Neutrophil defensin 1,26569,49,1.30 [0.87-1.95],0.1971371012211396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DEFB103A_DEFB103B,Beta-defensin 103,22801,39,0.93 [0.42-2.04],0.8477431521966804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DEFB104A_DEFB104B,Beta-defensin 104,22880,37,0.96 [0.53-1.73],0.8855499962102974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DEFB116,Beta-defensin 116,22880,37,1.14 [0.80-1.61],0.4742676717509344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DEFB118,Beta-defensin 118,22880,37,1.06 [0.63-1.76],0.8309014586521364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DEFB4A_DEFB4B,Beta-defensin 4A,26756,48,1.16 [0.98-1.37],0.0807020506190454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DENND2B,DENN domain-containing protein 2B,22889,39,0.63 [0.27-1.47],0.2878071272417392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DENR,Density-regulated protein,22978,40,0.69 [0.38-1.25],0.2240961103998793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DFFA,DNA fragmentation factor subunit alpha,27414,49,0.92 [0.63-1.34],0.6660193953407092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DGCR6,Protein DGCR6,22880,37,1.40 [0.88-2.23],0.1521918699476332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DGKA,Diacylglycerol kinase alpha,22978,40,0.67 [0.37-1.22],0.1900148010599873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DGKZ,Diacylglycerol kinase zeta,26592,46,1.58 [0.78-3.19],0.2016237482779256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DHODH,Dihydroorotate dehydrogenase,22889,39,1.06 [0.58-1.93],0.8457033290074067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DHPS,Deoxyhypusine synthase,23514,40,1.10 [0.55-2.19],0.7903637973917452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,23597,41,0.84 [0.43-1.66],0.6221839186018279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DIABLO,"Diablo homolog, mitochondrial",27044,49,0.85 [0.68-1.07],0.1612514738308816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DIPK1C,Divergent protein kinase domain 1C,22992,41,0.77 [0.35-1.69],0.5153436278926691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DIPK2B,Divergent protein kinase domain 2B,23153,40,1.35 [0.45-4.05],0.5980298338404186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DKK1,Dickkopf-related protein 1,27371,49,0.84 [0.55-1.28],0.4090576657703877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DKK3,Dickkopf-related protein 3,27462,47,1.37 [0.59-3.19],0.4709783525752395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DKK4,Dickkopf-related protein 4,26909,48,1.45 [0.89-2.38],0.1399483600066446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DKKL1,Dickkopf-like protein 1,27009,48,1.05 [0.79-1.41],0.7197079014357579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DLG4,Disks large homolog 4,23597,41,0.83 [0.53-1.29],0.4007767482718181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DLGAP5,Disks large-associated protein 5,23614,39,0.82 [0.40-1.65],0.5721272192401938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DLK1,Protein delta homolog 1,27462,47,0.67 [0.42-1.09],0.1106880010493934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DLL1,Delta-like protein 1,27225,47,1.65 [0.71-3.82],0.2428170741280191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DLL4,Delta-like protein 4,23041,41,1.16 [0.94-1.42],0.1594201913941806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DMD,Dystrophin,23041,41,0.88 [0.47-1.63],0.6740205282410713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DMP1,Dentin matrix acidic phosphoprotein 1,23041,41,1.68 [0.99-2.86],0.05470334846409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJA1,DnaJ homolog subfamily A member 1,22790,39,1.14 [0.63-2.06],0.6673438346819738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJA2,DnaJ homolog subfamily A member 2,27326,49,0.89 [0.65-1.20],0.4333272365605868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJA4,DnaJ homolog subfamily A member 4,23597,41,1.29 [0.88-1.90],0.1955065536217585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJB1,DnaJ homolog subfamily B member 1,27009,48,1.01 [0.76-1.35],0.9421342937828664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJB14,DnaJ homolog subfamily B member 14,23528,40,1.16 [0.73-1.83],0.5283301156224731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJB2,DnaJ homolog subfamily B member 2,23153,40,0.98 [0.56-1.69],0.931540157025837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJB6,DnaJ homolog subfamily B member 6,22931,40,0.85 [0.59-1.22],0.377829067793003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJB8,DnaJ homolog subfamily B member 8,26637,46,1.34 [0.96-1.87],0.0853535239611712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJC21,DnaJ homolog subfamily C member 21,23597,41,0.83 [0.37-1.86],0.6526244594004347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJC6,Putative tyrosine-protein phosphatase auxilin,23041,41,1.01 [0.71-1.44],0.9635654615651276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJC9,DnaJ homolog subfamily C member 9,23528,40,0.98 [0.67-1.46],0.9390068437927912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNER,Delta and Notch-like epidermal growth factor-related receptor,27093,49,0.34 [0.12-0.93],0.0359003056947113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNLZ,DNL-type zinc finger protein,22880,37,1.05 [0.77-1.44],0.7479782688071432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNM1,Dynamin-1,23528,40,0.91 [0.70-1.18],0.4627366877517923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNM3,Dynamin-3,23614,39,0.81 [0.45-1.46],0.483609004380492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNMBP,Dynamin-binding protein,26950,48,0.85 [0.56-1.31],0.4688110276089213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNPEP,Aspartyl aminopeptidase,23597,41,1.33 [0.79-2.25],0.2805830989299496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,27229,49,1.13 [0.71-1.81],0.6143374187074568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DOC2B,Double C2-like domain-containing protein beta,22992,41,0.44 [0.15-1.34],0.148109964823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DOCK9,Dedicator of cytokinesis protein 9,22880,37,0.90 [0.67-1.22],0.5123802846983596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DOK1,Docking protein 1,23597,41,0.93 [0.75-1.15],0.4787019734939161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DOK2,Docking protein 2,27132,49,0.85 [0.69-1.05],0.1321832770511132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPEP1,Dipeptidase 1,26900,48,0.78 [0.48-1.25],0.3010174238229799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPEP2,Dipeptidase 2,27009,48,0.71 [0.29-1.76],0.4632101385207393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPP10,Inactive dipeptidyl peptidase 10,27084,49,1.13 [0.56-2.28],0.7431463916752514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPP4,Dipeptidyl peptidase 4,26615,48,1.00 [0.41-2.41],0.9994723524267912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPP6,Dipeptidyl aminopeptidase-like protein 6,27009,48,0.92 [0.43-2.00],0.8372564068424309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPP7,Dipeptidyl peptidase 2,26902,49,0.87 [0.56-1.33],0.5133844070674891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPT,Dermatopontin,27462,47,0.86 [0.32-2.32],0.7716158191599474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPY30,Protein dpy-30 homolog,27268,49,1.03 [0.68-1.58],0.8790068699488702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DRAXIN,Draxin,26950,48,1.06 [0.59-1.91],0.8403124996331173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DRG2,Developmentally-regulated GTP-binding protein 2,27009,48,0.68 [0.43-1.10],0.1181171745033649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DSC2,Desmocollin-2,26858,49,1.27 [0.62-2.61],0.5177180425316151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DSCAM,Down syndrome cell adhesion molecule,23614,39,1.56 [0.67-3.64],0.3051157976349035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DSG2,Desmoglein-2,27137,49,0.69 [0.27-1.75],0.4309159275484269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DSG3,Desmoglein-3,27274,49,0.72 [0.34-1.52],0.3911719665171754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DSG4,Desmoglein-4,26924,48,0.94 [0.58-1.53],0.8130116570208543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DTD1,D-aminoacyl-tRNA deacylase 1,23153,40,0.85 [0.60-1.21],0.3671021950480723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DTNB,Dystrobrevin beta,23473,40,1.15 [0.56-2.36],0.7058785911557424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DTX2,Probable E3 ubiquitin-protein ligase DTX2,22992,41,1.08 [0.69-1.68],0.7452852163672308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DTX3,Probable E3 ubiquitin-protein ligase DTX3,27009,48,0.68 [0.23-2.07],0.5018828616551732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DTYMK,Thymidylate kinase,23652,40,0.94 [0.61-1.44],0.7687753413021591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DUOX2,Dual oxidase 2,26637,46,1.25 [0.94-1.65],0.1280748577480072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DUSP13,Dual specificity protein phosphatase 13 isoform A,23514,40,1.46 [0.80-2.68],0.2184747466837677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DUSP29,Dual specificity phosphatase 29,22992,41,0.96 [0.60-1.54],0.8781769855446899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DUSP3,Dual specificity protein phosphatase 3,26470,44,0.81 [0.56-1.17],0.2665055380063437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",23528,40,1.04 [0.78-1.39],0.7848287963590076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DXO,Decapping and exoribonuclease protein,23597,41,1.03 [0.54-1.99],0.9218881007544998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,23514,40,0.53 [0.23-1.26],0.1539357379985785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DYNLT1,Dynein light chain Tctex-type 1,22992,41,0.87 [0.59-1.29],0.4910683506856718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DYNLT3,Dynein light chain Tctex-type 3,23514,40,1.01 [0.51-1.98],0.988213295400478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,26950,48,0.89 [0.68-1.17],0.4100516167630241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EBI3_IL27,Interleukin-27,27315,49,1.70 [0.80-3.64],0.1693041037244143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ECE1,Endothelin-converting enzyme 1,26470,44,1.18 [0.56-2.49],0.6559490690975818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",23652,40,1.46 [1.04-2.03],0.0270235926722154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ECHS1,"Enoyl-CoA hydratase, mitochondrial",23041,41,1.08 [0.80-1.46],0.5997325898891287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ECI2,Enoyl-CoA delta isomerase 2,22889,39,1.16 [0.73-1.83],0.5298843194131686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ECM1,Extracellular matrix protein 1,23016,39,0.90 [0.39-2.07],0.8007535618949125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ECSCR,Endothelial cell-specific chemotaxis regulator,22880,37,0.62 [0.26-1.46],0.2714437020757979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDA2R,Tumor necrosis factor receptor superfamily member 27,27363,49,1.34 [0.68-2.66],0.3951248427888718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDAR,Tumor necrosis factor receptor superfamily member EDAR,27084,49,0.72 [0.55-0.96],0.0256170937706379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDDM3B,Epididymal secretory protein E3-beta,23514,40,1.22 [0.61-2.42],0.5761287785551158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,22889,39,0.86 [0.35-2.13],0.739067647339714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDF1,Endothelial differentiation-related factor 1,23614,39,0.84 [0.51-1.38],0.488429376937444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,26637,46,1.93 [1.06-3.54],0.0324425253002257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDN1,Endothelin-1,23041,41,2.35 [0.87-6.34],0.0918254892773133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDNRB,Endothelin receptor type B,22978,40,1.14 [0.63-2.05],0.6696015055331478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EEF1D,Elongation factor 1-delta,23652,40,0.87 [0.62-1.21],0.3966009918188646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFCAB14,EF-hand calcium-binding domain-containing protein 14,23528,40,1.05 [0.35-3.15],0.9360944762925968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFCAB2,Dynein regulatory complex protein 8,23202,40,0.68 [0.27-1.72],0.4209613857479981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,27177,49,1.63 [0.73-3.61],0.2314114221956176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFHD1,EF-hand domain-containing protein D1,23614,39,0.81 [0.32-2.06],0.6644616205396331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFNA1,Ephrin-A1,27097,49,1.34 [0.55-3.28],0.5254737037051569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFNA4,Ephrin-A4,26908,48,0.67 [0.27-1.67],0.3932706637085498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFNB2,Ephrin-B2,22992,41,1.02 [0.61-1.71],0.934174793289047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EGF,Pro-epidermal growth factor,27094,49,0.81 [0.64-1.02],0.0765357043892959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EGFL7,Epidermal growth factor-like protein 7,26496,46,1.27 [0.70-2.31],0.4351504716096597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EGFLAM,Pikachurin,23528,40,1.71 [0.81-3.62],0.158135561582148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EGFR,Epidermal growth factor receptor,27462,47,0.50 [0.23-1.09],0.079760699652289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EGLN1,Egl nine homolog 1,27084,49,0.95 [0.59-1.53],0.8357216503327575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EHBP1,EH domain-binding protein 1,23652,40,0.83 [0.55-1.25],0.3760595714684246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EHD3,EH domain-containing protein 3,23041,41,0.84 [0.66-1.08],0.1803047887140872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",23597,41,0.87 [0.47-1.60],0.6439229933905024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",23444,39,0.97 [0.73-1.28],0.823199102724679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,22889,39,1.00 [0.63-1.59],0.9980732030889704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,23041,41,0.74 [0.33-1.66],0.4722347865166296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF4B,Eukaryotic translation initiation factor 4B,26950,48,0.90 [0.58-1.38],0.6183818498524447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF4E,Eukaryotic translation initiation factor 4E,22978,40,0.92 [0.66-1.28],0.6036433057931413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,27132,49,1.08 [0.74-1.57],0.6927143667206189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,27414,49,0.90 [0.71-1.16],0.4222661593417323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,23614,39,0.75 [0.46-1.22],0.2457066305009208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF5,Eukaryotic translation initiation factor 5,22889,39,0.66 [0.30-1.48],0.3140244882054304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF5A,Eukaryotic translation initiation factor 5A-1,26592,46,1.25 [0.55-2.85],0.5923347320595538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ELAC1,Zinc phosphodiesterase ELAC protein 1,23614,39,0.83 [0.58-1.18],0.3006313652580057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ELAVL4,ELAV-like protein 4,22880,37,1.25 [0.91-1.71],0.1748326024714515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ELN,Elastin,23652,40,2.64 [1.23-5.69],0.013070929044397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ELOA,Elongin-A,27009,48,1.04 [0.65-1.64],0.8826397524245847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ELOB,Elongin-B,22889,39,0.65 [0.26-1.64],0.3624934895611943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENAH,Protein enabled homolog,26592,46,1.08 [0.62-1.88],0.7779175310405112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENDOU,Poly(U)-specific endoribonuclease,21839,38,0.62 [0.32-1.21],0.1651834133636466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENG,Endoglin,27462,47,1.48 [0.33-6.57],0.6040651039234723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENO1,Alpha-enolase,27089,48,0.91 [0.66-1.25],0.5551128300534375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENO2,Gamma-enolase,27371,49,0.72 [0.48-1.06],0.0990187187792751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENO3,Beta-enolase,23041,41,1.32 [0.81-2.15],0.2712227647704903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENOPH1,Enolase-phosphatase E1,23514,40,1.18 [0.74-1.87],0.4940424916183823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,22889,39,0.82 [0.25-2.66],0.7422900323315724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENPEP,Glutamyl aminopeptidase,22889,39,1.00 [0.53-1.92],0.9899373835428232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,27462,47,1.60 [0.69-3.69],0.2701889060643739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,27269,49,0.77 [0.45-1.32],0.3388787778829445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,23041,41,0.53 [0.24-1.17],0.1139557054256737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,26286,48,1.13 [0.84-1.52],0.4169123438393995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENSA,Alpha-endosulfine,23514,40,0.76 [0.40-1.42],0.3859208520416749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,26496,46,1.38 [0.79-2.41],0.2509310795113021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,26637,46,0.90 [0.26-3.17],0.8733579532716925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,26637,46,1.72 [0.60-4.91],0.3097579016355494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENTR1,Endosome-associated-trafficking regulator 1,23041,41,1.20 [0.73-1.96],0.4787669364920492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EP300,Histone acetyltransferase p300,22978,40,0.62 [0.22-1.73],0.3598815609986956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPB41L5,Band 4.1-like protein 5,22992,41,0.70 [0.39-1.26],0.2293435523084603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPCAM,Epithelial cell adhesion molecule,27144,49,1.11 [0.86-1.41],0.4236732107734626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPGN,Epigen,23514,40,1.60 [1.12-2.31],0.0108014079353934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPHA1,Ephrin type-A receptor 1,27229,49,1.00 [0.48-2.09],0.9989109315102216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPHA10,Ephrin type-A receptor 10,26470,44,1.32 [0.98-1.76],0.065228398477525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPHA2,Ephrin type-A receptor 2,26171,48,1.17 [0.52-2.60],0.70675151267404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPHA4,Ephrin type-A receptor 4,23153,40,0.82 [0.28-2.37],0.7135891566504609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPHB4,Ephrin type-B receptor 4,27462,47,1.88 [0.73-4.88],0.1936769587392092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPHB6,Ephrin type-B receptor 6,26900,48,0.67 [0.29-1.51],0.3323844897851391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPHX2,Bifunctional epoxide hydrolase 2,26637,46,0.90 [0.57-1.41],0.6426878131908049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPN1,Epsin-1,23202,40,0.85 [0.39-1.85],0.6793122047082066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPO,Erythropoietin,27084,49,1.43 [1.12-1.82],0.0035289252713322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPPK1,Epiplakin,23041,41,0.74 [0.48-1.13],0.1621880510832877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,27316,49,1.16 [0.51-2.64],0.7151360464566172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERBB2,Receptor tyrosine-protein kinase erbB-2,27225,47,0.92 [0.31-2.76],0.8864623746212139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERBB3,Receptor tyrosine-protein kinase erbB-3,27058,49,0.37 [0.10-1.35],0.1323634603015033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERBB4,Receptor tyrosine-protein kinase erbB-4,27225,47,0.45 [0.16-1.27],0.1331920227057752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERBIN,Erbin,27009,48,0.90 [0.70-1.14],0.3807128571330284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERC2,ERC protein 2,22992,41,0.58 [0.32-1.05],0.072668221929351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERCC1,DNA excision repair protein ERCC-1,22790,39,0.52 [0.18-1.53],0.2332810311154143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EREG,Proepiregulin,26900,48,0.80 [0.57-1.12],0.1925368110983564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERI1,3'-5' exoribonuclease 1,23202,40,0.52 [0.19-1.40],0.1962931054805361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERMAP,Erythroid membrane-associated protein,22978,40,1.50 [0.77-2.90],0.2286814213411461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,23514,40,1.01 [0.46-2.22],0.9850651253437558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERP29,Endoplasmic reticulum resident protein 29,23153,40,0.88 [0.68-1.14],0.330124272419001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERP44,Endoplasmic reticulum resident protein 44,26962,48,1.58 [0.59-4.19],0.3590537779948616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,22889,39,0.65 [0.29-1.47],0.3029100219812774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ESAM,Endothelial cell-selective adhesion molecule,27462,47,0.97 [0.43-2.20],0.9464181913500572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ESM1,Endothelial cell-specific molecule 1,27139,49,2.11 [1.03-4.30],0.0401210269627164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ESPL1,Separin,22790,39,1.00 [0.59-1.69],0.997098005398628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ESR1,Estrogen receptor,22978,40,1.01 [0.59-1.73],0.9797379283035746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ESYT2,Extended synaptotagmin-2,23597,41,0.87 [0.60-1.26],0.4466696872046314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EVI2B,Protein EVI2B,22790,39,1.26 [0.68-2.34],0.4665523370246051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EVI5,Ecotropic viral integration site 5 protein homolog,22978,40,0.91 [0.65-1.27],0.5795505922664888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EVPL,Envoplakin,23202,40,0.53 [0.18-1.56],0.2480187678605828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EXOSC10,Exosome component 10,22889,39,0.89 [0.51-1.57],0.6974032332627947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EXTL1,Exostosin-like 1,22889,39,1.00 [0.52-1.90],0.9904683101846848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EZR,Ezrin,27371,49,1.16 [0.41-3.29],0.7804267768027247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F10,Coagulation factor X,23663,40,0.33 [0.15-0.75],0.0084356384683667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F11,Coagulation factor XI,23345,39,0.63 [0.20-1.97],0.4253163970217688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F11R,Junctional adhesion molecule A,27137,49,0.90 [0.57-1.42],0.6611441073328392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F12,Coagulation factor XII,23695,41,0.59 [0.31-1.11],0.1042525689293683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F13B,Coagulation factor XIII B chain,23555,41,0.40 [0.13-1.23],0.1092882841152183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F2,Prothrombin,23695,41,0.78 [0.11-5.77],0.8117427324634751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F2R,Proteinase-activated receptor 1,27224,49,0.83 [0.53-1.29],0.4071722601821992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F3,Tissue factor,27202,49,1.15 [0.48-2.76],0.7611749749252492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F7,Coagulation factor VII,27182,49,0.36 [0.17-0.77],0.0088634472881775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F9,Coagulation factor IX,27177,49,0.80 [0.20-3.26],0.7593391528272238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FABP1,"Fatty acid-binding protein, liver",27139,49,1.16 [0.89-1.50],0.2696857178357944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FABP2,"Fatty acid-binding protein, intestinal",27132,49,1.18 [0.86-1.61],0.302196248441631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FABP3,"Fatty acid-binding protein, heart",23652,40,1.11 [0.60-2.05],0.743660579555153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FABP4,"Fatty acid-binding protein, adipocyte",27462,47,0.86 [0.51-1.47],0.583701914277071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FABP5,Fatty acid-binding protein 5,27285,49,0.73 [0.50-1.07],0.1104392989948635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FABP6,Gastrotropin,26593,45,1.15 [0.75-1.76],0.5201489391421505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FABP9,Fatty acid-binding protein 9,27084,49,0.77 [0.49-1.22],0.2682756678411044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FADD,FAS-associated death domain protein,27132,49,0.86 [0.61-1.20],0.3625800874472489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM13A,Protein FAM13A,23528,40,1.08 [0.69-1.68],0.7387405175651105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM171A2,Protein FAM171A2,23614,39,0.96 [0.78-1.17],0.6681328702749809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM171B,Protein FAM171B,23514,40,1.06 [0.35-3.17],0.9214314083707004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM172A,Cotranscriptional regulator FAM172A,23041,41,0.74 [0.45-1.22],0.2326896020464623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM20A,Pseudokinase FAM20A,23652,40,1.24 [0.44-3.49],0.6811996061309721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM3B,Protein FAM3B,27009,48,0.97 [0.48-1.96],0.9305610414716812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM3C,Protein FAM3C,27087,49,0.77 [0.33-1.84],0.5595914205169072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM3D,Protein FAM3D,23528,40,1.11 [0.77-1.60],0.5685165650369881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAP,Prolyl endopeptidase FAP,27462,47,1.27 [0.49-3.29],0.6234265301445163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FARSA,Phenylalanine--tRNA ligase alpha subunit,22992,41,0.77 [0.47-1.25],0.2908620330523944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAS,Tumor necrosis factor receptor superfamily member 6,27373,47,1.21 [0.59-2.45],0.6043703064298962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FASLG,Tumor necrosis factor ligand superfamily member 6,27414,49,0.90 [0.46-1.76],0.7540694061650414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FBLN2,Fibulin-2,23649,41,2.40 [1.03-5.62],0.0431438434685471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FBN2,Fibrillin-2,22992,41,0.91 [0.55-1.51],0.7172410819019328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FBP1,"Fructose-1,6-bisphosphatase 1",27132,49,1.10 [0.79-1.54],0.5703636984970281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,23652,40,1.12 [0.75-1.68],0.5736169108690388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCAR,Immunoglobulin alpha Fc receptor,27084,49,1.17 [0.70-1.97],0.5467637326544332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,23614,39,0.37 [0.11-1.21],0.0995332171456606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCER2,Low affinity immunoglobulin epsilon Fc receptor,27137,49,0.69 [0.41-1.17],0.1652773363741668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,27005,49,1.21 [0.75-1.96],0.4302337388672451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,26496,46,0.83 [0.52-1.32],0.419730001673436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,27138,49,1.14 [0.68-1.90],0.6194405456292711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCN1,Ficolin-1,23614,40,1.17 [0.66-2.06],0.5918265306579072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCN2,Ficolin-2,27011,49,1.05 [0.57-1.96],0.8704884437686026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCRL1,Fc receptor-like protein 1,27132,49,1.03 [0.59-1.79],0.9260555717462764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCRL2,Fc receptor-like protein 2,27284,48,1.23 [0.77-1.97],0.3860688391426936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCRL3,Fc receptor-like protein 3,26592,46,1.12 [0.70-1.78],0.6434717681048628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCRL5,Fc receptor-like protein 5,27137,49,1.03 [0.66-1.59],0.9117467003885144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCRL6,Fc receptor-like protein 6,27084,49,0.87 [0.60-1.24],0.4336488880086726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCRLB,Fc receptor-like B,26496,46,1.28 [0.91-1.80],0.1530023606778732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FDX1,"Adrenodoxin, mitochondrial",22889,39,1.17 [0.77-1.78],0.4646598525009811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FDX2,"Ferredoxin-2, mitochondrial",22889,39,0.92 [0.52-1.62],0.7612912843727232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FEN1,Flap endonuclease 1,26496,46,1.24 [0.93-1.67],0.1463957562940707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FES,Tyrosine-protein kinase Fes/Fps,26496,46,1.09 [0.64-1.86],0.7611252431781595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FETUB,Fetuin-B,27177,49,1.46 [0.65-3.28],0.3637717578775431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGA,Fibrinogen alpha chain,23119,40,0.87 [0.32-2.37],0.7854090850295621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",23614,39,0.86 [0.58-1.27],0.4509172383244491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF12,Fibroblast growth factor 12,22978,40,1.07 [0.58-1.95],0.8304789574466347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF16,Fibroblast growth factor 16,22978,40,1.00 [0.53-1.88],0.9947766778522724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF19,Fibroblast growth factor 19,27269,49,1.02 [0.74-1.42],0.9021163332882912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF2,Fibroblast growth factor 2,27084,49,0.69 [0.46-1.04],0.0729691077988774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF20,Fibroblast growth factor 20,22978,40,0.60 [0.24-1.47],0.2638503859010025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF21,Fibroblast growth factor 21,27315,49,0.96 [0.77-1.20],0.7369165514652009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF23,Fibroblast growth factor 23,27321,49,1.75 [1.34-2.28],4.588559330257018e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF3,Fibroblast growth factor 3,22978,40,1.28 [0.56-2.91],0.563181928054558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF5,Fibroblast growth factor 5,26592,46,1.55 [0.75-3.23],0.2407452437506399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF6,Fibroblast growth factor 6,22978,40,1.21 [0.72-2.04],0.4663292550971031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF7,Fibroblast growth factor 7,22790,39,1.17 [0.85-1.61],0.3360438903800015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF9,Fibroblast growth factor 9,22748,39,0.94 [0.45-1.96],0.8776349280274305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGFBP1,Fibroblast growth factor-binding protein 1,27225,47,0.30 [0.15-0.63],0.0013537990054625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGFBP2,Fibroblast growth factor-binding protein 2,23649,41,0.92 [0.50-1.67],0.7718246163301645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGFBP3,Fibroblast growth factor-binding protein 3,23597,41,1.12 [0.49-2.56],0.7824454153133698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGFR2,Fibroblast growth factor receptor 2,27225,47,1.19 [0.36-3.92],0.780563637290776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGFR4,Fibroblast growth factor receptor 4,23153,40,0.81 [0.46-1.44],0.4805277239361272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGL1,Fibrinogen-like protein 1,23663,40,1.66 [1.04-2.63],0.0327891409131072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGR,Tyrosine-protein kinase Fgr,26470,44,1.23 [0.85-1.77],0.2732079413486966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FH,"Fumarate hydratase, mitochondrial",22880,37,1.07 [0.76-1.51],0.7028633322872435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FHIP2A,FHF complex subunit HOOK interacting protein 2A,22889,39,0.50 [0.23-1.06],0.0692182742336337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FHIT,Bis(5'-adenosyl)-triphosphatase,26470,44,0.75 [0.53-1.07],0.1144046071030083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FIS1,Mitochondrial fission 1 protein,27140,49,0.83 [0.59-1.16],0.2718899810838134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,23614,39,0.93 [0.69-1.27],0.6515846247136674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,27197,47,0.88 [0.70-1.12],0.2940274987756399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,26950,48,0.80 [0.45-1.41],0.4379297290044133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,26950,48,0.95 [0.73-1.25],0.7292632488445806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,26420,44,0.73 [0.38-1.40],0.3438530233906105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FKBPL,FK506-binding protein-like,23528,40,0.96 [0.57-1.61],0.8792660386663402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FLI1,Friend leukemia integration 1 transcription factor,26496,46,0.93 [0.73-1.18],0.5313911322466225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,26950,48,3.43 [1.72-6.83],0.0004626941868202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FLT1,Vascular endothelial growth factor receptor 1,26966,48,1.39 [0.47-4.11],0.5498575720497167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FLT3,Receptor-type tyrosine-protein kinase FLT3,26496,46,0.88 [0.37-2.11],0.776467762379612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FLT3LG,Fms-related tyrosine kinase 3 ligand,27414,49,0.92 [0.43-2.00],0.8415457509901001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FLT4,Vascular endothelial growth factor receptor 3,27225,47,1.02 [0.47-2.21],0.9623352353302114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FMNL1,Formin-like protein 1,26470,44,1.12 [0.77-1.62],0.5530611024560301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FMR1,Synaptic functional regulator FMR1,26496,46,0.75 [0.35-1.61],0.4661032629604682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FN1,Fibronectin,23695,41,0.39 [0.13-1.16],0.0901300550207171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FNDC1,Fibronectin type III domain-containing protein 1,23597,41,0.93 [0.49-1.78],0.8257390998017132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,23514,40,0.91 [0.38-2.20],0.8417680233630224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOLH1,Glutamate carboxypeptidase 2,22978,40,1.08 [0.83-1.41],0.57095740870533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOLR1,Folate receptor alpha,27092,47,1.01 [0.40-2.51],0.9907444235358728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOLR2,Folate receptor beta,27371,49,1.40 [0.61-3.23],0.4296938601688462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOLR3,Folate receptor gamma,27138,47,1.02 [0.90-1.17],0.7493961642500877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOS,Proto-oncogene c-Fos,22748,39,0.86 [0.36-2.05],0.7381897966141268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOSB,Protein fosB,26470,44,1.02 [0.53-1.99],0.9426590985404852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOXJ3,Forkhead box protein J3,22978,40,0.45 [0.19-1.02],0.0565230805311323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOXO1,Forkhead box protein O1,27084,49,0.92 [0.68-1.24],0.5827890251800105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOXO3,Forkhead box protein O3,26496,46,0.91 [0.68-1.21],0.5091783814896956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FRMD4B,FERM domain-containing protein 4B,22889,39,1.00 [0.65-1.55],0.9956823741664078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FRMD7,FERM domain-containing protein 7,22992,41,0.62 [0.26-1.48],0.2844205506502093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FRZB,Secreted frizzled-related protein 3,26857,48,1.17 [0.44-3.12],0.7465053791655196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FSHB,Follitropin subunit beta,23041,41,0.79 [0.50-1.23],0.2947450588279455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FST,Follistatin,27224,49,1.69 [1.06-2.69],0.0261045803519278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FSTL1,Follistatin-related protein 1,23041,41,2.84 [0.97-8.29],0.0561477333714331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FSTL3,Follistatin-related protein 3,27094,49,0.79 [0.35-1.79],0.5691577764152898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FTCD,Formimidoyltransferase-cyclodeaminase,23556,41,1.26 [0.92-1.74],0.1523826792827328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FUCA1,Tissue alpha-L-fucosidase,27307,46,1.19 [0.84-1.69],0.3265598438902442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FUOM,Fucose mutarotase,23153,40,1.63 [1.07-2.49],0.0236821335396874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FURIN,Furin,27225,47,1.35 [0.62-2.94],0.4469842975634082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FUS,RNA-binding protein FUS,26455,46,0.94 [0.48-1.86],0.8657064522544247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",23153,40,1.13 [0.73-1.74],0.5799022011738195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,27371,49,1.31 [0.77-2.25],0.3220572610908002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FUT8,"Alpha-(1,6)-fucosyltransferase",26950,48,0.81 [0.52-1.27],0.3648157781495245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FXN,"Frataxin, mitochondrial",27363,49,0.90 [0.64-1.26],0.5279466228921179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FXYD5,FXYD domain-containing ion transport regulator 5,26592,46,0.77 [0.50-1.18],0.2260233375260441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FYB1,FYN-binding protein 1,27096,49,0.87 [0.66-1.14],0.3086924880329162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FZD10,Frizzled-10,22992,41,0.92 [0.53-1.59],0.7641011069014009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FZD8,Frizzled-8,22880,37,1.60 [1.02-2.50],0.0416395019821606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GABARAP,Gamma-aminobutyric acid receptor-associated protein,23514,40,1.38 [0.87-2.19],0.169565792677304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,23202,40,1.03 [0.66-1.62],0.8894234796234535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,22880,37,0.75 [0.41-1.37],0.3444760827455945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAD1,Glutamate decarboxylase 1,22790,39,0.48 [0.14-1.57],0.2219738382524644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAD2,Glutamate decarboxylase 2,22978,40,1.22 [0.70-2.12],0.4883661202759184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,23202,40,1.03 [0.58-1.84],0.9065807581467432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,23041,41,0.55 [0.29-1.04],0.0671858159104364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAGE2A,G antigen 2A,22790,39,1.08 [0.70-1.68],0.7184752283341089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAL,Galanin peptides,27269,49,0.72 [0.47-1.09],0.1187821941036499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,27009,48,1.51 [0.61-3.75],0.3727078999500032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,27363,49,1.79 [0.69-4.66],0.2314138795321952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,26592,46,1.47 [0.80-2.70],0.2173130686746829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,23652,40,0.80 [0.26-2.43],0.6922710910822283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GALNT7,N-acetylgalactosaminyltransferase 7,27009,48,0.85 [0.25-2.83],0.7867470915868993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAMT,Guanidinoacetate N-methyltransferase,22889,39,0.96 [0.42-2.18],0.9279367220278438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,22650,40,1.19 [0.47-3.02],0.7116129933700742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GART,Trifunctional purine biosynthetic protein adenosine-3,23614,39,0.82 [0.25-2.62],0.7326449619387817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAS2,Growth arrest-specific protein 2,23202,40,1.14 [0.68-1.89],0.624939627319459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAS6,Growth arrest-specific protein 6,27276,47,1.04 [0.38-2.84],0.937174444190603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GASK1A,Golgi-associated kinase 1A,22889,39,0.89 [0.44-1.82],0.7475043268225928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAST,Gastrin,23597,41,1.00 [0.81-1.23],0.9933275191152632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,22790,39,0.86 [0.27-2.75],0.7999570048231299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",23041,41,0.97 [0.66-1.43],0.8862543405912985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GBA,Lysosomal acid glucosylceramidase,22992,41,1.04 [0.59-1.81],0.9023833380386516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GBP1,Guanylate-binding protein 1,23557,41,1.54 [1.05-2.28],0.0287312368899296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GBP2,Guanylate-binding protein 2,26592,46,1.03 [0.67-1.59],0.9036998373933391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GBP4,Guanylate-binding protein 4,26470,44,1.18 [0.70-2.00],0.532256215935826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GBP6,Guanylate-binding protein 6,22889,39,1.00 [0.51-1.97],0.9899666359719468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GC,Vitamin D-binding protein,23695,41,0.63 [0.19-2.05],0.4431671538115612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GCC1,GRIP and coiled-coil domain-containing protein 1,23597,41,0.92 [0.70-1.20],0.5294687074430637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GCG,Pro-glucagon,26496,46,1.04 [0.85-1.28],0.7059532714976071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,22600,40,1.17 [0.66-2.06],0.5885854112137282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GCLM,Glutamate--cysteine ligase regulatory subunit,22889,39,0.77 [0.36-1.61],0.4823867975142814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",27009,48,1.32 [0.64-2.72],0.4482462618420556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GDF15,Growth/differentiation factor 15,27462,47,1.52 [0.93-2.50],0.0984916398666423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GDF2,Growth/differentiation factor 2,27132,49,0.67 [0.33-1.36],0.2666030354494546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GDNF,Glial cell line-derived neurotrophic factor,26470,44,1.03 [0.52-2.05],0.93132273412943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GET3,ATPase GET3,23652,40,0.91 [0.51-1.59],0.7317357283180719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GFAP,Glial fibrillary acidic protein,26453,45,1.18 [0.69-2.02],0.5459648768967649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GFER,FAD-linked sulfhydryl oxidase ALR,26496,46,0.87 [0.57-1.33],0.5237901064676439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,26496,46,0.90 [0.69-1.15],0.3925122945262869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GFRA1,GDNF family receptor alpha-1,27315,49,0.90 [0.37-2.20],0.8179529028533655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GFRA2,GDNF family receptor alpha-2,27009,48,1.06 [0.33-3.45],0.920969578766422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GFRA3,GDNF family receptor alpha-3,26865,47,1.32 [0.54-3.21],0.5448064482743008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GFRAL,GDNF family receptor alpha-like,22883,39,1.53 [1.03-2.28],0.0357078273409691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GGA1,ADP-ribosylation factor-binding protein GGA1,26470,44,1.01 [0.67-1.51],0.9689679010190236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GGACT,Gamma-glutamylaminecyclotransferase,23652,40,1.01 [0.66-1.54],0.9646098719762414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GGCT,Gamma-glutamylcyclotransferase,23605,40,0.73 [0.39-1.39],0.3394682273004166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GGH,Gamma-glutamyl hydrolase,26660,47,1.02 [0.49-2.15],0.954840554546316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GGT1,Glutathione hydrolase 1 proenzyme,27097,49,1.53 [0.98-2.37],0.0599183480595503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GGT5,Glutathione hydrolase 5 proenzyme,26950,48,1.34 [0.44-4.01],0.6057459243954051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GH1,Somatotropin,27087,49,1.08 [0.94-1.25],0.2870643150814709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GH2,Growth hormone variant,26496,46,1.17 [1.03-1.32],0.0118388725925101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GHR,Growth hormone receptor,23153,40,0.46 [0.16-1.33],0.1494756295015563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GHRHR,Growth hormone-releasing hormone receptor,26470,44,0.89 [0.52-1.51],0.6550910390559624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GHRL,Appetite-regulating hormone,27132,49,1.14 [0.84-1.55],0.4019709275965559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GID8,Glucose-induced degradation protein 8 homolog,23614,39,0.63 [0.20-2.00],0.4341826690815717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIGYF2,GRB10-interacting GYF protein 2,23614,39,0.84 [0.55-1.26],0.3963591658994448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIMAP7,GTPase IMAP family member 7,23153,40,0.86 [0.32-2.29],0.7657530966772856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIMAP8,GTPase IMAP family member 8,22790,39,1.30 [0.83-2.04],0.2529759491033932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIP,Gastric inhibitory polypeptide,23041,41,0.87 [0.51-1.49],0.6163102152382058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIPC2,PDZ domain-containing protein GIPC2,23597,41,1.26 [0.48-3.32],0.6448440711761165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIPC3,PDZ domain-containing protein GIPC3,23528,40,0.90 [0.66-1.21],0.4710870424541251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIPR,Gastric inhibitory polypeptide receptor,22978,40,0.95 [0.50-1.79],0.8744903986363689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIT1,ARF GTPase-activating protein GIT1,22978,40,0.88 [0.64-1.20],0.4227894281307991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GJA8,Gap junction alpha-8 protein,22790,39,0.98 [0.60-1.60],0.9335305994095724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GKN1,Gastrokine-1,25949,41,0.74 [0.27-2.02],0.5585346437977965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLA,Alpha-galactosidase A,23105,40,1.34 [0.60-2.96],0.4737402997788787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLB1,Beta-galactosidase,26950,48,0.87 [0.46-1.65],0.6689760404593202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLI2,Zinc finger protein GLI2,22978,40,1.38 [0.62-3.08],0.4246129907450728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLO1,Lactoylglutathione lyase,26637,46,1.19 [0.77-1.82],0.4297254539473589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLOD4,Glyoxalase domain-containing protein 4,27095,49,0.80 [0.40-1.61],0.538081398965842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLP1R,Glucagon-like peptide 1 receptor,22880,37,0.81 [0.32-2.02],0.6466531934957189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLRX,Glutaredoxin-1,26956,48,1.12 [0.72-1.73],0.6214853881318575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",23153,40,1.04 [0.74-1.46],0.8111768719419292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,26470,44,1.20 [0.74-1.94],0.4655090769252401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLYR1,Putative oxidoreductase GLYR1,23514,40,0.95 [0.55-1.64],0.8400127913378224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GM2A,Ganglioside GM2 activator,23074,41,1.01 [0.47-2.20],0.9733694474978988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GMFG,Glia maturation factor gamma,23652,40,0.79 [0.52-1.19],0.2581610405354438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GMPR,GMP reductase 1,27414,49,1.02 [0.62-1.66],0.9519126716240028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GMPR2,GMP reductase 2,23153,40,0.92 [0.59-1.44],0.7266562783431199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GNAS,Neuroendocrine secretory protein 55,23614,39,1.18 [0.87-1.60],0.2971501336755435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,26496,46,0.99 [0.66-1.48],0.946804782357018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,22992,41,0.81 [0.40-1.62],0.5489287747737549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GNLY,Granulysin,27137,49,0.86 [0.53-1.40],0.5409058388614092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GNPDA1,Glucosamine-6-phosphate isomerase 1,23041,41,1.19 [0.52-2.73],0.6844296852163897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GNPDA2,Glucosamine-6-phosphate isomerase 2,23153,40,0.62 [0.27-1.44],0.2639599457946431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GOLGA3,Golgin subfamily A member 3,23614,39,0.76 [0.50-1.16],0.2024572247697551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GOLM2,Protein GOLM2,27371,49,1.15 [0.38-3.47],0.8006046331071908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,27084,49,0.95 [0.74-1.21],0.6656167718587184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GORASP2,Golgi reassembly-stacking protein 2,23528,40,0.88 [0.46-1.69],0.7035853871914335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GOT1,"Aspartate aminotransferase, cytoplasmic",23649,41,1.70 [0.93-3.12],0.0866339856453147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GP1BA,Platelet glycoprotein Ib alpha chain,27002,49,0.53 [0.24-1.19],0.1241631289072965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GP1BB,Platelet glycoprotein Ib beta chain,22889,39,0.89 [0.56-1.41],0.609575578974465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,26299,46,1.02 [0.76-1.38],0.8959974005639563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GP5,Platelet glycoprotein V,23153,40,0.64 [0.29-1.41],0.2703254550083117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GP6,Platelet glycoprotein VI,27096,49,0.85 [0.64-1.14],0.2799839748581371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPA33,Cell surface A33 antigen,27009,48,1.08 [0.90-1.30],0.4111500451680228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPC1,Glypican-1,27363,49,0.90 [0.38-2.11],0.8061866216015142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPC5,Glypican-5,26950,48,0.66 [0.42-1.03],0.0699892612266959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPD1,Glycerol-3-phosphate dehydrogenase,23514,40,1.73 [1.07-2.78],0.0246025895940486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPHA2,Glycoprotein hormone alpha-2,23528,40,0.84 [0.41-1.71],0.6279319264464784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPI,Glucose-6-phosphate isomerase,23663,40,0.93 [0.49-1.76],0.8202816790057161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,23528,40,0.94 [0.62-1.42],0.7596093705061833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPKOW,G-patch domain and KOW motifs-containing protein,26470,44,1.10 [0.45-2.69],0.8343602003949583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPNMB,Transmembrane glycoprotein NMB,26389,48,2.11 [0.85-5.19],0.1055943960057415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPR101,Probable G-protein coupled receptor 101,22880,37,1.25 [0.86-1.81],0.2341202311038028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPR158,Probable G-protein coupled receptor 158,23614,39,0.79 [0.32-1.98],0.6168849948498971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPR15L,Protein GPR15L,23528,40,1.17 [0.73-1.90],0.5149959783102438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPR37,Prosaposin receptor GPR37,26637,46,1.18 [0.80-1.74],0.4005004932938714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPRC5C,G-protein coupled receptor family C group 5 member C,23514,40,1.63 [1.17-2.29],0.0043127141778237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRAP2,GRB2-related adapter protein 2,27132,49,0.93 [0.77-1.13],0.4806109156806489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,23652,40,0.78 [0.49-1.25],0.3005281533797898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRIK2,"Glutamate receptor ionotropic, kainate 2",23614,39,1.23 [0.66-2.29],0.5233883258324181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",22880,37,1.21 [0.77-1.89],0.4095123020490568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRK5,G protein-coupled receptor kinase 5,26637,46,0.92 [0.53-1.58],0.756900860395861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRN,Progranulin,27017,49,0.82 [0.29-2.38],0.7219829453418944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRP,Gastrin-releasing peptide,23041,41,1.20 [0.71-2.03],0.4999162718958505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRPEL1,"GrpE protein homolog 1, mitochondrial",27009,48,1.54 [1.09-2.18],0.0133372942801602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRSF1,G-rich sequence factor 1,22667,39,0.85 [0.57-1.28],0.4474552582000429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSAP,Gamma-secretase-activating protein,26496,46,1.02 [0.76-1.37],0.8866816911724311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSN,Gelsolin,23583,40,0.73 [0.18-2.94],0.6614476001469634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSR,"Glutathione reductase, mitochondrial",23522,39,2.44 [0.63-9.34],0.1944283917114901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSTA1,Glutathione S-transferase A1,27091,49,1.04 [0.77-1.41],0.7752872525766068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSTA3,Glutathione S-transferase A3,26496,46,1.03 [0.74-1.45],0.8455053213784101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSTM4,Glutathione S-transferase Mu 4,22889,39,0.93 [0.59-1.46],0.7434168790321529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSTP1,Glutathione S-transferase P,26302,43,0.81 [0.53-1.23],0.3212760288279654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSTT2B,Glutathione S-transferase theta-2B,23597,41,0.98 [0.86-1.10],0.6901756960312544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,23202,40,1.00 [0.66-1.52],0.993471001337156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GTPBP2,GTP-binding protein 2,22992,41,0.86 [0.59-1.25],0.4269635640400142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GUCA2A,Guanylin,27011,48,0.83 [0.39-1.78],0.6377336467515589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GUCY2C,Heat-stable enterotoxin receptor,23202,40,1.03 [0.73-1.46],0.8755012650223769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GUK1,Guanylate kinase,22889,39,1.19 [0.56-2.51],0.6456979007732853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GUSB,Beta-glucuronidase,27255,46,1.17 [0.76-1.78],0.4762071046166718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GYS1,"Glycogen [starch] synthase, muscle",26637,46,0.82 [0.61-1.09],0.1689105980727682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GZMA,Granzyme A,27414,49,1.34 [0.69-2.62],0.3839047955912845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GZMB,Granzyme B,27084,49,0.96 [0.63-1.44],0.8264668714415622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GZMH,Granzyme H,26637,46,1.15 [0.85-1.56],0.356768926725754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,H2AP,Huntingtin-interacting protein M,22790,39,0.95 [0.49-1.83],0.8784820098755115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",22889,39,1.42 [1.09-1.85],0.0098013667717484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",27278,49,1.16 [0.84-1.60],0.3809192636347182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HAO1,Hydroxyacid oxidase 1,27363,49,1.15 [0.96-1.38],0.1236734326526259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HARS1,"Histidine--tRNA ligase, cytoplasmic",27137,49,0.87 [0.63-1.21],0.4162584105443451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HAVCR1,Hepatitis A virus cellular receptor 1,27326,49,1.23 [0.83-1.83],0.3019914715347768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HAVCR2,Hepatitis A virus cellular receptor 2,27137,49,1.59 [0.81-3.14],0.1770162497238701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HBEGF,Proheparin-binding EGF-like growth factor,27278,49,0.78 [0.55-1.11],0.1698023119234253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HBQ1,Hemoglobin subunit theta-1,27363,49,0.98 [0.64-1.48],0.9087880398798464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HBZ,Hemoglobin subunit zeta,23652,40,1.14 [0.87-1.49],0.3521996058577967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HCG22,Protein PBMUCL2,22889,39,0.83 [0.40-1.72],0.6136899420764991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HCLS1,Hematopoietic lineage cell-specific protein,27414,49,0.90 [0.57-1.41],0.6426277659621676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HDAC8,Histone deacetylase 8,22978,40,0.87 [0.48-1.59],0.6557204688334239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HDAC9,Histone deacetylase 9,22880,37,0.98 [0.59-1.65],0.951057520540453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HDDC2,5'-deoxynucleotidase HDDC2,23528,40,0.93 [0.47-1.83],0.8235032258489269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HDGF,Hepatoma-derived growth factor,27328,49,0.91 [0.70-1.19],0.4811662399843014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HDGFL2,Hepatoma-derived growth factor-related protein 2,23597,41,0.97 [0.60-1.55],0.8838871705171364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HEBP1,Heme-binding protein 1,26637,46,1.12 [0.74-1.70],0.5891932636174225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HEG1,Protein HEG homolog 1,23153,40,4.44 [1.50-13.17],0.0072363785705835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HEPACAM2,HEPACAM family member 2,23597,41,1.04 [0.50-2.14],0.9254971297523102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HEPH,Hephaestin,23652,40,1.33 [0.40-4.36],0.640153762710143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HEXIM1,Protein HEXIM1,27084,49,0.89 [0.65-1.22],0.4882887095840476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HGF,Hepatocyte growth factor,27414,49,0.81 [0.38-1.73],0.5937990982094303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HGFAC,Hepatocyte growth factor activator,23431,39,0.99 [0.34-2.85],0.982606834771693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,26496,46,1.05 [0.76-1.47],0.7573144298511412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HHEX,Hematopoietically-expressed homeobox protein HHEX,23597,41,0.86 [0.58-1.29],0.4773400544589481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HIF1A,Hypoxia-inducible factor 1-alpha,22978,40,0.97 [0.60-1.57],0.9068489773154558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HIP1,Huntingtin-interacting protein 1,22889,39,0.80 [0.51-1.27],0.3510739623690384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HIP1R,Huntingtin-interacting protein 1-related protein,23554,41,1.61 [1.03-2.53],0.0373588844962527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HJV,Hemojuvelin,23614,39,1.47 [0.92-2.36],0.1099939695382196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HK2,Hexokinase-2,26637,46,0.67 [0.26-1.73],0.4056488036399168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",23614,39,2.08 [0.80-5.42],0.1355533591393407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",27006,48,1.57 [0.82-3.02],0.1726752134862709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",27084,49,1.54 [0.68-3.47],0.3009511962720563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HMBS,Porphobilinogen deaminase,27363,49,1.29 [0.74-2.24],0.3664880730424783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HMCN2,Hemicentin-2,23110,39,1.34 [0.77-2.33],0.2940288744899865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",23041,41,0.76 [0.40-1.44],0.4022602675831878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",22889,39,1.02 [0.51-2.04],0.9551834932146004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HMMR,Hyaluronan mediated motility receptor,22750,39,1.13 [0.63-2.01],0.6871405166359484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HMOX1,Heme oxygenase 1,26818,48,1.37 [0.81-2.29],0.2375045360245066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HMOX2,Heme oxygenase 2,26470,44,1.45 [0.90-2.32],0.1251191684209817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HNF1A,Hepatocyte nuclear factor 1-alpha,22992,41,1.13 [0.81-1.59],0.4673712852374433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HNMT,Histamine N-methyltransferase,26818,48,0.87 [0.50-1.49],0.602729032894921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,26559,46,0.95 [0.68-1.34],0.7691681088076526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,23614,39,0.79 [0.39-1.58],0.5030795647933874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HPCAL1,Hippocalcin-like protein 1,27414,49,0.89 [0.64-1.24],0.4924436578755145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HPGDS,Hematopoietic prostaglandin D synthase,26496,46,0.64 [0.31-1.31],0.2193645583423059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HPSE,Heparanase,23323,41,0.88 [0.65-1.21],0.438868192035718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HRAS,GTPase Hras,23157,39,1.15 [0.91-1.46],0.2300363270962681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,23041,41,1.26 [0.67-2.37],0.4779390733167401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HRG,Histidine-rich glycoprotein,23555,41,0.49 [0.19-1.23],0.1283197512226871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HS1BP3,HCLS1-binding protein 3,23041,41,0.81 [0.58-1.15],0.2431625806412073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,27009,48,1.01 [0.52-1.95],0.98081146175257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,27363,49,0.78 [0.37-1.63],0.507055880162905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,22978,40,0.40 [0.15-1.05],0.063827854204798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSBP1,Heat shock factor-binding protein 1,23041,41,1.06 [0.77-1.45],0.7294813784609854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,27084,49,0.71 [0.37-1.33],0.2806217959019381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,23597,41,1.17 [0.74-1.88],0.4996535285595267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSD17B3,Testosterone 17-beta-dehydrogenase 3,22889,39,0.83 [0.42-1.65],0.5878909630753526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,23041,41,0.58 [0.29-1.14],0.1139180309234825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSP90B1,Endoplasmin,26337,44,0.61 [0.34-1.12],0.1126972408831279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSPA1A,Heat shock 70 kDa protein 1A,27229,49,1.00 [0.70-1.41],0.9871817462770768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSPA2,Heat shock-related 70 kDa protein 2,23514,40,0.59 [0.21-1.65],0.3184628593266239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSPB1,Heat shock protein beta-1,26686,48,0.98 [0.67-1.42],0.8951901949212105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSPB6,Heat shock protein beta-6,27363,49,1.23 [0.62-2.43],0.5542332565259911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,26912,49,1.51 [0.59-3.86],0.3854446716049639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HTR1A,5-hydroxytryptamine receptor 1A,22880,37,0.96 [0.64-1.45],0.8496743271307654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HTR1B,5-hydroxytryptamine receptor 1B,22880,37,0.99 [0.47-2.07],0.971813397070524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HTRA2,"Serine protease HTRA2, mitochondrial",27225,47,1.12 [0.74-1.70],0.5761319112897922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HYAL1,Hyaluronidase-1,26952,49,0.76 [0.43-1.33],0.3393203459838601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HYOU1,Hypoxia up-regulated protein 1,27462,47,0.90 [0.28-2.88],0.8624412611830676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ICA1,Islet cell autoantigen 1,26592,46,0.79 [0.56-1.12],0.1808103271115688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ICAM1,Intercellular adhesion molecule 1,27006,49,1.17 [0.49-2.81],0.7258877346080677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ICAM2,Intercellular adhesion molecule 2,27462,47,1.62 [0.71-3.68],0.2478442076702662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ICAM3,Intercellular adhesion molecule 3,27462,47,0.82 [0.30-2.22],0.6948580830697358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ICAM4,Intercellular adhesion molecule 4,27084,49,1.16 [0.72-1.89],0.5400445309109954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ICAM5,Intercellular adhesion molecule 5,27132,49,0.70 [0.40-1.21],0.2023650742049437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ICOSLG,ICOS ligand,27009,48,0.53 [0.14-2.00],0.3489924194006978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ID4,DNA-binding protein inhibitor ID-4,23202,40,1.09 [0.57-2.05],0.8011013987407624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IDI2,Isopentenyl-diphosphate delta-isomerase 2,26470,44,0.63 [0.33-1.20],0.1560667193778879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IDO1,"Indoleamine 2,3-dioxygenase 1",23041,41,0.87 [0.54-1.41],0.5740177727780267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IDS,Iduronate 2-sulfatase,27414,49,0.66 [0.04-11.21],0.7717457866433701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IDUA,Alpha-L-iduronidase,27363,49,1.03 [0.59-1.79],0.9120077894365756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,22950,40,1.52 [0.74-3.13],0.2561472476416744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,23202,40,0.74 [0.40-1.38],0.346889641673028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,23202,40,0.73 [0.31-1.73],0.4726827812727389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNAR1,Interferon alpha/beta receptor 1,23528,40,1.56 [0.57-4.25],0.3830023843976401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNG,Interferon gamma,26592,46,1.09 [0.86-1.37],0.4814190970747583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNGR1,Interferon gamma receptor 1,27269,49,1.13 [0.34-3.79],0.8475346266355003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNGR2,Interferon gamma receptor 2,26950,48,1.40 [0.88-2.22],0.1521444185542779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNL1,Interferon lambda-1,26470,44,1.18 [0.66-2.09],0.580608343556156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNL2,Interferon lambda-2,22880,37,0.95 [0.56-1.60],0.8403275443641813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNLR1,Interferon lambda receptor 1,27084,49,1.11 [0.58-2.10],0.7549990102462143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNW1,Interferon omega-1,22889,39,1.39 [0.76-2.55],0.2897060362771273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFT20,Intraflagellar transport protein 20 homolog,22992,41,0.56 [0.25-1.23],0.1484046013766324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGBP1,Immunoglobulin-binding protein 1,23614,39,0.83 [0.50-1.36],0.4504140752657615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,22880,37,0.86 [0.41-1.82],0.6896846794909917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,23649,41,1.05 [0.33-3.31],0.936530844632708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGF1R,Insulin-like growth factor 1 receptor,27009,48,0.50 [0.14-1.76],0.279587528323874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,22889,39,1.25 [0.70-2.21],0.4523876779042335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGF2R,Cation-independent mannose-6-phosphate receptor,27137,49,0.58 [0.19-1.73],0.3284719469649034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBP1,Insulin-like growth factor-binding protein 1,27412,47,1.16 [0.93-1.45],0.1886123505293447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBP2,Insulin-like growth factor-binding protein 2,27417,47,1.13 [0.75-1.70],0.56916271043756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBP3,Insulin-like growth factor-binding protein 3,27224,49,0.70 [0.30-1.65],0.4158300544222867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBP4,Insulin-like growth factor-binding protein 4,26770,48,1.04 [0.57-1.91],0.8883975244842937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBP6,Insulin-like growth factor-binding protein 6,27005,49,0.68 [0.28-1.68],0.4039437177800773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBP7,Insulin-like growth factor-binding protein 7,27462,47,1.72 [0.85-3.46],0.1292477911552327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBPL1,Insulin-like growth factor-binding protein-like 1,27132,49,1.53 [0.75-3.13],0.2421526286843671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFL4,Insulin growth factor-like family member 4,22978,40,0.84 [0.51-1.38],0.4841755350720071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGHMBP2,DNA-binding protein SMUBP-2,22889,39,0.98 [0.56-1.72],0.942731104464484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGLC2,Immunoglobulin lambda constant 2,23644,41,1.13 [0.40-3.21],0.8197999870688039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGLON5,IgLON family member 5,22790,39,0.98 [0.69-1.38],0.9029628191088376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGSF21,Immunoglobulin superfamily member 21,23041,41,0.81 [0.35-1.89],0.6314229264851918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGSF3,Immunoglobulin superfamily member 3,27009,48,1.31 [0.65-2.65],0.4523002927018338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGSF8,Immunoglobulin superfamily member 8,27132,49,0.69 [0.29-1.63],0.4001901330696892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGSF9,Protein turtle homolog A,23652,40,1.01 [0.70-1.48],0.94188225077735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IKBKG,NF-kappa-B essential modulator,27084,49,0.94 [0.71-1.24],0.673140188504044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IKZF2,Zinc finger protein Helios,26496,46,1.19 [0.94-1.50],0.1399832428975803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL10,Interleukin-10,26592,46,1.08 [0.81-1.43],0.6121446145710338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL10RA,Interleukin-10 receptor subunit alpha,26592,46,0.58 [0.30-1.13],0.1076443494650021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL10RB,Interleukin-10 receptor subunit beta,27269,49,0.85 [0.35-2.06],0.7206018140278779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL11,Interleukin-11,26592,46,0.84 [0.52-1.34],0.4554386578511785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL12A_IL12B,Interleukin-12,27009,48,0.99 [0.72-1.37],0.9729219907968232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL12B,Interleukin-12 subunit beta,27414,49,0.89 [0.56-1.41],0.6220326208279616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL12RB1,Interleukin-12 receptor subunit beta-1,26592,46,1.37 [0.70-2.65],0.356973771513283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL12RB2,Interleukin-12 receptor subunit beta-2,22978,40,1.04 [0.50-2.15],0.9161197486161972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL13,Interleukin-13,26592,46,0.93 [0.52-1.68],0.814401192576101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL13RA1,Interleukin-13 receptor subunit alpha-1,26795,46,0.85 [0.24-3.05],0.8017549975706408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL13RA2,Interleukin-13 receptor subunit alpha-2,22880,37,0.77 [0.26-2.30],0.6359419583488819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL15,Interleukin-15,27084,49,1.13 [0.53-2.40],0.7488285088686695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL15RA,Interleukin-15 receptor subunit alpha,26592,46,1.19 [0.56-2.50],0.6550607065342888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL16,Pro-interleukin-16,27414,49,0.97 [0.52-1.80],0.9149999272132316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL17A,Interleukin-17A,26563,46,1.21 [0.72-2.04],0.4676148966641016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL17C,Interleukin-17C,26592,46,1.04 [0.74-1.48],0.811350121638592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL17D,Interleukin-17D,26592,46,1.45 [0.83-2.52],0.1878396249466566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL17F,Interleukin-17F,26592,46,1.00 [0.72-1.39],0.9921819537633428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL17RA,Interleukin-17 receptor A,27137,49,0.96 [0.55-1.68],0.879332980078831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL17RB,Interleukin-17 receptor B,26740,48,1.07 [0.66-1.75],0.7816779744064266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL18,Interleukin-18,27051,49,0.89 [0.53-1.52],0.6728923796588246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL18BP,Interleukin-18-binding protein,27224,49,1.65 [0.78-3.50],0.193435520815949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL18R1,Interleukin-18 receptor 1,27414,49,2.06 [1.01-4.22],0.0472108253045336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL18RAP,Interleukin-18 receptor accessory protein,26780,48,0.96 [0.83-1.12],0.5989543195294913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL19,Interleukin-19,26456,49,1.23 [0.88-1.73],0.2292962350609282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1A,Interleukin-1 alpha,26592,46,0.90 [0.54-1.51],0.6864674151854244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1B,Interleukin-1 beta,26463,46,0.58 [0.33-0.99],0.0470916291980734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1R1,Interleukin-1 receptor type 1,27097,49,2.93 [1.07-8.03],0.0366492834934656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1R2,Interleukin-1 receptor type 2,27097,49,0.59 [0.17-2.05],0.404209104435478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1RAP,Interleukin-1 receptor accessory protein,27137,49,0.44 [0.23-0.84],0.0122339378923713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1RL1,Interleukin-1 receptor-like 1,27373,47,1.33 [0.75-2.38],0.3259505003172395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1RL2,Interleukin-1 receptor-like 2,26592,46,0.86 [0.44-1.67],0.6618285523073713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1RN,Interleukin-1 receptor antagonist protein,27092,49,0.59 [0.35-1.01],0.0544208156483011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL2,Interleukin-2,26592,46,1.57 [0.69-3.58],0.2837379152216548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL20,Interleukin-20,26592,46,0.79 [0.43-1.45],0.4445073085164371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL20RA,Interleukin-20 receptor subunit alpha,26592,46,1.60 [1.16-2.21],0.004451208152207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL20RB,Interleukin-20 receptor subunit beta,22978,40,0.93 [0.44-1.94],0.8402687184465512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL21R,Interleukin-21 receptor,22978,40,1.28 [0.84-1.94],0.2511380744132884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL22,Interleukin-22,23514,40,1.02 [0.66-1.59],0.9181793088454728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL22RA1,Interleukin-22 receptor subunit alpha-1,26592,46,0.83 [0.43-1.61],0.5894283468509107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL24,Interleukin-24,26592,46,1.17 [0.74-1.85],0.4957097844976568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL25,Interleukin-25,22711,39,0.92 [0.38-2.24],0.8609880712602089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL2RA,Interleukin-2 receptor subunit alpha,26920,47,0.99 [0.52-1.86],0.9726755390972904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL2RB,Interleukin-2 receptor subunit beta,26592,46,0.98 [0.50-1.90],0.9533454516554152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL2RG,Cytokine receptor common subunit gamma,23514,40,0.48 [0.17-1.37],0.1693790949920085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL3,Interleukin-3,22790,39,1.21 [0.70-2.07],0.4984198583913359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL31,Interleukin-31,22978,40,1.19 [0.76-1.87],0.4501832793557095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL31RA,Interleukin-31 receptor subunit alpha,22884,40,2.02 [0.99-4.11],0.052718046201008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL32,Interleukin-32,27084,49,1.06 [0.59-1.91],0.8503302430924246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL33,Interleukin-33,26592,46,1.66 [0.84-3.27],0.1414272435837138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL34,Interleukin-34,26428,44,0.79 [0.38-1.64],0.5203591306005835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL36A,Interleukin-36 alpha,22978,40,0.90 [0.50-1.61],0.7214192713376368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL36G,Interleukin-36 gamma,22880,40,0.84 [0.51-1.39],0.4987042474676078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL3RA,Interleukin-3 receptor subunit alpha,26592,46,1.51 [0.71-3.22],0.2898686385168139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL4,Interleukin-4,26592,46,0.87 [0.69-1.10],0.2437456720648008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL4R,Interleukin-4 receptor subunit alpha,27084,49,1.77 [0.97-3.22],0.0636917385475627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL5,Interleukin-5,26592,46,1.23 [1.08-1.40],0.0019678803835022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL5RA,Interleukin-5 receptor subunit alpha,27084,49,1.20 [0.78-1.87],0.4061792461637048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL6,Interleukin-6,27009,48,1.35 [1.09-1.68],0.006578795126709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL6R,Interleukin-6 receptor subunit alpha,26955,49,1.22 [0.58-2.56],0.5980303360688344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL6ST,Interleukin-6 receptor subunit beta,27132,49,0.54 [0.12-2.36],0.409107580208544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL7,Interleukin-7,27084,49,0.95 [0.64-1.41],0.7971330560935626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL7R,Interleukin-7 receptor subunit alpha,27137,49,0.93 [0.58-1.49],0.7505169103901764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL9,Interleukin-9,23202,40,0.88 [0.49-1.58],0.678382006483798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,26433,44,0.69 [0.42-1.15],0.1588068118577505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IMMT,MICOS complex subunit MIC60,23514,40,1.24 [0.68-2.23],0.4816971208549737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IMPA1,Inositol monophosphatase 1,26950,48,0.67 [0.43-1.04],0.0758054212945475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IMPACT,Protein IMPACT,23597,41,1.08 [0.64-1.82],0.7674434027480084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IMPG1,Interphotoreceptor matrix proteoglycan 1,22880,37,1.00 [0.33-2.97],0.9933729209380538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ING1,Inhibitor of growth protein 1,26420,44,0.88 [0.47-1.66],0.7012648215021517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INHBB,Inhibin beta B chain,23153,40,1.65 [0.97-2.80],0.064060578183439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INHBC,Inhibin beta C chain,27137,49,1.34 [0.73-2.47],0.3462573747640542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INPP1,Inositol polyphosphate 1-phosphatase,27009,48,1.00 [0.62-1.60],0.9989071784663964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",23041,41,0.92 [0.54-1.58],0.7612022025244308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",23614,39,1.26 [0.68-2.33],0.4701797730431239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",27009,48,0.88 [0.68-1.15],0.3466807315515666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INSL3,Insulin-like 3,23597,41,1.23 [0.70-2.14],0.4736378462767483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INSL4,Early placenta insulin-like peptide,23514,40,1.14 [0.67-1.92],0.63156214106855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INSL5,Insulin-like peptide INSL5,23528,40,1.02 [0.74-1.40],0.917047138924832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INSR,Insulin receptor,22978,40,1.92 [0.33-11.31],0.4696249451665665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IPCEF1,Interactor protein for cytohesin exchange factors 1,26908,48,0.91 [0.69-1.22],0.5324515911620519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IQGAP2,Ras GTPase-activating-like protein IQGAP2,27009,48,0.83 [0.52-1.34],0.4477375439455329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",26637,46,0.90 [0.66-1.23],0.5048099688362393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IRAK1,Interleukin-1 receptor-associated kinase 1,26592,46,0.85 [0.58-1.27],0.4316741398315717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IRAK4,Interleukin-1 receptor-associated kinase 4,27084,49,0.93 [0.73-1.18],0.5436810751161476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,26102,42,0.82 [0.39-1.76],0.6162037494412442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ISM1,Isthmin-1,27084,49,0.77 [0.40-1.48],0.4359625741921847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ISM2,Isthmin-2,23649,41,0.64 [0.30-1.36],0.248918110274865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IST1,IST1 homolog,23361,39,0.91 [0.67-1.23],0.5406454824827449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGA11,Integrin alpha-11,27084,49,0.68 [0.33-1.43],0.3078151453937746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGA2,Integrin alpha-2,23153,40,0.59 [0.25-1.42],0.2407134148469634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGA5,Integrin alpha-5,27137,49,0.97 [0.35-2.70],0.9603910809054728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGA6,Integrin alpha-6,27084,49,0.60 [0.35-1.03],0.0616430159044172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGAL,Integrin alpha-L,22978,40,1.11 [0.55-2.24],0.7606176683789321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGAM,Integrin alpha-M,27137,49,0.51 [0.22-1.15],0.1036659412641266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGAV,Integrin alpha-V,27363,49,0.32 [0.07-1.46],0.1406227087914752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGAX,Integrin alpha-X,23202,40,1.32 [0.85-2.03],0.2167247266034971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGB1,Integrin beta-1,27087,49,1.09 [0.34-3.49],0.8891970856597572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGB1BP1,Integrin beta-1-binding protein 1,26496,46,1.07 [0.57-2.01],0.8309959028932984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGB1BP2,Integrin beta-1-binding protein 2,26637,46,0.95 [0.75-1.20],0.667730072540978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGB2,Integrin beta-2,26958,46,0.49 [0.19-1.23],0.1288314253171128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGB5,Integrin beta-5,27225,47,1.41 [0.73-2.72],0.3094063744876974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGB6,Integrin beta-6,26592,46,1.89 [0.78-4.57],0.1573776281230006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGB7,Integrin beta-7,27363,49,1.04 [0.60-1.80],0.8881111564978655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGBL1,Integrin beta-like protein 1,23649,41,2.25 [1.14-4.45],0.0192152674627229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,23695,41,0.66 [0.13-3.25],0.6054197471273582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,27224,49,1.96 [0.98-3.90],0.0554461116036795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,23695,41,0.38 [0.11-1.26],0.114790403666351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,23514,40,1.45 [0.84-2.51],0.1855022453473257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITM2A,Integral membrane protein 2A,27084,49,0.95 [0.62-1.46],0.8286280222516988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITPA,Inosine triphosphate pyrophosphatase,22889,39,0.63 [0.39-1.02],0.0609925711704068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",23041,41,0.94 [0.60-1.46],0.7694477820780055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",22880,37,0.71 [0.30-1.64],0.4198538779168392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",26470,44,1.02 [0.59-1.76],0.9488079666547208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IZUMO1,Izumo sperm-egg fusion protein 1,22790,39,1.00 [0.53-1.89],0.9896540997994318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,JAM2,Junctional adhesion molecule B,27371,49,1.12 [0.43-2.93],0.8176823320907133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,JAM3,Junctional adhesion molecule C,23153,40,0.60 [0.31-1.17],0.1332739404193988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,JCHAIN,Immunoglobulin J chain,26592,46,1.51 [1.03-2.22],0.0339022759624386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,22790,39,0.57 [0.30-1.11],0.0984870131685003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,JPT2,Jupiter microtubule associated homolog 2,23528,40,0.94 [0.66-1.32],0.7117907401304442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,JUN,Transcription factor AP-1,26592,46,1.00 [0.59-1.70],0.987391613572794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,27009,48,1.69 [0.92-3.13],0.0928761531478873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KAZN,Kazrin,23528,40,0.87 [0.65-1.16],0.3348011884821038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KCNC4,Potassium voltage-gated channel subfamily C member 4,22880,37,1.20 [0.75-1.91],0.4457546052305587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KCNH2,Potassium voltage-gated channel subfamily H member 2,22992,41,0.82 [0.50-1.33],0.4116726459020228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KCNIP4,Kv channel-interacting protein 4,26470,44,0.48 [0.23-1.01],0.0520098785107425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KCTD5,BTB/POZ domain-containing protein KCTD5,23157,40,1.32 [0.72-2.41],0.362302282280362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KDM3A,Lysine-specific demethylase 3A,22978,40,1.05 [0.76-1.46],0.7597940553826407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KDR,Vascular endothelial growth factor receptor 2,27225,47,0.57 [0.21-1.55],0.272850823235434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KEL,Kell blood group glycoprotein,26470,44,1.25 [0.60-2.63],0.5512061568492317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KHDC3L,KH domain-containing protein 3,22790,39,1.14 [0.77-1.69],0.5110756495411588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KHK,Ketohexokinase,23041,41,1.04 [0.66-1.67],0.8537443840882015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIAA0319,Dyslexia-associated protein KIAA0319,23597,41,0.97 [0.36-2.61],0.954216175550944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIAA1549,UPF0606 protein KIAA1549,23202,40,1.17 [0.78-1.75],0.4483996904727352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIAA1549L,UPF0606 protein KIAA1549L,23202,40,0.75 [0.26-2.21],0.6047186702439615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIAA2013,Uncharacterized protein KIAA2013,23514,40,0.61 [0.28-1.34],0.2148514694702655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIF1C,Kinesin-like protein KIF1C,22889,39,0.54 [0.18-1.64],0.2770474810250949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIF20B,Kinesin-like protein KIF20B,22880,37,1.27 [0.92-1.76],0.1482770044109685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIF22,Kinesin-like protein KIF22,22889,39,0.87 [0.68-1.11],0.2755173851275982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIFBP,KIF-binding protein,27009,48,0.90 [0.66-1.21],0.4777864234030795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,23514,40,0.88 [0.62-1.24],0.4623533583373072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,26496,46,0.97 [0.69-1.34],0.8357139310459298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,23528,40,0.93 [0.78-1.11],0.4210186999066327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,26496,46,1.12 [0.91-1.38],0.2952037987724211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,22790,39,1.09 [0.79-1.51],0.5844807182506949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIRREL1,Kin of IRRE-like protein 1,22880,37,0.93 [0.52-1.67],0.8153500445290593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIRREL2,Kin of IRRE-like protein 2,26470,44,0.98 [0.49-1.94],0.9524215285676044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIT,Mast/stem cell growth factor receptor Kit,27177,49,0.46 [0.20-1.06],0.0684183012975387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KITLG,Kit ligand,27132,49,0.39 [0.21-0.73],0.0032673184886638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLB,Beta-klotho,26470,44,0.87 [0.60-1.26],0.4508356490276661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLF4,Krueppel-like factor 4,22880,37,1.21 [0.54-2.67],0.6435413602313647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLHL41,Kelch-like protein 41,23614,39,0.77 [0.37-1.61],0.4831803846448865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK1,Kallikrein-1,26858,46,0.84 [0.67-1.05],0.1249924813749766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK10,Kallikrein-10,27134,47,1.24 [0.67-2.31],0.4932942121908421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK11,Kallikrein-11,26963,47,0.46 [0.19-1.13],0.0919131897137278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK12,Kallikrein-12,26496,46,0.88 [0.74-1.05],0.1540549193764114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK13,Kallikrein-13,26532,47,1.01 [0.57-1.77],0.9806539424918482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK14,Kallikrein-14,27363,49,0.87 [0.51-1.49],0.6091450891597191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK15,Kallikrein-15,23476,40,1.19 [0.67-2.12],0.556347077648238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK3,Prostate-specific antigen,23649,41,0.88 [0.52-1.50],0.6412031779748768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK4,Kallikrein-4,27363,49,1.65 [1.17-2.34],0.0047283063475241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK6,Kallikrein-6,27185,47,1.04 [0.45-2.39],0.9265351933762186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK7,Kallikrein-7,22538,39,0.93 [0.42-2.08],0.8688431595412498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK8,Kallikrein-8,26225,44,0.65 [0.30-1.39],0.2620058881875497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLKB1,Plasma kallikrein,23220,41,0.55 [0.17-1.77],0.3164285196151861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLRB1,Killer cell lectin-like receptor subfamily B member 1,27414,49,1.83 [0.98-3.42],0.0560807302138596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,22880,37,1.00 [0.60-1.67],0.992187213450344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLRD1,Natural killer cells antigen CD94,27414,49,1.52 [0.89-2.60],0.1227049869052875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLRF1,Killer cell lectin-like receptor subfamily F member 1,22978,40,1.59 [1.05-2.40],0.0291571561093875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLRK1,NKG2-D type II integral membrane protein,23597,41,1.56 [0.84-2.89],0.1580855386115878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT14,"Keratin, type I cytoskeletal 14",25609,44,0.87 [0.32-2.35],0.787414062853844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT17,"Keratin, type I cytoskeletal 17",22889,39,1.47 [0.69-3.13],0.3156623381228838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT18,"Keratin, type I cytoskeletal 18",27009,48,1.28 [0.95-1.71],0.1035636429632154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT19,"Keratin, type I cytoskeletal 19",27043,49,1.43 [1.03-1.98],0.0325849818744258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT5,"Keratin, type II cytoskeletal 5",26470,44,0.86 [0.49-1.53],0.6149564726197937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT6C,"Keratin, type II cytoskeletal 6C",22889,39,1.34 [0.70-2.55],0.3720952272407052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT8,"Keratin, type II cytoskeletal 8",22880,37,0.71 [0.39-1.32],0.2846293323840102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KYAT1,Kynurenine--oxoglutarate transaminase 1,27085,49,0.89 [0.57-1.38],0.6046081336448823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KYNU,Kynureninase,27414,49,1.10 [0.63-1.90],0.7404389589488337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,L1CAM,Neural cell adhesion molecule L1,27225,47,0.78 [0.32-1.91],0.5908706572012303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,23652,40,0.87 [0.62-1.21],0.3989147140738246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LACRT,Extracellular glycoprotein lacritin,23471,40,0.92 [0.51-1.67],0.7917485806405703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LACTB2,Endoribonuclease LACTB2,27132,49,0.81 [0.54-1.19],0.279192981475909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAG3,Lymphocyte activation gene 3 protein,27009,48,1.49 [0.85-2.63],0.1651888535524282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,27139,49,1.39 [0.81-2.36],0.2281496245706458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,26950,48,1.27 [0.98-1.66],0.0749098051014776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAMA1,Laminin subunit alpha-1,22889,39,1.23 [0.79-1.93],0.3618581286952608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAMA4,Laminin subunit alpha-4,27269,49,0.53 [0.24-1.18],0.1184591232351084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAMB1,Laminin subunit beta-1,23041,41,0.65 [0.24-1.78],0.3985334594863908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAMP1,Lysosome-associated membrane glycoprotein 1,22984,40,0.73 [0.20-2.75],0.6472837493105237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAMP2,Lysosome-associated membrane glycoprotein 2,26319,47,0.62 [0.15-2.53],0.5078205058148219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAMP3,Lysosome-associated membrane glycoprotein 3,27369,48,1.55 [0.96-2.49],0.0706241708861501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAMTOR5,Ragulator complex protein LAMTOR5,23514,40,1.41 [0.78-2.55],0.2510015748424298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAP3,Cytosol aminopeptidase,26592,46,1.06 [0.62-1.81],0.8244525653781547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LARP1,La-related protein 1,23514,40,0.82 [0.49-1.39],0.4702102040980577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAT,Linker for activation of T-cells family member 1,27414,49,0.85 [0.62-1.16],0.3100613022155404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAT2,Linker for activation of T-cells family member 2,27009,48,0.92 [0.75-1.14],0.4496417815367034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LATS1,Serine/threonine-protein kinase LATS1,22978,40,0.77 [0.53-1.11],0.1642973073097169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAYN,Layilin,26900,48,1.37 [0.68-2.79],0.3768322927091818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LBP,Lipopolysaccharide-binding protein,27224,49,1.54 [1.03-2.32],0.0366586673377214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LBR,Delta(14)-sterol reductase LBR,27371,49,1.16 [0.83-1.62],0.3742733804850238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LCAT,Phosphatidylcholine-sterol acyltransferase,23663,40,0.57 [0.21-1.57],0.2773336714260793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LCN15,Lipocalin-15,23614,39,1.10 [0.69-1.75],0.6803370564601365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LCN2,Neutrophil gelatinase-associated lipocalin,26296,48,0.87 [0.44-1.71],0.685580241281711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LCP1,Plastin-2,23649,41,0.89 [0.47-1.69],0.7231097507247046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LDLR,Low-density lipoprotein receptor,27201,46,1.12 [0.69-1.82],0.6570088480767279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LDLRAP1,Low density lipoprotein receptor adapter protein 1,23614,39,0.82 [0.60-1.13],0.2246802725622777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LECT2,Leukocyte cell-derived chemotaxin-2,23652,40,0.93 [0.58-1.47],0.7454015440619275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LEFTY2,Left-right determination factor 2,27315,49,1.14 [0.68-1.90],0.6243863257845603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LEG1,Protein LEG1 homolog,22342,39,0.94 [0.60-1.46],0.7725938972176432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LELP1,Late cornified envelope-like proline-rich protein 1,22880,37,0.88 [0.55-1.40],0.575691128934759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LEO1,RNA polymerase-associated protein LEO1,23614,39,1.22 [0.58-2.56],0.5946545452496108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LEP,Leptin,27132,49,0.74 [0.50-1.08],0.1196743390859285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LEPR,Leptin receptor,27132,49,1.19 [0.53-2.68],0.6737833397864132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LETM1,Mitochondrial proton/calcium exchanger protein,23614,39,1.03 [0.58-1.83],0.918519837393748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS1,Galectin-1,27132,49,0.50 [0.24-1.06],0.0692791394504605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS3,Galectin-3,27189,47,2.13 [1.04-4.36],0.0387640484639809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS3BP,Galectin-3-binding protein,23695,41,1.71 [0.85-3.44],0.1313400729105395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS4,Galectin-4,27139,49,1.40 [0.90-2.17],0.137104335764499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS7_LGALS7B,Galectin-7,27052,48,1.20 [0.66-2.18],0.5589470261245537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS8,Galectin-8,27371,49,0.90 [0.59-1.37],0.621430861374042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS9,Galectin-9,27135,49,1.57 [0.75-3.30],0.2279422139263439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGMN,Legumain,27269,49,1.48 [0.75-2.91],0.2608309468030143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LHB,Lutropin subunit beta,26496,46,0.99 [0.72-1.36],0.947653298368408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,27181,49,1.07 [0.71-1.61],0.7384502235519343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LIF,Leukemia inhibitory factor,26470,44,1.08 [0.66-1.76],0.7704863484251062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LIFR,Leukemia inhibitory factor receptor,27084,49,2.11 [0.79-5.66],0.1377403572678338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,27137,49,1.26 [0.62-2.57],0.5243541596171477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,23649,41,0.97 [0.80-1.18],0.7765926411559115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,22889,39,1.68 [1.18-2.41],0.0043695624595472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,27087,49,0.65 [0.30-1.43],0.2851155476643817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,23652,40,1.47 [0.96-2.24],0.0751709956087835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,27462,47,0.81 [0.32-2.03],0.6483867246201602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,27328,47,0.71 [0.35-1.46],0.3539443382780681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,26592,46,1.51 [0.86-2.68],0.1526306208562532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,27462,47,1.12 [0.77-1.63],0.5642273093951728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LIPF,Gastric triacylglycerol lipase,23041,41,0.86 [0.53-1.41],0.5616792243497609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LMNB1,Lamin-B1,23481,40,1.06 [0.65-1.71],0.8188798530357437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LMNB2,Lamin-B2,23597,41,2.29 [0.93-5.67],0.0725816592179732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LMOD1,Leiomodin-1,23614,39,1.07 [0.46-2.46],0.8816313339077937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LMOD2,Leiomodin-2,22880,37,0.84 [0.48-1.47],0.5347902309728243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LONP1,"Lon protease homolog, mitochondrial",23041,41,0.92 [0.65-1.30],0.6374638625599554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LPA,Apolipoprotein(a),23110,40,0.94 [0.79-1.11],0.4426508272007456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LPCAT2,Lysophosphatidylcholine acyltransferase 2,27009,48,1.05 [0.58-1.88],0.8753019544355819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LPL,Lipoprotein lipase,27132,49,1.16 [0.66-2.01],0.6113916140082196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LPO,Lactoperoxidase,26300,46,1.14 [0.75-1.74],0.5394288627090345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LPP,Lipoma-preferred partner,22889,39,0.84 [0.52-1.34],0.4560098812316636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,22889,39,0.86 [0.54-1.39],0.5410910491691879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,22992,41,1.10 [0.62-1.95],0.7518384601461953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRG1,Leucine-rich alpha-2-glycoprotein,23695,41,2.03 [0.69-5.97],0.2006903036270073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,27278,49,2.02 [0.97-4.20],0.0593388129236894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,22888,39,0.36 [0.09-1.37],0.1344760739519748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRP1,Prolow-density lipoprotein receptor-related protein 1,27009,48,1.08 [0.41-2.84],0.883552935317136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRP11,Low-density lipoprotein receptor-related protein 11,27132,49,0.82 [0.40-1.66],0.5745701576727891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRP2,Low-density lipoprotein receptor-related protein 2,22992,41,0.58 [0.23-1.48],0.2552419097520722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRP2BP,LRP2-binding protein,22992,41,0.72 [0.45-1.17],0.1872074519214793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,27371,49,0.95 [0.60-1.49],0.8158640095425183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRRC25,Leucine-rich repeat-containing protein 25,27009,48,0.84 [0.42-1.65],0.6070244077190083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRRC37A2,Leucine-rich repeat-containing protein 37A2,23528,40,0.85 [0.42-1.74],0.6620739413901426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRRC38,Leucine-rich repeat-containing protein 38,22992,41,1.28 [0.75-2.18],0.3582115943514397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRRC59,Leucine-rich repeat-containing protein 59,23652,40,1.00 [0.54-1.87],0.9893733597131348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,23514,40,0.71 [0.36-1.38],0.3106396395571294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRRN1,Leucine-rich repeat neuronal protein 1,26592,46,0.62 [0.31-1.21],0.158041316422667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,22992,41,1.07 [0.53-2.16],0.8440386725664228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,23614,39,1.22 [0.43-3.50],0.7113099169770406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LSM1,U6 snRNA-associated Sm-like protein LSm1,26496,46,1.17 [0.79-1.74],0.421188800308806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LSM8,U6 snRNA-associated Sm-like protein LSm8,23202,40,0.95 [0.67-1.35],0.780412459195463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LSP1,Lymphocyte-specific protein 1,27084,49,1.23 [0.67-2.28],0.5019153855138789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTA,Lymphotoxin-alpha,27084,49,1.48 [0.85-2.61],0.1684630233841084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTA4H,Leukotriene A-4 hydrolase,27363,49,0.98 [0.63-1.52],0.9276310759528348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTB,Lymphotoxin-beta,23514,40,1.06 [0.45-2.51],0.8960851492034401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTBP2,Latent-transforming growth factor beta-binding protein 2,27462,47,2.71 [1.30-5.61],0.0075000587784039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTBP3,Latent-transforming growth factor beta-binding protein 3,26496,46,1.51 [1.07-2.12],0.0195663014383389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTBR,Tumor necrosis factor receptor superfamily member 3,27010,49,1.73 [0.74-4.06],0.2039779985520608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTO1,Protein LTO1 homolog,26592,46,1.52 [1.00-2.29],0.0481285584005046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LUZP2,Leucine zipper protein 2,23514,40,0.95 [0.46-1.94],0.8789111848939715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LXN,Latexin,26828,47,1.30 [0.93-1.83],0.1274564494461684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LY6D,Lymphocyte antigen 6D,27001,49,0.82 [0.41-1.63],0.5679890868213333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LY75,Lymphocyte antigen 75,27084,49,0.79 [0.42-1.50],0.4744421197825258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LY9,T-lymphocyte surface antigen Ly-9,26847,47,1.52 [0.64-3.59],0.3393152925531401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LY96,Lymphocyte antigen 96,26950,48,1.60 [0.84-3.02],0.149443702174923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYAR,Cell growth-regulating nucleolar protein,26496,46,0.88 [0.50-1.53],0.6404343352595838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYN,Tyrosine-protein kinase Lyn,27009,48,0.90 [0.67-1.21],0.4854095403959405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYPD1,Ly6/PLAUR domain-containing protein 1,26470,44,0.99 [0.64-1.53],0.9601271485568608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYPD3,Ly6/PLAUR domain-containing protein 3,27000,46,0.54 [0.25-1.18],0.122365196412379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYPD8,Ly6/PLAUR domain-containing protein 8,26496,46,0.77 [0.45-1.33],0.3461870452908938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYPLA2,Acyl-protein thioesterase 2,22880,37,0.82 [0.57-1.19],0.3019562909475321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,22992,41,1.04 [0.79-1.37],0.7626482171038966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,23695,41,0.72 [0.16-3.20],0.6610533170732288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYZL2,Lysozyme-like protein 2,22790,39,1.19 [0.53-2.70],0.676032913318152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LZTFL1,Leucine zipper transcription factor-like protein 1,23153,40,0.75 [0.48-1.16],0.1902276097561816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,M6PR,Cation-dependent mannose-6-phosphate receptor,23041,41,0.34 [0.11-1.04],0.0580253439550121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,26857,48,1.31 [0.87-1.96],0.1960972144222195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAEA,E3 ubiquitin-protein transferase MAEA,26496,46,1.22 [0.68-2.20],0.4994462050226479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAG,Myelin-associated glycoprotein,22992,41,1.23 [0.66-2.28],0.5172048026409701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAGEA3,Melanoma-associated antigen 3,23202,40,1.16 [0.79-1.71],0.437482226852703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAGED1,Melanoma-associated antigen D1,26496,46,1.14 [0.68-1.93],0.6144529290434241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAMDC2,MAM domain-containing protein 2,23652,40,1.55 [0.69-3.49],0.2888772463747551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAMDC4,Apical endosomal glycoprotein,23514,40,0.86 [0.48-1.53],0.606869443910461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",23041,41,1.53 [0.46-5.11],0.4885409898338857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAN2B2,Epididymis-specific alpha-mannosidase,23652,40,0.90 [0.54-1.50],0.6805783643997071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",22790,39,1.34 [0.78-2.31],0.2930281054798285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MANF,Mesencephalic astrocyte-derived neurotrophic factor,27269,49,0.91 [0.75-1.12],0.384751393642043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MANSC1,MANSC domain-containing protein 1,27225,47,1.03 [0.41-2.61],0.9515771645055576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MANSC4,MANSC domain-containing protein 4,22889,39,1.08 [0.70-1.67],0.7164861510959365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,22880,37,1.22 [0.45-3.31],0.6968774905773553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,22889,39,0.96 [0.58-1.57],0.8698580477935443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAP2,Microtubule-associated protein 2,23597,41,1.35 [0.77-2.37],0.2987759041652295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,23528,40,0.96 [0.60-1.54],0.8727622200729124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,27084,49,0.83 [0.65-1.07],0.1525713152797004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,26496,46,0.84 [0.63-1.11],0.2111560123160973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,26900,48,0.93 [0.74-1.16],0.5119691656262539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAPK13,Mitogen-activated protein kinase 13,22790,39,0.89 [0.42-1.88],0.755767463196898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAPK9,Mitogen-activated protein kinase 9,27084,49,0.90 [0.50-1.62],0.7244758403346281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAPKAPK2,MAP kinase-activated protein kinase 2,23202,40,0.67 [0.44-1.03],0.0669129330467473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAPRE3,Microtubule-associated protein RP/EB family member 3,22790,39,1.09 [0.90-1.32],0.3652411098746456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAPT,Microtubule-associated protein tau,26470,44,0.87 [0.54-1.41],0.5755659227437153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MARCO,Macrophage receptor MARCO,27132,49,1.54 [0.60-3.97],0.3709183485151455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MARS1,"Methionine--tRNA ligase, cytoplasmic",23105,40,0.91 [0.64-1.30],0.6091764039725063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MASP1,Mannan-binding lectin serine protease 1,26900,48,1.52 [0.51-4.51],0.448104860888761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MATN2,Matrilin-2,27187,49,2.33 [1.01-5.37],0.0466093142276313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MATN3,Matrilin-3,26908,48,1.75 [0.81-3.75],0.1527458609951597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAVS,Mitochondrial antiviral-signaling protein,26496,46,1.01 [0.76-1.34],0.945957150258842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAX,Protein max,26470,44,0.84 [0.65-1.09],0.196404747040808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MB,Myoglobin,27462,47,1.08 [0.65-1.79],0.7768458503990919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MBL2,Mannose-binding protein C,23342,40,1.04 [0.78-1.38],0.7981001699521422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MCAM,Cell surface glycoprotein MUC18,27224,49,1.02 [0.49-2.13],0.9609285850579355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",23614,39,0.84 [0.39-1.82],0.6582130326594171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MCEMP1,Mast cell-expressed membrane protein 1,22978,40,0.74 [0.51-1.06],0.0954085221966012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MCFD2,Multiple coagulation factor deficiency protein 2,27016,49,0.84 [0.47-1.52],0.5650784696797335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MCTS1,Malignant T-cell-amplified sequence 1,23528,40,0.90 [0.27-3.01],0.8627038295745263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,26950,48,1.03 [0.71-1.49],0.8718409298113037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MDH1,"Malate dehydrogenase, cytoplasmic",23523,40,0.91 [0.43-1.93],0.8147584075096742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MDK,Midkine,27147,46,1.09 [0.68-1.74],0.7175688656579033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MDM1,Nuclear protein MDM1,22992,41,0.81 [0.31-2.14],0.6716488597859129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",23041,41,0.89 [0.64-1.24],0.4744248819923435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MED18,Mediator of RNA polymerase II transcription subunit 18,26496,46,0.94 [0.67-1.33],0.7363893959752013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MED21,Mediator of RNA polymerase II transcription subunit 21,22889,39,0.67 [0.30-1.50],0.3272138030928146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MEGF10,Multiple epidermal growth factor-like domains protein 10,27139,49,0.70 [0.36-1.39],0.3105462859704404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MEGF11,Multiple epidermal growth factor-like domains protein 11,22889,39,1.16 [0.50-2.67],0.7334952686115037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MEGF9,Multiple epidermal growth factor-like domains protein 9,27373,47,0.42 [0.12-1.52],0.1884383092190244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MELTF,Melanotransferrin,23652,40,2.22 [0.88-5.60],0.0919244363282616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MENT,Protein MENT,23153,40,0.74 [0.19-2.83],0.655577190757804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MEP1A,Meprin A subunit alpha,23528,40,0.95 [0.61-1.47],0.8032783580491613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MEP1B,Meprin A subunit beta,27132,49,0.83 [0.68-1.01],0.0576449528418657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MEPE,Matrix extracellular phosphoglycoprotein,27139,49,1.18 [0.46-3.02],0.7225068301550011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MERTK,Tyrosine-protein kinase Mer,27414,49,1.10 [0.42-2.87],0.8518469995626055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MESD,LRP chaperone MESD,27137,49,0.90 [0.73-1.11],0.3454451297406857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MET,Hepatocyte growth factor receptor,27210,46,1.02 [0.29-3.61],0.9780948803606672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,METAP1,Methionine aminopeptidase 1,26470,44,1.26 [0.53-2.95],0.6016048855496265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",27084,49,0.89 [0.65-1.21],0.4482524789633211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,METAP2,Methionine aminopeptidase 2,27315,49,0.94 [0.61-1.44],0.7792075667840399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MFAP3,Microfibril-associated glycoprotein 3,26637,46,0.50 [0.26-0.96],0.0382331555851179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MFAP3L,Microfibrillar-associated protein 3-like,22992,41,0.97 [0.61-1.54],0.8863208740128529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MFAP4,Microfibril-associated glycoprotein 4,23153,40,2.99 [1.20-7.48],0.0191100999947237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MFAP5,Microfibrillar-associated protein 5,27462,47,0.88 [0.47-1.65],0.6902673955089245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MFGE8,Lactadherin,27137,49,1.55 [0.90-2.69],0.1156657526343522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MGLL,Monoglyceride lipase,27224,49,0.89 [0.67-1.19],0.4395069415886081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MGMT,Methylated-DNA--protein-cysteine methyltransferase,27084,49,0.83 [0.68-1.01],0.0565768756652612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MIA,Melanoma-derived growth regulatory protein,27225,47,0.71 [0.34-1.45],0.3426635673029242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MICALL2,MICAL-like protein 2,22992,41,0.94 [0.60-1.46],0.7703105992433928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,27084,49,1.10 [0.91-1.32],0.344108118585147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MIF,Macrophage migration inhibitory factor,27099,49,0.86 [0.60-1.24],0.4301844639418658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MILR1,Allergin-1,26592,46,1.25 [0.75-2.08],0.3939038523282122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,23514,40,0.94 [0.71-1.23],0.6371423870579146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MINK1,Misshapen-like kinase 1,23597,41,0.95 [0.69-1.30],0.7400744410853745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MITD1,MIT domain-containing protein 1,26950,48,0.92 [0.71-1.20],0.5473004639321448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MKI67,Proliferation marker protein Ki-67,22978,40,0.78 [0.32-1.91],0.583173090854084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MLLT1,Protein ENL,22790,39,1.09 [0.72-1.67],0.6736421539991835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MLN,Promotilin,27084,49,1.04 [0.79-1.38],0.7671334714506144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MME,Neprilysin,27009,48,1.21 [0.91-1.62],0.1873607917956277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP1,Interstitial collagenase,26093,47,0.98 [0.74-1.31],0.9134570141381376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP10,Stromelysin-2,27097,49,0.63 [0.40-1.00],0.0505444270991774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP12,Macrophage metalloelastase,27142,49,0.85 [0.52-1.38],0.5107309965002221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP13,Collagenase 3,26470,44,0.97 [0.43-2.17],0.9354389053115711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP15,Matrix metalloproteinase-15,23652,40,0.92 [0.48-1.78],0.8125631392573217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP3,Stromelysin-1,27137,49,1.33 [0.82-2.14],0.2440588795303172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP7,Matrilysin,26592,46,1.03 [0.59-1.80],0.9099232237024364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP8,Neutrophil collagenase,27324,49,0.93 [0.66-1.31],0.6777005335296968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP9,Matrix metalloproteinase-9,27088,49,0.73 [0.48-1.11],0.1421725711721744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",22889,39,0.70 [0.35-1.40],0.3078376461615273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MN1,Transcriptional activator MN1,22992,41,1.54 [1.09-2.16],0.0134584674585567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MNAT1,CDK-activating kinase assembly factor MAT1,23202,40,0.93 [0.45-1.90],0.8410426876660464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MNDA,Myeloid cell nuclear differentiation antigen,27091,49,1.14 [0.91-1.42],0.2501599888092098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MOCS2,Molybdopterin synthase catalytic subunit,23153,40,0.96 [0.61-1.51],0.8557027309809279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MOG,Myelin-oligodendrocyte glycoprotein,27363,49,0.74 [0.34-1.59],0.4344463033912747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MORC3,MORC family CW-type zinc finger protein 3,23597,41,0.72 [0.22-2.35],0.5817852494845605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MORF4L1,Mortality factor 4-like protein 1,23202,40,0.58 [0.24-1.43],0.2374970288189752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MORF4L2,Mortality factor 4-like protein 2,22790,39,0.34 [0.11-1.06],0.0638256575953784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MORN4,MORN repeat-containing protein 4,22790,39,0.92 [0.60-1.42],0.7026726820167719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MPHOSPH8,M-phase phosphoprotein 8,26637,46,0.97 [0.68-1.37],0.8445344052605767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MPI,Mannose-6-phosphate isomerase,27009,48,0.89 [0.65-1.20],0.4312496753886002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,27224,49,0.78 [0.58-1.06],0.1097629754288953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MPO,Myeloperoxidase,27137,49,1.25 [0.76-2.06],0.3844233022453185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MPRIP,Myosin phosphatase Rho-interacting protein,23465,40,1.04 [0.53-2.05],0.9004064637301551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRC1,Macrophage mannose receptor 1,23663,40,2.09 [0.80-5.43],0.131715874066283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRI1,Methylthioribose-1-phosphate isomerase,22992,41,0.98 [0.63-1.52],0.919749290542802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRPL24,"39S ribosomal protein L24, mitochondrial",22889,39,1.05 [0.47-2.34],0.907285580443566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRPL28,"39S ribosomal protein L28, mitochondrial",23614,39,1.29 [0.72-2.30],0.3959691490430641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRPL46,"39S ribosomal protein L46, mitochondrial",26470,44,0.65 [0.23-1.85],0.4221965311789498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRPL52,"39S ribosomal protein L52, mitochondrial",22750,39,0.85 [0.25-2.87],0.7915673191698412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",23614,39,0.89 [0.56-1.41],0.615403219718124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRPS16,"28S ribosomal protein S16, mitochondrial",22978,40,0.76 [0.45-1.30],0.3156383874614458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MSLN,Mesothelin,26967,48,0.95 [0.60-1.49],0.8242822592677556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MSLNL,Mesothelin-like protein,22992,41,0.79 [0.34-1.82],0.5796445377777952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MSMB,Beta-microseminoprotein,27034,47,0.88 [0.62-1.26],0.4770581789255569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MSR1,Macrophage scavenger receptor types I and II,27371,49,1.33 [0.75-2.35],0.3237743155851056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MSRA,Mitochondrial peptide methionine sulfoxide reductase,27225,47,0.86 [0.60-1.23],0.4102600731664076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MST1,Hepatocyte growth factor-like protein,23301,39,0.81 [0.58-1.15],0.2410498071442741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MSTN,Growth/differentiation factor 8,26637,46,0.66 [0.40-1.10],0.1091394998916748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTDH,Protein LYRIC,22978,40,0.97 [0.69-1.35],0.8375725630288489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",23597,41,0.40 [0.10-1.58],0.1933818195489148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,23202,40,0.75 [0.57-0.99],0.0450783500162497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTIF3,"Translation initiation factor IF-3, mitochondrial",23528,40,0.90 [0.64-1.27],0.5498556513685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTPN,Myotrophin,26637,46,1.10 [0.52-2.31],0.8050440872787485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTR,Methionine synthase,22889,39,1.09 [0.71-1.67],0.6960978703208791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTSS1,Protein MTSS 1,23528,40,0.95 [0.72-1.24],0.693367655112304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTSS2,Protein MTSS 2,23514,40,0.88 [0.65-1.20],0.42182925435855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTUS1,Microtubule-associated tumor suppressor 1,23202,40,1.42 [0.93-2.16],0.1002914781214385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MUC13,Mucin-13,26470,44,1.17 [0.70-1.97],0.5491945239590419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MUC16,Mucin-16,27009,48,1.02 [0.89-1.16],0.8077921477230842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MUC2,Mucin-2,23649,41,1.08 [0.79-1.49],0.6226197076502107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MUCL3,Mucin-like protein 3,22790,39,0.77 [0.34-1.76],0.5363901985466661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MVK,Mevalonate kinase,26592,46,1.03 [0.73-1.43],0.8824151890454477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MXRA8,Matrix remodeling-associated protein 8,23153,40,0.93 [0.35-2.46],0.878599649310571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYBPC1,"Myosin-binding protein C, slow-type",23652,40,1.19 [0.77-1.84],0.4421515363547635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYBPC2,"Myosin-binding protein C, fast-type",23041,41,0.90 [0.60-1.35],0.6028399409888283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,23614,39,1.06 [0.68-1.64],0.8082557588684667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYDGF,Myeloid-derived growth factor,23652,40,0.93 [0.69-1.26],0.6481200094702533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYH4,Myosin-4,22889,39,1.21 [0.68-2.13],0.5181507845449451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYH7B,Myosin-7B,22790,39,1.07 [0.55-2.08],0.847973119162082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYH9,Myosin-9,23649,41,0.94 [0.72-1.22],0.6447937942503709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",22889,39,1.23 [0.67-2.23],0.5034947717425229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYL3,Myosin light chain 3,23041,41,0.97 [0.62-1.50],0.8833190770239835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYL4,Myosin light chain 4,23041,41,1.07 [0.62-1.83],0.8149852110951276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYL6B,Myosin light chain 6B,22992,41,0.99 [0.71-1.39],0.950061886113349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",22992,41,0.66 [0.26-1.63],0.3650297190687549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYO6,Unconventional myosin-VI,23614,39,1.21 [0.56-2.62],0.6196519660021635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYO9B,Unconventional myosin-IXb,26592,46,0.98 [0.66-1.46],0.9293252228182994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYOC,Myocilin,27137,49,0.90 [0.52-1.58],0.7230157462725262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYOM1,Myomesin-1,22880,37,1.19 [0.67-2.10],0.5579681927094705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYOM2,Myomesin-2,22889,39,0.95 [0.48-1.91],0.8911195841734444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYOM3,Myomesin-3,23153,40,1.04 [0.74-1.46],0.8138885549207587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MZB1,Marginal zone B- and B1-cell-specific protein,27232,49,1.13 [0.71-1.82],0.5998030353559232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MZT1,Mitotic-spindle organizing protein 1,26496,46,0.86 [0.51-1.45],0.5682825809600898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAA10,N-alpha-acetyltransferase 10,22889,39,0.96 [0.52-1.75],0.8841538212513733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAA80,N-alpha-acetyltransferase 80,22992,41,0.85 [0.65-1.09],0.2019611949299395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAAA,N-acylethanolamine-hydrolyzing acid amidase,26824,47,0.76 [0.48-1.20],0.2320991014420121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NACC1,Nucleus accumbens-associated protein 1,23514,40,1.01 [0.58-1.76],0.9760631082964202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NADK,NAD kinase,27132,49,1.26 [0.86-1.86],0.2321060411784239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAGA,Alpha-N-acetylgalactosaminidase,22930,40,1.01 [0.59-1.74],0.973944303696226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAGK,N-acetyl-D-glucosamine kinase,22996,41,0.85 [0.49-1.46],0.5465831991448998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,23153,40,2.54 [0.63-10.22],0.1897591925754297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAMPT,Nicotinamide phosphoribosyltransferase,26496,46,1.19 [0.79-1.78],0.4090884178642658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAP1L4,Nucleosome assembly protein 1-like 4,23487,40,1.28 [0.61-2.69],0.5213475198115702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAPRT,Nicotinate phosphoribosyltransferase,23597,41,1.40 [0.62-3.17],0.4200951823805604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NARS1,"Asparagine--tRNA ligase, cytoplasmic",23614,39,0.97 [0.51-1.84],0.9289743392883308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NBL1,Neuroblastoma suppressor of tumorigenicity 1,27225,47,0.68 [0.25-1.82],0.439287359169893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NBN,Nibrin,26592,46,1.17 [0.76-1.81],0.4719017475679126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCAM1,Neural cell adhesion molecule 1,27224,49,1.35 [0.56-3.28],0.50490222860307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCAM2,Neural cell adhesion molecule 2,27137,49,0.43 [0.17-1.10],0.0784227484548071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCAN,Neurocan core protein,27371,49,0.59 [0.31-1.14],0.1199856604826479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCF2,Neutrophil cytosol factor 2,27047,49,1.04 [0.78-1.39],0.7837344408681776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCK2,Cytoplasmic protein NCK2,27269,49,0.95 [0.75-1.21],0.6798313563762086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCLN,Nicalin,26592,46,0.99 [0.58-1.68],0.9721399389605264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCR1,Natural cytotoxicity triggering receptor 1,27044,49,1.32 [0.66-2.61],0.4327841711202058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,23528,40,3.78 [1.79-7.99],0.0004871272218212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCS1,Neuronal calcium sensor 1,27363,49,0.86 [0.35-2.10],0.7415088459061785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NDRG1,Protein NDRG1,26470,44,0.71 [0.42-1.21],0.2072731819848615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,23514,40,1.03 [0.65-1.61],0.9136196826703992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,22937,40,1.28 [0.55-2.97],0.572746623241776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,23528,40,0.86 [0.61-1.21],0.3818555904387136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",26496,46,1.29 [1.02-1.64],0.0359143772879085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEB,Nebulin,22889,39,0.81 [0.31-2.07],0.6539371605580235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NECAP2,Adaptin ear-binding coat-associated protein 2,22889,39,0.74 [0.45-1.23],0.2515562773157182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NECTIN1,Nectin-1,22978,40,1.24 [0.54-2.86],0.6188679618395617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NECTIN2,Nectin-2,27087,49,1.81 [0.80-4.10],0.156985256707644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NECTIN4,Nectin-4,27225,47,0.80 [0.33-1.92],0.6142502171120793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,22978,40,0.71 [0.40-1.26],0.2374329615136733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEDD9,Enhancer of filamentation 1,22978,40,0.94 [0.37-2.41],0.8929306043782584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEFL,Neurofilament light polypeptide,26382,44,2.00 [1.17-3.40],0.0106935419006396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEK7,Serine/threonine-protein kinase Nek7,23202,40,0.63 [0.37-1.08],0.0936568879326191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NELL1,Protein kinase C-binding protein NELL1,27225,47,1.03 [0.56-1.88],0.9260986704148056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NELL2,Protein kinase C-binding protein NELL2,27269,49,0.60 [0.24-1.48],0.2673493353160184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NENF,Neudesin,23514,40,0.91 [0.67-1.24],0.5659762518541367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEO1,Neogenin,23614,39,1.10 [0.28-4.37],0.8946773954329229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEXN,Nexilin,23663,40,0.86 [0.55-1.34],0.4948559883632075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFASC,Neurofascin,27414,49,0.98 [0.39-2.45],0.9585118247333552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFAT5,Nuclear factor of activated T-cells 5,22978,40,0.85 [0.58-1.23],0.3817854951770908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",27084,49,0.89 [0.68-1.17],0.419736603841171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",26592,46,1.06 [0.67-1.66],0.8089046774240817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFE2,Transcription factor NF-E2 45 kDa subunit,23041,41,0.87 [0.58-1.31],0.4985984120849971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFIC,Nuclear factor 1 C-type,23614,39,1.15 [0.64-2.08],0.6428755876235397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFKB1,Nuclear factor NF-kappa-B p105 subunit,22889,39,0.87 [0.57-1.34],0.5297171466302178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFKB2,Nuclear factor NF-kappa-B p100 subunit,23202,40,0.87 [0.47-1.62],0.6640438848542505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFKBIE,NF-kappa-B inhibitor epsilon,26496,46,1.13 [0.67-1.91],0.6391663599196522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",23528,40,0.91 [0.68-1.23],0.548392066607942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFX1,Transcriptional repressor NF-X1,22889,39,0.91 [0.56-1.46],0.6853273797937947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFYA,Nuclear transcription factor Y subunit alpha,22889,39,0.94 [0.40-2.21],0.8906057436536696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NGF,Beta-nerve growth factor,26950,48,0.55 [0.19-1.60],0.2680154784114384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NGFR,Tumor necrosis factor receptor superfamily member 16,23652,40,0.79 [0.26-2.42],0.6733335178825501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NGRN,Neugrin,23597,41,1.02 [0.26-4.00],0.9719397428325208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NHLRC3,NHL repeat-containing protein 3,22586,39,1.53 [0.57-4.14],0.3990087779633497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NID1,Nidogen-1,27133,49,1.33 [0.72-2.46],0.3671202172138288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NID2,Nidogen-2,27137,49,0.94 [0.67-1.32],0.7191027664289331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NINJ1,Ninjurin-1,26496,46,0.98 [0.60-1.61],0.9300350787708188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NIT1,Deaminated glutathione amidase,23041,41,0.87 [0.48-1.58],0.6455215435814112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NIT2,Omega-amidase NIT2,23568,40,0.87 [0.58-1.30],0.490429041973854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NLGN1,Neuroligin-1,22992,41,0.66 [0.35-1.24],0.1935678943139603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NLGN2,Neuroligin-2,22880,37,0.96 [0.49-1.89],0.9046184010210948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NME1,Nucleoside diphosphate kinase A,22978,40,0.54 [0.13-2.21],0.3923939525052349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NME3,Nucleoside diphosphate kinase 3,27187,49,0.69 [0.22-2.15],0.5165551626904703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NMI,N-myc-interactor,23430,40,1.23 [0.83-1.82],0.2968385124359954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,26950,48,1.10 [0.79-1.51],0.5756731556963992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NMRK2,Nicotinamide riboside kinase 2,22790,39,0.52 [0.19-1.47],0.2200449877918363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,23614,39,0.77 [0.45-1.31],0.3309929854814431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOMO1,Nodal modulator 1,27137,49,0.60 [0.20-1.76],0.348377949923748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOP56,Nucleolar protein 56,22889,39,1.01 [0.77-1.34],0.9363988883301262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOS1,"Nitric oxide synthase, brain",26470,44,0.78 [0.44-1.38],0.38842025633043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOS2,"Nitric oxide synthase, inducible",22889,39,0.99 [0.44-2.21],0.9753366471011262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOS3,"Nitric oxide synthase, endothelial",26470,44,1.40 [0.97-2.02],0.0743502417327601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOTCH1,Neurogenic locus notch homolog protein 1,27462,47,0.59 [0.11-3.07],0.5293776319950461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOTCH2,Neurogenic locus notch homolog protein 2,23649,41,2.38 [0.70-8.06],0.1640133775724431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOTCH3,Neurogenic locus notch homolog protein 3,27462,47,1.20 [0.57-2.52],0.6256053025484605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPC2,NPC intracellular cholesterol transporter 2,23251,41,1.26 [0.52-3.05],0.6156476528903945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPDC1,Neural proliferation differentiation and control protein 1,27132,49,1.05 [0.47-2.36],0.9065400769839492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPHS1,Nephrin,22978,40,0.70 [0.27-1.81],0.4661034602733602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPHS2,Podocin,22978,40,1.10 [0.85-1.42],0.4593700179146928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPL,N-acetylneuraminate lyase,23652,40,1.33 [0.71-2.48],0.3756302571904971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPPB,Natriuretic peptides B,26637,46,1.24 [1.01-1.52],0.0414355894706223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPPC,C-type natriuretic peptide,27084,49,0.86 [0.47-1.56],0.6154205955886195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPR1,Atrial natriuretic peptide receptor 1,22889,39,0.99 [0.43-2.26],0.9809171652635812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPTN,Neuroplastin,26496,46,0.91 [0.64-1.31],0.6199458129353352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPTX1,Neuronal pentraxin-1,27137,49,1.40 [0.75-2.64],0.2935960293664948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPTX2,Neuronal pentraxin-2,23649,41,3.77 [1.64-8.65],0.0017311306018084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPTXR,Neuronal pentraxin receptor,27132,49,1.14 [0.56-2.31],0.7113531003212216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPY,Pro-neuropeptide Y,27363,49,1.11 [0.75-1.63],0.6073201107637272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRCAM,Neuronal cell adhesion molecule,27132,49,0.86 [0.35-2.12],0.7401447584121829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRGN,Neurogranin,23663,40,0.85 [0.61-1.18],0.3275245102266572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRN1,Neuritin,23614,39,0.42 [0.13-1.35],0.1458675319715028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRP1,Neuropilin-1,27271,49,1.47 [0.61-3.55],0.3912320985280417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRP2,Neuropilin-2,27137,49,2.09 [0.96-4.55],0.0636949904864109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRTN,Neurturin,26592,46,1.43 [0.96-2.12],0.0787438125314673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRXN3,Neurexin-3,22992,41,0.75 [0.48-1.17],0.2012647845034549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NSFL1C,NSFL1 cofactor p47,27371,49,0.98 [0.68-1.43],0.9234102986203412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",23652,40,0.83 [0.56-1.23],0.3568566917781597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NT5C1A,Cytosolic 5'-nucleotidase 1A,23597,41,1.66 [0.80-3.45],0.1724599124497736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NT5C3A,Cytosolic 5'-nucleotidase 3A,27047,48,0.91 [0.69-1.22],0.5399640819763154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NT5E,5'-nucleotidase,27225,47,1.68 [1.18-2.39],0.0042187858389028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NTF3,Neurotrophin-3,27084,49,1.91 [1.14-3.18],0.0131662761677426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NTF4,Neurotrophin-4,26496,46,1.23 [0.72-2.11],0.4495646181897209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NTRK2,BDNF/NT-3 growth factors receptor,27132,49,0.55 [0.20-1.49],0.241564225817556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NTRK3,NT-3 growth factor receptor,27371,49,0.45 [0.14-1.40],0.1676720662792845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NTproBNP,N-terminal prohormone of brain natriuretic peptide,27132,49,1.31 [1.04-1.65],0.0199180338862994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUB1,NEDD8 ultimate buster 1,27084,49,0.99 [0.73-1.34],0.951934138365824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,23514,40,1.03 [0.75-1.41],0.8507785259497804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUCB2,Nucleobindin-2,27315,49,0.93 [0.47-1.86],0.8417105144433837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUDC,Nuclear migration protein nudC,27414,49,0.94 [0.63-1.40],0.7727601171356077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,23041,41,0.59 [0.14-2.41],0.4628083582315162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,22889,39,0.85 [0.43-1.69],0.650721604828133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUDT16,U8 snoRNA-decapping enzyme,23487,40,0.86 [0.60-1.22],0.3980939889215604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],27009,48,0.85 [0.54-1.36],0.509488741981968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUDT5,ADP-sugar pyrophosphatase,27137,49,0.78 [0.47-1.30],0.3441084980944386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUMB,Protein numb homolog,22978,40,0.84 [0.58-1.21],0.3535247399706525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUP50,Nuclear pore complex protein Nup50,22889,39,1.00 [0.41-2.48],0.9925321922666516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NXPE4,NXPE family member 4,22889,39,0.86 [0.32-2.30],0.7661968690332355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NXPH1,Neurexophilin-1,26470,44,0.57 [0.27-1.20],0.1405640349805939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NXPH3,Neurexophilin-3,22978,40,0.49 [0.20-1.17],0.1096071747624805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OBP2B,Odorant-binding protein 2b,26864,48,1.26 [0.84-1.89],0.2637000730795821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OCLN,Occludin,23614,39,1.68 [0.92-3.07],0.0936389437008819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ODAM,Odontogenic ameloblast-associated protein,26428,44,1.08 [0.69-1.70],0.7340503425267915
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OFD1,Oral-facial-digital syndrome 1 protein,23202,40,0.92 [0.55-1.52],0.738734221701489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OGA,Protein O-GlcNAcase,23528,40,0.85 [0.55-1.32],0.4698875912021487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OGFR,Opioid growth factor receptor,27009,48,0.84 [0.39-1.83],0.6615943366942163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OGN,Mimecan,27137,49,1.02 [0.55-1.90],0.9504346173333628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,23202,40,0.98 [0.60-1.60],0.927349547268603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OLFM4,Olfactomedin-4,22295,39,0.86 [0.67-1.10],0.2373546191273516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OLR1,Oxidized low-density lipoprotein receptor 1,26868,49,0.71 [0.45-1.14],0.15431961495664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OMD,Osteomodulin,27269,49,1.88 [1.01-3.47],0.0456603398274084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OMG,Oligodendrocyte-myelin glycoprotein,27009,48,0.78 [0.52-1.16],0.2236608406537062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OMP,Olfactory marker protein,22880,37,1.10 [0.60-2.01],0.7614180449763562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OPHN1,Oligophrenin-1,23597,41,0.96 [0.72-1.26],0.7508376638406145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OPLAH,5-oxoprolinase,23041,41,0.85 [0.54-1.34],0.4843678851821058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OPTC,Opticin,27009,48,0.91 [0.51-1.64],0.7628410914655248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ORM1,Alpha-1-acid glycoprotein 1,23614,41,0.48 [0.10-2.24],0.3485235603904081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OSBPL2,Oxysterol-binding protein-related protein 2,23597,41,0.61 [0.23-1.63],0.326569475717099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OSCAR,Osteoclast-associated immunoglobulin-like receptor,27187,49,1.18 [0.56-2.48],0.6558600364082637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OSM,Oncostatin-M,26957,49,0.88 [0.62-1.25],0.4669439973753507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OSMR,Oncostatin-M-specific receptor subunit beta,27271,49,1.40 [0.42-4.73],0.5859376572316849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OSTN,Osteocrin,22992,41,0.55 [0.22-1.41],0.2156208237529533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OTOA,Otoancorin,22880,37,0.99 [0.54-1.81],0.96718342243581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OTUD6B,Deubiquitinase OTUD6B,23528,40,0.81 [0.48-1.36],0.425363771240656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OTUD7B,OTU domain-containing protein 7B,23614,39,0.78 [0.47-1.28],0.3195218620782155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",23041,41,0.92 [0.59-1.42],0.6945093270357634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OXT,Oxytocin-neurophysin 1,27371,49,1.05 [0.87-1.27],0.5850306484615777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,P4HB,Protein disulfide-isomerase,27006,47,0.88 [0.45-1.74],0.7226521238604636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PACS2,Phosphofurin acidic cluster sorting protein 2,22889,39,0.81 [0.48-1.36],0.4280264282370519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PADI2,Protein-arginine deiminase type-2,26592,46,1.03 [0.65-1.64],0.9031550742558618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PADI4,Protein-arginine deiminase type-4,26428,44,1.07 [0.76-1.51],0.691497921454427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAEP,Glycodelin,26950,48,1.22 [0.97-1.52],0.0829860494695236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,23614,39,1.00 [0.76-1.31],0.996512785417844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",23202,40,0.56 [0.29-1.11],0.0952994129720739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,26637,46,1.19 [0.77-1.86],0.4336527225264542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAGR1,PAXIP1-associated glutamate-rich protein 1,23041,41,0.78 [0.38-1.63],0.510111681541491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,22748,39,0.58 [0.30-1.13],0.1076861334535133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAK4,Serine/threonine-protein kinase PAK 4,26470,44,0.84 [0.53-1.36],0.4833970808057599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PALLD,Palladin,22978,40,1.21 [0.63-2.32],0.5631815790297621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PALM,Paralemmin-1,23403,40,1.29 [0.48-3.43],0.6148898047666274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PALM2,Paralemmin-2,23597,41,2.48 [1.36-4.52],0.0029099204535624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PALM3,Paralemmin-3,22889,39,1.06 [0.71-1.57],0.7826728684460598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAM,Peptidyl-glycine alpha-amidating monooxygenase,27315,47,1.15 [0.44-2.97],0.7797581225161196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAMR1,Inactive serine protease PAMR1,27137,49,0.79 [0.32-1.98],0.6141181138077803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAPPA,Pappalysin-1,26592,46,0.88 [0.50-1.56],0.6656450818266755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PARD3,Partitioning defective 3 homolog,23202,40,1.08 [0.74-1.59],0.6919056570506701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PARK7,Parkinson disease protein 7,27137,49,0.85 [0.53-1.36],0.4989956980599127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PARP1,Poly [ADP-ribose] polymerase 1,27084,49,0.80 [0.46-1.38],0.4177984216658085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAXX,Protein PAXX,23153,40,0.79 [0.40-1.56],0.4922540453303743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PBK,Lymphokine-activated killer T-cell-originated protein kinase,22790,39,0.93 [0.34-2.54],0.8860656321287164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PBLD,Phenazine biosynthesis-like domain-containing protein,26470,44,0.99 [0.58-1.68],0.9695913574707786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,23528,40,0.48 [0.15-1.55],0.2218297297320609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCARE,Photoreceptor cilium actin regulator,22880,37,1.25 [0.97-1.61],0.0905005784255244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,23111,40,1.50 [0.85-2.65],0.1597299118024747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCBP2,Poly(rC)-binding protein 2,23614,39,0.78 [0.51-1.20],0.2551650276924917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCDH1,Protocadherin-1,27326,48,0.91 [0.28-2.98],0.869775436134294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCDH12,Protocadherin-12,23614,39,2.92 [1.14-7.51],0.0257296733450998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCDH17,Protocadherin-17,27132,49,1.69 [0.85-3.37],0.1319964245072591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCDH7,Protocadherin-7,23528,40,0.49 [0.16-1.47],0.1999949544619675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCDH9,Protocadherin-9,23528,40,1.75 [0.74-4.11],0.202090238692494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCDHB15,Protocadherin beta-15,23514,40,1.58 [0.83-2.98],0.1623065231428445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCNA,Proliferating cell nuclear antigen,22790,39,0.89 [0.51-1.55],0.6759984461843391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCSK7,Proprotein convertase subtilisin/kexin type 7,23514,40,1.34 [0.79-2.27],0.2759132523934762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCSK9,Proprotein convertase subtilisin/kexin type 9,27462,47,0.91 [0.47-1.74],0.7697478676313374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCYT2,Ethanolamine-phosphate cytidylyltransferase,23528,40,0.93 [0.62-1.38],0.7063026224012937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDAP1,28 kDa heat- and acid-stable phosphoprotein,23652,40,0.85 [0.62-1.16],0.2999626250629414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDCD1,Programmed cell death protein 1,27323,49,1.11 [0.64-1.94],0.7062271823357223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDCD1LG2,Programmed cell death 1 ligand 2,27009,48,0.84 [0.37-1.89],0.6715234178592573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDCD5,Programmed cell death protein 5,27371,49,0.97 [0.63-1.49],0.8934962079732224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDCD6,Programmed cell death protein 6,27132,49,0.97 [0.68-1.38],0.8700861306937162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDCL2,Phosducin-like protein 2,22790,39,1.14 [0.69-1.87],0.6100401406897286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",22790,39,1.27 [0.84-1.90],0.2552857863920605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",22889,39,0.93 [0.54-1.63],0.8075512360719332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",23153,40,1.00 [0.75-1.34],0.9996594040578546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDGFA,Platelet-derived growth factor subunit A,27462,47,0.85 [0.60-1.20],0.3529929359853021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDGFB,Platelet-derived growth factor subunit B,27269,49,0.87 [0.65-1.16],0.3299938033198378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDGFC,Platelet-derived growth factor C,26496,46,1.43 [0.63-3.24],0.3960702004406652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDGFRA,Platelet-derived growth factor receptor alpha,27132,49,1.13 [0.47-2.70],0.7885441246224353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDGFRB,Platelet-derived growth factor receptor beta,27462,47,1.16 [0.55-2.45],0.6960449085154468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDIA2,Protein disulfide-isomerase A2,22790,39,1.11 [0.54-2.27],0.7780706710482634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDIA3,Protein disulfide-isomerase A3,23153,40,1.72 [0.76-3.92],0.194176663322701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDIA4,Protein disulfide-isomerase A4,23649,41,0.92 [0.56-1.51],0.7292724622507447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDIA5,Protein disulfide-isomerase A5,22790,39,0.55 [0.30-1.00],0.0496203880260136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDLIM5,PDZ and LIM domain protein 5,23614,39,0.93 [0.72-1.20],0.5859553014603605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDLIM7,PDZ and LIM domain protein 7,27269,49,0.92 [0.75-1.12],0.4064305194716952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",26496,46,0.79 [0.43-1.45],0.4419760632013519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDRG1,p53 and DNA damage-regulated protein 1,22992,41,0.77 [0.39-1.49],0.4336317702509545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,22790,39,0.60 [0.25-1.41],0.238026366240122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDZD2,PDZ domain-containing protein 2,22889,39,0.86 [0.50-1.48],0.5819255578448379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,22978,40,1.65 [0.94-2.90],0.0831520092752635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PEAR1,Platelet endothelial aggregation receptor 1,27462,47,1.07 [0.34-3.34],0.9100512780926536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PEBP1,Phosphatidylethanolamine-binding protein 1,27137,49,0.94 [0.61-1.45],0.7951822938249951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PECAM1,Platelet endothelial cell adhesion molecule,27137,49,1.41 [0.63-3.16],0.4062192691905177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PECR,Peroxisomal trans-2-enoyl-CoA reductase,23041,41,0.36 [0.11-1.20],0.0956642159484926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PENK,Proenkephalin-A,23153,40,1.18 [0.46-3.03],0.7240770412475994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PEPD,Xaa-Pro dipeptidase,23663,40,1.25 [0.39-3.97],0.7105375676305088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PER3,Period circadian protein homolog 3,22978,40,1.02 [0.80-1.31],0.855428402805194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PF4,Platelet factor 4,23523,41,0.89 [0.65-1.21],0.4478975494612409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PFDN2,Prefoldin subunit 2,26470,44,0.74 [0.44-1.22],0.2317397458496214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PFDN4,Prefoldin subunit 4,22790,39,0.41 [0.20-0.86],0.0183802993183421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PFDN6,Prefoldin subunit 6,22992,41,0.90 [0.55-1.49],0.6894700219400021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",26962,48,0.82 [0.59-1.15],0.2577874174110102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGA4,Pepsin A-4,23663,40,1.19 [0.80-1.79],0.3925299087321864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",23652,40,1.09 [0.63-1.88],0.7556064190315557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGF,Placenta growth factor,27414,49,0.79 [0.27-2.28],0.6591246276113173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGLYRP1,Peptidoglycan recognition protein 1,27328,47,0.77 [0.41-1.45],0.4253475152206002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,23388,40,0.70 [0.27-1.82],0.4631959304788253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGLYRP4,Peptidoglycan recognition protein 4,22889,39,0.85 [0.48-1.49],0.5637815755080912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGM2,Phosphoglucomutase-2,22992,41,0.83 [0.45-1.52],0.5396864480210999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGR,Progesterone receptor,22978,40,0.86 [0.58-1.28],0.4596581894820346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PHACTR2,Phosphatase and actin regulator 2,23614,39,0.95 [0.73-1.24],0.7195355508154861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PHLDB1,Pleckstrin homology-like domain family B member 1,23528,40,1.18 [0.68-2.04],0.5476980944507861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PHLDB2,Pleckstrin homology-like domain family B member 2,22790,39,1.11 [0.85-1.46],0.4312088762679152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,26950,48,0.59 [0.27-1.27],0.1769603605677424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,23153,40,1.48 [0.71-3.08],0.2909328509144707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PI16,Peptidase inhibitor 16,23663,40,1.25 [0.39-4.03],0.7135041424987925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PI3,Elafin,26765,46,0.79 [0.48-1.31],0.3641130467108825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",23614,39,0.81 [0.54-1.22],0.3142551728543327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PIGR,Polymeric immunoglobulin receptor,26782,49,1.59 [0.80-3.18],0.1881436443238858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,27084,49,1.16 [0.78-1.73],0.4713003244423183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,27137,49,0.75 [0.29-1.97],0.5606334240251002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,22978,40,0.75 [0.40-1.40],0.3666184936641308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PILRA,Paired immunoglobulin-like type 2 receptor alpha,27137,49,0.96 [0.52-1.74],0.881039290069457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PILRB,Paired immunoglobulin-like type 2 receptor beta,27132,49,0.92 [0.59-1.42],0.6965019435375222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,23153,40,1.04 [0.67-1.63],0.8581594665957635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PITHD1,PITH domain-containing protein 1,22748,39,1.03 [0.72-1.48],0.8561740659063293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PKD1,Polycystin-1,23652,40,2.09 [0.66-6.66],0.2131010171030135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PKD2,Polycystin-2,22889,39,1.12 [0.68-1.86],0.6489764702469052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PKLR,Pyruvate kinase PKLR,27184,49,1.22 [0.86-1.73],0.2612262936751228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PKN3,Serine/threonine-protein kinase N3,23202,40,0.92 [0.60-1.40],0.689271644709419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLA2G10,Group 10 secretory phospholipase A2,26950,48,1.02 [0.66-1.56],0.9343389353875045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLA2G15,Phospholipase A2 group XV,27225,47,2.22 [0.86-5.74],0.1002215447210374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLA2G1B,Phospholipase A2,27415,47,0.68 [0.38-1.20],0.1816170619709613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLA2G2A,"Phospholipase A2, membrane associated",27048,47,1.36 [0.96-1.92],0.0795916030712594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLA2G4A,Cytosolic phospholipase A2,27269,49,0.93 [0.70-1.24],0.6212000368050479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLA2G7,Platelet-activating factor acetylhydrolase,27137,49,0.67 [0.33-1.39],0.2858093645552007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLAT,Tissue-type plasminogen activator,27373,47,0.99 [0.59-1.66],0.9613694048096446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLAU,Urokinase-type plasminogen activator,27137,49,0.99 [0.43-2.28],0.9774273688698712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLAUR,Urokinase plasminogen activator surface receptor,26962,49,1.28 [0.50-3.23],0.6073979744209719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLB1,"Phospholipase B1, membrane-associated",23597,41,1.05 [0.64-1.75],0.8406869046170076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",22978,40,0.86 [0.41-1.84],0.7047725695872501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",23597,41,0.85 [0.63-1.15],0.2951324217362724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLEKHO1,Pleckstrin homology domain-containing family O member 1,23597,41,0.79 [0.51-1.24],0.3097241180235688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLG,Plasminogen,23074,40,0.65 [0.33-1.26],0.1999640655419803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLIN1,Perilipin-1,26470,44,1.01 [0.46-2.20],0.9835741456676343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLIN3,Perilipin-3,27132,49,0.75 [0.41-1.38],0.3533424570692959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLPBP,Pyridoxal phosphate homeostasis protein,27132,49,0.89 [0.61-1.29],0.5267807866051198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLSCR3,Phospholipid scramblase 3,23560,41,0.90 [0.54-1.49],0.6824395758981175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLTP,Phospholipid transfer protein,27367,47,0.62 [0.30-1.26],0.1835324990861082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLXDC1,Plexin domain-containing protein 1,26496,46,0.35 [0.13-0.98],0.0454830198076692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLXDC2,Plexin domain-containing protein 2,23597,41,1.24 [0.47-3.28],0.6626740120221243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLXNA4,Plexin-A4,27084,49,0.75 [0.55-1.01],0.0595659669594839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLXNB2,Plexin-B2,27329,47,1.39 [0.47-4.10],0.5497450352021667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLXNB3,Plexin-B3,27045,49,0.69 [0.39-1.21],0.1911747359518374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,26992,48,1.05 [0.91-1.22],0.5142729235972279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PMCH,Pro-MCH,22889,39,1.14 [0.85-1.53],0.3836251088358607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PMM2,Phosphomannomutase 2,22889,39,0.80 [0.47-1.36],0.4127867692254762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PMS1,PMS1 protein homolog 1,22992,41,1.15 [0.67-1.99],0.6177784422552917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PMVK,Phosphomevalonate kinase,26427,43,0.94 [0.74-1.18],0.5798143541351122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PNLIP,Pancreatic triacylglycerol lipase,23663,40,0.76 [0.47-1.24],0.2756544495254135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PNLIPRP1,Inactive pancreatic lipase-related protein 1,23597,41,0.75 [0.51-1.10],0.1412217098603755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PNLIPRP2,Pancreatic lipase-related protein 2,27139,49,0.97 [0.89-1.05],0.4129052828284231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PNMA1,Paraneoplastic antigen Ma1,23041,41,0.83 [0.48-1.45],0.5146397819857961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PNMA2,Paraneoplastic antigen Ma2,22880,37,0.92 [0.44-1.92],0.8279371640043016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",26592,46,0.92 [0.72-1.18],0.5341016237701947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PODXL,Podocalyxin,27009,48,0.49 [0.09-2.54],0.3929316987436074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PODXL2,Podocalyxin-like protein 2,27225,47,1.27 [0.50-3.19],0.6147107870322814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,POF1B,Protein POF1B,22978,40,0.70 [0.34-1.46],0.3402848076472798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,POLR2A,DNA-directed RNA polymerase II subunit RPB1,22978,40,0.74 [0.25-2.20],0.5848835873185612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",27009,48,1.01 [0.47-2.14],0.9883382305905662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,POMC,Pro-opiomelanocortin,23041,41,0.64 [0.41-0.98],0.0408721615377518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PON1,Serum paraoxonase/arylesterase 1,23663,40,1.36 [0.42-4.44],0.6129294670849641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PON2,Serum paraoxonase/arylesterase 2,26637,46,0.85 [0.40-1.81],0.6773584095415828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PON3,Serum paraoxonase/lactonase 3,27269,49,0.62 [0.42-0.91],0.0154868330418614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,POSTN,Periostin,23649,41,2.25 [1.17-4.31],0.0145727286762919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPBP,Platelet basic protein,23524,41,0.78 [0.55-1.11],0.1657923744644099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPCDC,Phosphopantothenoylcysteine decarboxylase,27371,49,1.01 [0.59-1.72],0.973564568724972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPIB,Peptidyl-prolyl cis-trans isomerase B,27147,46,0.91 [0.69-1.19],0.4814858247686094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPIE,Peptidyl-prolyl cis-trans isomerase E,23202,40,1.02 [0.64-1.62],0.9444668443720916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",23649,41,0.79 [0.47-1.33],0.3832824702474994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPL,Periplakin,22978,40,0.55 [0.20-1.48],0.2344053235302517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPM1A,Protein phosphatase 1A,26496,46,0.87 [0.36-2.06],0.7436149253251969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPM1B,Protein phosphatase 1B,22978,40,0.90 [0.51-1.58],0.7071375894838481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPM1F,Protein phosphatase 1F,23652,40,0.81 [0.45-1.45],0.4730246100751856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPME1,Protein phosphatase methylesterase 1,27009,48,1.07 [0.71-1.61],0.7470480177052005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,23514,40,0.85 [0.59-1.24],0.3988351670487864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,27225,47,1.02 [0.78-1.33],0.8859524275813072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,23202,40,1.12 [0.78-1.62],0.541963629921032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,23614,39,0.74 [0.49-1.12],0.1556655373282146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,23614,39,1.54 [0.81-2.93],0.1837185315152734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP1R2,Protein phosphatase inhibitor 2,27132,49,0.84 [0.60-1.16],0.276377513385356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP1R9B,Neurabin-2,27414,49,0.95 [0.73-1.24],0.7311527419699348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,23528,40,0.92 [0.71-1.20],0.5446201510625848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP3R1,Calcineurin subunit B type 1,26950,48,0.86 [0.46-1.59],0.6219534115019208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPT1,Palmitoyl-protein thioesterase 1,22992,41,0.92 [0.59-1.42],0.7013141154824916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPY,Pancreatic prohormone,27119,46,0.98 [0.76-1.27],0.8906626161249691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PQBP1,Polyglutamine-binding protein 1,26496,46,1.04 [0.66-1.64],0.8524548548829193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRAME,Melanoma antigen preferentially expressed in tumors,22790,39,0.38 [0.11-1.30],0.1226783568583248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRAP1,Proline-rich acidic protein 1,23649,41,1.04 [0.51-2.11],0.9151626657344464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRC1,Protein regulator of cytokinesis 1,23514,40,1.12 [0.64-1.97],0.6980971142783845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRCP,Lysosomal Pro-X carboxypeptidase,27297,46,1.43 [0.68-3.03],0.349540607869277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRDX1,Peroxiredoxin-1,26398,47,0.99 [0.74-1.34],0.9638464361484496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRDX2,Peroxiredoxin-2,23272,39,1.11 [0.70-1.76],0.6527176235861702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",26592,46,0.93 [0.64-1.34],0.6912473402298456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRDX5,"Peroxiredoxin-5, mitochondrial",27414,49,0.86 [0.60-1.22],0.3957664611238368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRDX6,Peroxiredoxin-6,27363,49,1.11 [0.74-1.65],0.6240954017974241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PREB,Prolactin regulatory element-binding protein,26592,46,1.78 [0.99-3.21],0.0560898511798057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRELP,Prolargin,27139,49,0.47 [0.22-1.01],0.0536337210812657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRG2,Bone marrow proteoglycan,23649,41,1.58 [0.93-2.68],0.0926975915144986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRG3,Proteoglycan 3,23649,41,0.91 [0.51-1.62],0.7498979860384931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,26592,46,1.04 [0.64-1.68],0.8790779279377646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,22992,41,1.01 [0.38-2.63],0.9911033484770452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,27132,49,0.86 [0.64-1.15],0.3044115276412125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,23557,41,0.93 [0.65-1.34],0.709120527547733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKCQ,Protein kinase C theta type,26592,46,1.31 [0.82-2.09],0.2605567318066911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKD2,Serine/threonine-protein kinase D2,22889,39,0.99 [0.52-1.90],0.9842173590634952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKG1,cGMP-dependent protein kinase 1,23153,40,0.93 [0.73-1.18],0.5330695672032595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,26496,46,1.15 [0.78-1.68],0.4751884134090145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRL,Prolactin,27371,49,1.21 [0.88-1.66],0.2410094642102563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRND,Prion-like protein doppel,23597,41,1.60 [0.97-2.62],0.0654294610668793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PROC,Vitamin K-dependent protein C,27177,49,0.40 [0.15-1.06],0.0644866225886391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PROCR,Endothelial protein C receptor,22889,39,1.16 [0.56-2.43],0.6916212927437074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PROK1,Prokineticin-1,27084,49,0.88 [0.58-1.35],0.5682241669995782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PROS1,Vitamin K-dependent protein S,23695,41,0.32 [0.10-1.02],0.0540718370583459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRR4,Proline-rich protein 4,22989,40,1.22 [0.80-1.86],0.3500802846188157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRR5,Proline-rich protein 5,22978,40,0.89 [0.45-1.79],0.7519774153503432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRRT3,Proline-rich transmembrane protein 3,23041,41,0.83 [0.38-1.80],0.6379954818483822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRSS2,Trypsin-2,27224,49,0.79 [0.48-1.31],0.36547223357858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRSS22,Brain-specific serine protease 4,22978,40,0.53 [0.19-1.47],0.2189367645473412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRSS27,Serine protease 27,27044,49,0.59 [0.31-1.10],0.0966395542307234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRSS53,Serine protease 53,23597,41,1.74 [0.83-3.68],0.1444476205629684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRSS8,Prostasin,27043,49,0.72 [0.38-1.35],0.301071360562115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,26470,44,0.87 [0.69-1.10],0.2519258161352481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRTG,Protogenin,27363,49,1.19 [0.43-3.30],0.7367789147814111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRTN3,Myeloblastin,26425,45,1.58 [1.04-2.39],0.032509965951851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRUNE2,Protein prune homolog 2,23202,40,1.45 [0.62-3.39],0.3969781174171533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSAP,Prosaposin,23422,41,1.93 [0.88-4.22],0.0991122334235147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSAPL1,Proactivator polypeptide-like 1,23528,40,0.74 [0.40-1.35],0.3273569363585317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSCA,Prostate stem cell antigen,23528,40,1.03 [0.91-1.15],0.6720184973955442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSG1,Pregnancy-specific beta-1-glycoprotein 1,26950,48,1.05 [0.84-1.32],0.6434765872894791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSIP1,PC4 and SFRS1-interacting protein,27084,49,1.13 [0.79-1.62],0.4924027740147944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSMA1,Proteasome subunit alpha type-1,26496,46,1.20 [0.70-2.06],0.5013482313006468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSMC3,26S proteasome regulatory subunit 6A,22790,39,0.82 [0.29-2.31],0.709089887264592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSMD1,26S proteasome non-ATPase regulatory subunit 1,23614,39,1.04 [0.56-1.91],0.900236217141805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSMD5,26S proteasome non-ATPase regulatory subunit 5,22992,41,1.22 [0.82-1.81],0.3223517388228059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSMD9,26S proteasome non-ATPase regulatory subunit 9,27009,48,1.16 [0.75-1.78],0.5025626079741538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSME1,Proteasome activator complex subunit 1,26911,48,1.33 [0.69-2.58],0.3945683734860993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSME2,Proteasome activator complex subunit 2,26821,48,1.26 [0.64-2.48],0.4966764462052278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSMG3,Proteasome assembly chaperone 3,27084,49,1.31 [0.83-2.08],0.2449204139514612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSMG4,Proteasome assembly chaperone 4,22978,40,1.16 [0.71-1.89],0.563799629737256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSPN,Persephin,27084,49,0.93 [0.72-1.21],0.5930834571617916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSRC1,Proline/serine-rich coiled-coil protein 1,26496,46,1.17 [0.77-1.78],0.4619257263306419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,22311,38,0.96 [0.72-1.28],0.7893236332735335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",26470,44,1.50 [0.62-3.59],0.3664991721166556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTGDS,Prostaglandin-H2 D-isomerase,26912,49,0.93 [0.39-2.21],0.8699716399635227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTGES2,Prostaglandin E synthase 2,22790,40,0.75 [0.42-1.33],0.3249452532197878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTGR1,Prostaglandin reductase 1,23652,40,1.05 [0.73-1.51],0.788820017028778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTH,Parathyroid hormone,22992,41,0.81 [0.54-1.19],0.2795615174832851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,27084,49,0.90 [0.44-1.84],0.7697615757035912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTK7,Inactive tyrosine-protein kinase 7,26470,44,1.02 [0.50-2.08],0.954139981266236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTN,Pleiotrophin,26637,46,1.55 [0.95-2.53],0.0793626070329777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTP4A3,Protein tyrosine phosphatase type IVA 3,22978,40,1.05 [0.61-1.79],0.8616750354538474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,26950,48,0.98 [0.71-1.35],0.8833145764511454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,27224,49,0.91 [0.69-1.20],0.508976209684328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,22932,40,1.88 [1.17-3.02],0.0086609539569516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRB,Receptor-type tyrosine-protein phosphatase beta,23652,40,1.89 [0.69-5.14],0.2122685329306178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRC,Receptor-type tyrosine-protein phosphatase C,23649,41,1.07 [0.28-4.05],0.9204397097388828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRF,Receptor-type tyrosine-protein phosphatase F,27462,47,0.93 [0.38-2.24],0.8677380868268014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRH,Receptor-type tyrosine-protein phosphatase H,23528,40,2.55 [1.58-4.13],0.0001300536097866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,23528,40,2.28 [0.92-5.66],0.0751977790355174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRM,Receptor-type tyrosine-protein phosphatase mu,27040,49,1.10 [0.39-3.05],0.8598506656845382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,26859,48,0.84 [0.38-1.85],0.6577830569901046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRR,Receptor-type tyrosine-protein phosphatase R,23597,41,0.81 [0.35-1.89],0.6316785231544413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRS,Receptor-type tyrosine-protein phosphatase S,27462,47,0.76 [0.26-2.17],0.603822973996812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,23652,40,1.70 [0.69-4.21],0.2486497681953414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,23153,40,0.87 [0.53-1.42],0.5713796045296862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTS,6-pyruvoyl tetrahydrobiopterin synthase,26352,44,1.58 [1.06-2.37],0.0246918157216593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTTG1,Securin,23202,40,0.62 [0.27-1.41],0.2527883130625999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTX3,Pentraxin-related protein PTX3,27084,49,1.52 [0.85-2.72],0.1590947038975171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PVALB,Parvalbumin alpha,27231,48,0.99 [0.79-1.24],0.9406497140194038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PVR,Poliovirus receptor,27371,49,1.60 [0.85-3.01],0.14824199523016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PXDNL,Peroxidasin-like protein,23514,40,1.60 [1.22-2.08],0.0005708951065334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PXN,Paxillin,26470,44,1.23 [0.77-1.96],0.3857346935824278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PYDC1,Pyrin domain-containing protein 1,23041,41,0.87 [0.41-1.84],0.70879632817756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PYY,Peptide YY,22889,39,0.99 [0.72-1.35],0.9278888833114912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PZP,Pregnancy zone protein,23695,41,0.82 [0.50-1.35],0.4396003764967263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,QDPR,Dihydropteridine reductase,27004,48,0.88 [0.49-1.59],0.6829957921353313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,QPCT,Glutaminyl-peptide cyclotransferase,27170,46,0.37 [0.16-0.86],0.0215617345059622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,QSOX1,Sulfhydryl oxidase 1,23209,41,0.72 [0.27-1.96],0.523359080888454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB10,Ras-related protein Rab-10,23652,40,0.60 [0.33-1.08],0.090224936691207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB11FIP3,Rab11 family-interacting protein 3,23652,40,0.88 [0.67-1.17],0.3866540697874657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB27B,Ras-related protein Rab-27B,23652,40,0.83 [0.58-1.17],0.2879485580817751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB2B,Ras-related protein Rab-2B,23514,40,0.83 [0.50-1.36],0.4555545682807973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB33A,Ras-related protein Rab-33A,22889,39,0.74 [0.46-1.21],0.2325761432573975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB37,Ras-related protein Rab-37,26592,46,1.11 [0.82-1.49],0.4984677398459458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB39B,Ras-related protein Rab-39B,22889,39,0.99 [0.69-1.41],0.950307933245578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,22880,37,0.92 [0.50-1.68],0.7796464574745622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB44,Ras-related protein Rab-44,23514,40,1.01 [0.51-2.03],0.9696818785852038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB6A,Ras-related protein Rab-6A,27084,49,0.65 [0.38-1.12],0.1210867101221215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB6B,Ras-related protein Rab-6B,26470,44,0.90 [0.50-1.63],0.7339253282146623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RABEP1,Rab GTPase-binding effector protein 1,23153,40,0.87 [0.59-1.28],0.4837157431462902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RABEPK,Rab9 effector protein with kelch motifs,26496,46,1.27 [0.86-1.86],0.2271843765544803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RABGAP1L,Rab GTPase-activating protein 1-like,26592,46,1.14 [0.74-1.73],0.5564200414204579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAC3,Ras-related C3 botulinum toxin substrate 3,22992,41,0.88 [0.53-1.44],0.6000529445408685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAD23B,UV excision repair protein RAD23 homolog B,26496,46,0.82 [0.46-1.47],0.5132161014556832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAD51,DNA repair protein RAD51 homolog 1,23202,40,1.20 [0.78-1.85],0.4141464263454122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RALB,Ras-related protein Ral-B,22978,40,0.43 [0.16-1.18],0.1020315944023665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RALY,RNA-binding protein Raly,23514,40,1.06 [0.58-1.94],0.8426769602285547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RANBP1,Ran-specific GTPase-activating protein,23041,41,1.00 [0.57-1.74],0.9887134083078796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RANBP2,E3 SUMO-protein ligase RanBP2,22880,37,0.82 [0.31-2.22],0.7023311200632998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RANGAP1,Ran GTPase-activating protein 1,26496,46,0.62 [0.32-1.21],0.1622578854642149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAP1A,Ras-related protein Rap-1A,22978,40,0.97 [0.60-1.56],0.8852308136917652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAPGEF2,Rap guanine nucleotide exchange factor 2,23202,40,0.62 [0.33-1.18],0.1456624840529802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RARRES1,Retinoic acid receptor responder protein 1,26496,46,0.64 [0.25-1.62],0.3470220084846671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RARRES2,Retinoic acid receptor responder protein 2,27271,49,0.74 [0.43-1.29],0.2928355624012582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RASA1,Ras GTPase-activating protein 1,26470,44,1.58 [0.92-2.71],0.0939963859619607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,22790,39,0.87 [0.43-1.75],0.6910793704077809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RASSF2,Ras association domain-containing protein 2,26496,46,0.95 [0.59-1.54],0.8442762221540765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBFOX3,RNA binding protein fox-1 homolog 3,23614,39,1.55 [0.83-2.87],0.1670336354337631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBKS,Ribokinase,26506,47,1.30 [0.80-2.11],0.2872755857504302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBM17,Splicing factor 45,23614,39,0.80 [0.53-1.21],0.2834031833573525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBM19,Probable RNA-binding protein 19,22889,39,0.82 [0.39-1.74],0.611027871011572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBM25,RNA-binding protein 25,22790,39,1.37 [0.76-2.45],0.2913516928255083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBP1,Retinol-binding protein 1,22992,41,0.87 [0.52-1.44],0.5853694685811315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBP2,Retinol-binding protein 2,27009,48,1.21 [0.87-1.68],0.2483294843060607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBP5,Retinol-binding protein 5,27009,48,1.10 [0.71-1.70],0.674221373793751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBP7,Retinoid-binding protein 7,23528,40,0.93 [0.55-1.57],0.7762168870682026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBPMS,RNA-binding protein with multiple splicing,22978,40,0.86 [0.50-1.48],0.580627454630962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBPMS2,RNA-binding protein with multiple splicing 2,23041,41,0.84 [0.63-1.13],0.2465262513917752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RCC1,Regulator of chromosome condensation,23514,40,1.48 [1.01-2.17],0.044109548399628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RCOR1,REST corepressor 1,26637,46,0.96 [0.53-1.74],0.8975160951312847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,23041,41,0.58 [0.13-2.57],0.4762148120729056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REEP4,Receptor expression-enhancing protein 4,23614,39,0.90 [0.54-1.49],0.6804670276886647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REG1A,Lithostathine-1-alpha,26963,49,0.89 [0.53-1.50],0.66684121558208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REG1B,Lithostathine-1-beta,27462,47,0.83 [0.51-1.34],0.4377310859621437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REG3A,Regenerating islet-derived protein 3-alpha,27462,47,0.85 [0.56-1.29],0.4375529719684601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REG3G,Regenerating islet-derived protein 3-gamma,23514,40,0.70 [0.32-1.53],0.3693311368066387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REG4,Regenerating islet-derived protein 4,27187,49,0.93 [0.56-1.55],0.789894457292147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RELB,Transcription factor RelB,22978,40,0.76 [0.38-1.51],0.4339317822123172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RELT,Tumor necrosis factor receptor superfamily member 19L,27137,49,1.07 [0.43-2.69],0.8821329938145935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REN,Renin,27132,49,0.81 [0.57-1.16],0.2516531846840397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REPS1,RalBP1-associated Eps domain-containing protein 1,22978,40,0.61 [0.26-1.42],0.2501925008680404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REST,RE1-silencing transcription factor,22790,39,1.34 [0.63-2.85],0.4475706548466612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,27009,48,0.77 [0.41-1.44],0.4124479361267298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RETN,Resistin,27065,46,1.12 [0.61-2.05],0.7152080090414501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REXO2,"Oligoribonuclease, mitochondrial",22889,39,1.24 [0.76-2.02],0.3826000043710178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RFC4,Replication factor C subunit 4,23514,40,0.48 [0.10-2.31],0.3568571606514766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RGCC,Regulator of cell cycle RGCC,23614,39,0.78 [0.52-1.16],0.2203437727457232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,23202,40,1.38 [1.03-1.85],0.0305467103904483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RGMA,Repulsive guidance molecule A,27371,49,0.62 [0.28-1.38],0.2395241675604733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RGMB,RGM domain family member B,27371,49,0.62 [0.23-1.65],0.3373382797389486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RGS10,Regulator of G-protein signaling 10,23614,39,0.71 [0.41-1.22],0.2162196631486948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RGS8,Regulator of G-protein signaling 8,26592,46,1.16 [0.83-1.60],0.3853702815892624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RHOC,Rho-related GTP-binding protein RhoC,26775,47,0.93 [0.75-1.15],0.4898925420241569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RICTOR,Rapamycin-insensitive companion of mTOR,22978,40,1.31 [0.85-2.02],0.2140457933915933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,23153,40,1.47 [0.86-2.49],0.1553150987812908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RILP,Rab-interacting lysosomal protein,27278,49,1.16 [0.77-1.75],0.4682749773428475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RILPL2,RILP-like protein 2,23652,40,0.88 [0.65-1.19],0.4061083333664612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,22889,39,0.80 [0.47-1.36],0.408153170863714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RLN1,Prorelaxin H1,23614,39,1.36 [0.99-1.87],0.0570513762773157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RLN2,Prorelaxin H2,23111,40,1.24 [0.95-1.62],0.1187354121449666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASE1,Ribonuclease pancreatic,23663,40,1.94 [0.83-4.51],0.1262700639242066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASE10,Inactive ribonuclease-like protein 10,23041,41,0.84 [0.44-1.58],0.5807923980804008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASE3,Eosinophil cationic protein,27003,49,0.95 [0.75-1.19],0.6355607120432633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASE4,Ribonuclease 4,22862,37,1.13 [0.36-3.59],0.8297284821285293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASE6,Ribonuclease K6,23483,39,1.49 [0.73-3.04],0.2716068898866003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASEH2A,Ribonuclease H2 subunit A,23614,39,0.95 [0.51-1.76],0.8683095963205483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASET2,Ribonuclease T2,27336,46,1.41 [0.59-3.39],0.436115142084253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNF149,E3 ubiquitin-protein ligase RNF149,23041,41,1.36 [0.57-3.26],0.489278572389894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNF168,E3 ubiquitin-protein ligase RNF168,22978,40,1.34 [0.70-2.56],0.3834000890020898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNF31,E3 ubiquitin-protein ligase RNF31,22978,40,0.63 [0.22-1.75],0.3717621842653126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNF4,E3 ubiquitin-protein ligase RNF4,23202,40,0.80 [0.47-1.37],0.4176752100767341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNF41,E3 ubiquitin-protein ligase NRDP1,26496,46,0.91 [0.62-1.36],0.6575882237776658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNF43,E3 ubiquitin-protein ligase RNF43,23202,40,0.72 [0.37-1.42],0.3480021848593185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNF5,E3 ubiquitin-protein ligase RNF5,23041,41,0.95 [0.63-1.44],0.8268886565943991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ROBO1,Roundabout homolog 1,27187,49,2.18 [0.85-5.60],0.1057629205764433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ROBO2,Roundabout homolog 2,27371,49,0.67 [0.23-1.95],0.4622301588972463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ROBO4,Roundabout homolog 4,23041,41,1.33 [0.24-7.28],0.7388496393298898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,27132,49,1.03 [0.47-2.26],0.9465213403885248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RP2,Protein XRP2,27009,48,0.85 [0.46-1.60],0.6196136782133617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RPA2,Replication protein A 32 kDa subunit,22978,40,0.51 [0.17-1.53],0.2259132713331013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RPE,Ribulose-phosphate 3-epimerase,23202,40,0.94 [0.60-1.47],0.7863010066498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RPGR,X-linked retinitis pigmentosa GTPase regulator,22992,41,0.82 [0.37-1.79],0.611408842815153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RPL14,60S ribosomal protein L14,23041,41,0.96 [0.44-2.08],0.9142084485975248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RPS10,40S ribosomal protein S10,22889,39,0.64 [0.26-1.57],0.3278420820285371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RRAS,Ras-related protein R-Ras,22992,41,0.93 [0.73-1.17],0.5203224702781624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RRM2,Ribonucleoside-diphosphate reductase subunit M2,26496,46,1.39 [1.05-1.85],0.0234103363772278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,26496,46,0.78 [0.52-1.16],0.216622791527391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RRP15,RRP15-like protein,22880,37,1.02 [0.73-1.43],0.896854614140912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RSPO1,R-spondin-1,26950,48,0.68 [0.32-1.45],0.3168496854195014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RSPO3,R-spondin-3,27363,49,0.76 [0.31-1.89],0.558863995674572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RTBDN,Retbindin,27009,48,0.97 [0.40-2.36],0.9499510685734156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RTKN2,Rhotekin-2,22889,39,1.43 [1.02-2.00],0.0389120247779173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",23614,39,0.91 [0.65-1.27],0.5714041144698361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RTN4R,Reticulon-4 receptor,27363,49,1.15 [0.56-2.36],0.7006815378746079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RUVBL1,RuvB-like 1,26496,46,0.95 [0.73-1.22],0.6710453644792759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RWDD1,RWD domain-containing protein 1,27371,49,0.95 [0.64-1.40],0.7963450517270995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RYR1,Ryanodine receptor 1,22889,39,1.66 [0.95-2.91],0.0733133881216151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A11,Protein S100-A11,26909,49,0.74 [0.39-1.39],0.3535683817495809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A12,Protein S100-A12,26763,48,1.07 [0.77-1.48],0.7034569003015102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A13,Protein S100-A13,22978,40,1.57 [0.74-3.33],0.2436645027894852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A14,Protein S100-A14,23614,39,1.42 [0.87-2.31],0.1579606543101134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A16,Protein S100-A16,26428,44,1.39 [0.97-2.00],0.0749165839690237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A3,Protein S100-A3,23514,40,0.42 [0.13-1.32],0.1375523007093601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A4,Protein S100-A4,27225,47,0.71 [0.45-1.10],0.1282556148077579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100G,Protein S100-G,23614,39,1.88 [1.06-3.32],0.0295706180361903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100P,Protein S100-P,26637,46,1.29 [0.88-1.91],0.1956154827717707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAA4,Serum amyloid A-4 protein,23695,41,0.70 [0.16-3.15],0.646928837689623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAFB2,Scaffold attachment factor B2,23614,39,0.76 [0.23-2.45],0.6427693455762974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAG,S-arrestin,22880,37,1.03 [0.56-1.89],0.9233613694735728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAMD9L,Sterile alpha motif domain-containing protein 9-like,27084,49,0.87 [0.61-1.25],0.460444666693075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAP18,Histone deacetylase complex subunit SAP18,23202,40,0.56 [0.33-0.96],0.0340276637388893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SARG,Specifically androgen-regulated gene protein,23556,40,0.85 [0.65-1.12],0.2506419167044502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SART1,U4/U6.U5 tri-snRNP-associated protein 1,22889,39,1.02 [0.45-2.30],0.9632599730889628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAT1,Diamine acetyltransferase 1,22889,39,0.49 [0.21-1.14],0.0983693262482345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAT2,Thialysine N-epsilon-acetyltransferase,23202,40,0.47 [0.27-0.85],0.0116243268999209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SATB1,DNA-binding protein SATB1,23614,39,0.77 [0.24-2.51],0.6709498886246905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SBSN,Suprabasin,23603,41,1.31 [0.55-3.09],0.543378067761962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCAMP3,Secretory carrier-associated membrane protein 3,27009,48,0.91 [0.68-1.23],0.5547607024165497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCARA5,Scavenger receptor class A member 5,27371,49,0.59 [0.25-1.41],0.2371353316660751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCARB1,Scavenger receptor class B member 1,26470,44,0.88 [0.52-1.48],0.6249601710092745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCARB2,Lysosome membrane protein 2,26452,45,1.50 [0.68-3.32],0.3195428599753912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCARF1,Scavenger receptor class F member 1,27462,47,0.81 [0.44-1.50],0.501606799366482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCARF2,Scavenger receptor class F member 2,27371,49,1.39 [0.59-3.26],0.44927715053271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCG2,Secretogranin-2,27230,49,1.57 [0.73-3.38],0.2500861776848394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCG3,Secretogranin-3,27187,49,0.95 [0.45-1.99],0.890464253800666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCGB1A1,Uteroglobin,27179,49,1.16 [0.74-1.82],0.5055346807568701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCGB2A2,Mammaglobin-A,22889,39,1.19 [0.50-2.82],0.6970752335106069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCGB3A1,Secretoglobin family 3A member 1,23153,40,1.82 [0.55-6.01],0.3290335728981647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCGB3A2,Secretoglobin family 3A member 2,27224,49,0.65 [0.46-0.93],0.0181730888468421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCGN,Secretagogin,26592,46,1.02 [0.58-1.82],0.9353779097473792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCIN,Adseverin,22880,37,1.28 [0.88-1.85],0.1926614899998939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCLY,Selenocysteine lyase,27278,49,1.74 [1.09-2.79],0.020858829656453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCN2A,Sodium channel protein type 2 subunit alpha,22880,37,1.29 [0.77-2.18],0.3326199432527937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCN2B,Sodium channel subunit beta-2,22992,41,0.88 [0.31-2.50],0.8043889056201606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCN3A,Sodium channel protein type 3 subunit alpha,22992,41,1.02 [0.45-2.30],0.9618084592880418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCN3B,Sodium channel subunit beta-3,22880,37,0.90 [0.45-1.83],0.7806515616069589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCN4B,Sodium channel subunit beta-4,23041,41,0.61 [0.30-1.25],0.1772203938596021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCP2,Non-specific lipid-transfer protein,26496,46,1.04 [0.74-1.46],0.8350490757797779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCPEP1,Retinoid-inducible serine carboxypeptidase,22948,41,0.91 [0.49-1.69],0.7574343748073384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCRG1,Scrapie-responsive protein 1,23652,40,1.47 [0.51-4.28],0.4796848633296275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCRIB,Protein scribble homolog,23041,41,1.02 [0.74-1.40],0.9171414089245492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCRN1,Secernin-1,27084,49,0.75 [0.46-1.20],0.231198620219956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCT,Secretin,22992,41,1.18 [0.64-2.17],0.6023782232039298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SDC1,Syndecan-1,27132,49,1.84 [1.08-3.15],0.0255890422286315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SDC4,Syndecan-4,27132,49,0.45 [0.27-0.74],0.001554052338406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SDCCAG8,Serologically defined colon cancer antigen 8,23514,40,0.95 [0.73-1.24],0.7098939958623913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SDHB,Succinate dehydrogenase,23528,40,1.36 [0.96-1.93],0.0877186591700721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SDK2,Protein sidekick-2,23153,40,1.61 [0.83-3.14],0.1583994968856531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEC31A,Protein transport protein Sec31A,23041,41,0.96 [0.65-1.41],0.8186785186620712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEL1L,Protein sel-1 homolog 1,23041,41,1.08 [0.45-2.55],0.8673822560566187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SELE,E-selectin,27462,47,1.34 [0.80-2.23],0.2699595158539133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SELENOP,Selenoprotein P,23695,41,1.49 [0.44-5.07],0.5248733151341649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SELL,L-selectin,23695,41,1.21 [0.33-4.41],0.768289066166623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SELP,P-selectin,27224,49,0.79 [0.51-1.24],0.3078195758318531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SELPLG,P-selectin glycoprotein ligand 1,27084,49,0.94 [0.40-2.20],0.8911005564285394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEMA3F,Semaphorin-3F,27132,49,0.96 [0.37-2.50],0.9286092797344364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEMA3G,Semaphorin-3G,23153,40,0.67 [0.32-1.37],0.2697451824486089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEMA4C,Semaphorin-4C,27009,48,1.21 [0.52-2.81],0.6645021216861098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEMA4D,Semaphorin-4D,27371,49,0.50 [0.22-1.14],0.0996466113434084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEMA6C,Semaphorin-6C,22978,40,1.33 [0.52-3.39],0.5565905804143747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEMA7A,Semaphorin-7A,27373,47,1.57 [0.67-3.64],0.2987975760061155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEPTIN3,Neuronal-specific septin-3,23614,39,0.71 [0.45-1.11],0.1358809492599021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEPTIN7,Septin-7,23202,40,0.51 [0.22-1.14],0.1014379558986759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEPTIN8,Septin-8,23551,41,1.81 [0.87-3.75],0.1107557155694532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEPTIN9,Septin-9,27009,48,0.53 [0.20-1.42],0.2076034271867677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA1,Alpha-1-antitrypsin,23243,40,2.37 [0.07-77.82],0.6288469036445898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA11,Serpin A11,27462,47,1.75 [0.91-3.36],0.0911297865656222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA12,Serpin A12,26343,47,1.03 [0.83-1.28],0.8171716036711045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA3,Alpha-1-antichymotrypsin,23595,41,3.33 [0.60-18.34],0.1677588547217023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA4,Kallistatin,23248,41,0.37 [0.11-1.24],0.1073497598427625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA5,Plasma serine protease inhibitor,23346,41,0.81 [0.52-1.27],0.3625153379858747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA6,Corticosteroid-binding globulin,23695,41,1.78 [0.31-10.37],0.5201144778480179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA7,Thyroxine-binding globulin,23695,41,0.55 [0.11-2.76],0.4712012891794269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA9,Serpin A9,26866,48,0.81 [0.57-1.14],0.2303711471877548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINB1,Leukocyte elastase inhibitor,27050,49,0.84 [0.63-1.12],0.2341256928439328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINB5,Serpin B5,26637,46,0.75 [0.48-1.19],0.220640310006345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINB6,Serpin B6,27283,49,0.69 [0.45-1.08],0.1026570662925369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINB8,Serpin B8,27414,49,0.90 [0.57-1.44],0.6695212294718895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINB9,Serpin B9,26950,48,0.66 [0.31-1.40],0.2768845776432178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINC1,Antithrombin-III,23645,41,0.90 [0.12-6.70],0.91619763488047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPIND1,Heparin cofactor 2,23645,41,0.51 [0.17-1.49],0.2171830158846215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINE1,Plasminogen activator inhibitor 1,27462,47,0.80 [0.55-1.16],0.2330698567098951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINE2,Glia-derived nexin,23652,40,0.60 [0.36-0.97],0.0390349508723113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINF1,Pigment epithelium-derived factor,23346,40,0.40 [0.13-1.27],0.1191437491700261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINF2,Alpha-2-antiplasmin,23255,41,0.65 [0.07-5.73],0.6973511872041044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPING1,Plasma protease C1 inhibitor,23645,41,0.83 [0.16-4.27],0.8254853924514389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINH1,Serpin H1,23202,40,0.97 [0.77-1.22],0.7900760974421993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINI1,Neuroserpin,23105,40,0.55 [0.19-1.54],0.2531381109474749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINI2,Serpin I2,23528,40,0.83 [0.48-1.44],0.5106913319480642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,26470,44,0.83 [0.54-1.29],0.4089786986859923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SETMAR,Histone-lysine N-methyltransferase SETMAR,26869,48,1.64 [0.76-3.53],0.2069185796967897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEZ6,Seizure protein 6 homolog,22992,41,0.77 [0.28-2.11],0.6152811312006568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEZ6L,Seizure 6-like protein,27225,47,0.66 [0.26-1.69],0.3863863438688321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEZ6L2,Seizure 6-like protein 2,27009,48,2.57 [0.99-6.66],0.052888478891694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SF3B4,Splicing factor 3B subunit 4,27009,48,0.92 [0.65-1.29],0.6185443002357304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SFRP1,Secreted frizzled-related protein 1,26867,48,1.09 [0.62-1.94],0.759751991279583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SFRP4,Secreted frizzled-related protein 4,23153,40,1.66 [0.78-3.53],0.1876181493614574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SFTPA1,Pulmonary surfactant-associated protein A1,26496,46,1.16 [0.79-1.70],0.4399597707239802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SFTPA2,Pulmonary surfactant-associated protein A2,26496,46,1.54 [1.00-2.36],0.0493520926857892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SFTPD,Pulmonary surfactant-associated protein D,27132,49,1.06 [0.73-1.55],0.7512618132060976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SGSH,N-sulphoglucosamine sulphohydrolase,23240,40,1.17 [0.70-1.95],0.5495586444659579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SH2B3,SH2B adapter protein 3,26496,46,0.93 [0.71-1.22],0.617106004585526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SH2D1A,SH2 domain-containing protein 1A,27084,49,1.17 [0.78-1.74],0.4541046393091065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,22880,37,0.70 [0.35-1.37],0.2939218324089977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SH3BP1,SH3 domain-binding protein 1,23528,40,0.99 [0.53-1.85],0.9751810269908952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SH3GL3,Endophilin-A3,23075,40,1.01 [0.70-1.46],0.9497176837633744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SH3GLB2,Endophilin-B2,23597,41,0.91 [0.58-1.41],0.664564672023616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHBG,Sex hormone-binding globulin,23663,40,1.34 [0.75-2.39],0.3215145464833548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHC1,SHC-transforming protein 1,22790,39,1.15 [0.92-1.43],0.2311235582822795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHD,SH2 domain-containing adapter protein D,22841,39,1.02 [0.72-1.43],0.925254410986602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHH,Sonic hedgehog protein,22978,40,0.78 [0.36-1.67],0.5164097797022171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHISA5,Protein shisa-5,23649,41,2.36 [1.05-5.29],0.0377164164095121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHMT1,"Serine hydroxymethyltransferase, cytosolic",27224,49,0.84 [0.63-1.13],0.2445976362291348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHPK,Sedoheptulokinase,23202,40,0.73 [0.32-1.71],0.4739179138024653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIAE,Sialate O-acetylesterase,27182,47,1.18 [0.69-2.03],0.5506694768175011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC1,Sialoadhesin,27269,49,1.54 [0.89-2.67],0.1248633438463982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC10,Sialic acid-binding Ig-like lectin 10,27084,49,1.50 [0.73-3.09],0.2674530191191703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC15,Sialic acid-binding Ig-like lectin 15,26470,44,1.01 [0.73-1.41],0.939569799600908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC5,Sialic acid-binding Ig-like lectin 5,27137,49,0.92 [0.76-1.10],0.3594605567182214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC6,Sialic acid-binding Ig-like lectin 6,27363,49,0.91 [0.42-1.94],0.8033430726510906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC7,Sialic acid-binding Ig-like lectin 7,27132,49,1.00 [0.40-2.48],0.999316319848717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC8,Sialic acid-binding Ig-like lectin 8,23041,41,1.40 [0.72-2.70],0.3201466596727418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC9,Sialic acid-binding Ig-like lectin 9,27326,49,1.56 [0.66-3.67],0.30939097295787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIL1,Nucleotide exchange factor SIL1,23041,41,1.22 [0.56-2.65],0.618961326362121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,27197,46,1.19 [0.74-1.93],0.4670210552147968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIRPB1,Signal-regulatory protein beta-1,27099,49,1.18 [0.68-2.03],0.5580338145816013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIRT1,NAD-dependent protein deacetylase sirtuin-1,22978,40,0.90 [0.58-1.39],0.6214518441970427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIRT2,NAD-dependent protein deacetylase sirtuin-2,27009,48,0.92 [0.69-1.22],0.5658786976273957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",26470,44,1.02 [0.63-1.64],0.930590054570104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIT1,Signaling threshold-regulating transmembrane adapter 1,26592,46,1.01 [0.63-1.61],0.9643411133186066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SKAP1,Src kinase-associated phosphoprotein 1,26900,48,1.12 [0.80-1.58],0.50942367799289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SKAP2,Src kinase-associated phosphoprotein 2,27269,49,0.81 [0.64-1.03],0.0793818325452835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SKIV2L,Helicase SKI2W,22889,39,0.97 [0.45-2.08],0.9301468635446474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLA2,Src-like-adapter 2,23614,39,0.89 [0.66-1.19],0.4277242662493498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLAMF1,Signaling lymphocytic activation molecule,26592,46,1.53 [0.98-2.38],0.0619181074328815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLAMF6,SLAM family member 6,26496,46,1.24 [0.62-2.45],0.5466395629712293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLAMF7,SLAM family member 7,27084,49,1.01 [0.65-1.56],0.9715570420136442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLAMF8,SLAM family member 8,26496,46,1.57 [0.97-2.54],0.0667230151137675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC12A2,Solute carrier family 12 member 2,22889,39,1.09 [0.39-3.02],0.8678751597283705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC13A1,Solute carrier family 13 member 1,23514,40,0.99 [0.60-1.63],0.964993402227106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC16A1,Monocarboxylate transporter 1,26470,44,1.18 [0.81-1.72],0.3893028990046845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC1A4,Neutral amino acid transporter A,22992,41,0.87 [0.45-1.67],0.6709625550842248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC27A4,Long-chain fatty acid transport protein 4,26470,44,1.04 [0.70-1.53],0.8581557881799994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC28A1,Sodium/nucleoside cotransporter 1,22790,39,0.37 [0.17-0.81],0.0127902561264354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC34A3,Sodium-dependent phosphate transport protein 2C,22790,39,1.33 [0.86-2.07],0.1948557037116494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC39A14,Zinc transporter ZIP14,26470,44,1.06 [0.48-2.37],0.88395507360874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC39A5,Zinc transporter ZIP5,27084,49,0.75 [0.46-1.23],0.2559193437155805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC44A4,Choline transporter-like protein 4,22992,41,0.92 [0.57-1.48],0.7273490646891296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC4A1,Band 3 anion transport protein,23649,41,0.83 [0.43-1.58],0.5664323026398237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC51B,Organic solute transporter subunit beta,22889,39,1.20 [0.86-1.69],0.2788090281103407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,23153,40,0.78 [0.54-1.13],0.1890768858052047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,23528,40,1.16 [0.70-1.93],0.5665446440064856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",22790,39,1.18 [0.73-1.91],0.4930889539213744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLIT2,Slit homolog 2 protein,26470,44,1.11 [0.69-1.80],0.6612745477270903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLITRK1,SLIT and NTRK-like protein 1,22978,40,0.72 [0.28-1.87],0.4988441122244017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLITRK2,SLIT and NTRK-like protein 2,27363,49,1.20 [0.62-2.31],0.589818679320826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLITRK6,SLIT and NTRK-like protein 6,26637,46,0.62 [0.28-1.34],0.2219163540184059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLK,STE20-like serine/threonine-protein kinase,23202,40,0.86 [0.54-1.37],0.5273641459965084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLMAP,Sarcolemmal membrane-associated protein,23528,40,0.88 [0.60-1.27],0.4835253555425729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLURP1,Secreted Ly-6/uPAR-related protein 1,23470,41,1.18 [0.58-2.43],0.6430334656882974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMAD1,Mothers against decapentaplegic homolog 1,26496,46,0.93 [0.67-1.29],0.6699980446526446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMAD2,Mothers against decapentaplegic homolog 2,23514,40,0.77 [0.48-1.22],0.2591781964545783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMAD3,Mothers against decapentaplegic homolog 3,23514,40,0.99 [0.55-1.79],0.9854235892430524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMAD5,Mothers against decapentaplegic homolog 5,27009,48,0.61 [0.19-1.99],0.4096189930707069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMARCA2,Probable global transcription activator SNF2L2,26470,44,0.84 [0.56-1.26],0.4058379600074656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMC3,Structural maintenance of chromosomes protein 3,22790,39,1.04 [0.62-1.75],0.8711038384635403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMNDC1,Survival of motor neuron-related-splicing factor 30,23528,40,0.93 [0.55-1.59],0.8014832818810049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMOC1,SPARC-related modular calcium-binding protein 1,27363,49,1.89 [0.91-3.91],0.0864410321701272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMOC2,SPARC-related modular calcium-binding protein 2,27269,49,0.85 [0.43-1.67],0.6368210060931647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMPD1,Sphingomyelin phosphodiesterase,27238,49,1.26 [0.75-2.12],0.385411981188933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMPD3,Sphingomyelin phosphodiesterase 3,22978,40,0.64 [0.29-1.44],0.2825285806832756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,27229,49,0.97 [0.66-1.44],0.8872694687285061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,23514,40,0.94 [0.62-1.44],0.7880129231815645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMS,Spermine synthase,22880,37,0.68 [0.37-1.25],0.2131679911398657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMTN,Smoothelin,23554,41,1.00 [0.73-1.36],0.9864260387275932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNAP23,Synaptosomal-associated protein 23,27132,49,0.86 [0.65-1.14],0.3061288163469149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNAP25,Synaptosomal-associated protein 25,22880,37,0.90 [0.46-1.77],0.7613881400508327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNAP29,Synaptosomal-associated protein 29,27225,47,0.94 [0.71-1.25],0.6930154462354028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNAPIN,SNARE-associated protein Snapin,23614,39,0.68 [0.39-1.20],0.183122291525727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNCA,Alpha-synuclein,23153,40,0.99 [0.76-1.29],0.9154543613241838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNCG,Gamma-synuclein,26950,48,0.99 [0.68-1.45],0.9718600498513856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",23041,41,0.86 [0.34-2.18],0.755486298670543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNRPB2,U2 small nuclear ribonucleoprotein B'',23597,41,1.07 [0.56-2.06],0.8337508935643001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNU13,NHP2-like protein 1,22889,39,0.41 [0.18-0.94],0.0352943535921649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNX15,Sorting nexin-15,23153,40,1.17 [0.68-2.02],0.5726676726314142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNX18,Sorting nexin-18,23528,40,1.21 [0.64-2.26],0.5619788872637639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNX2,Sorting nexin-2,23514,40,0.88 [0.59-1.31],0.5147333733994834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNX5,Sorting nexin-5,23041,41,0.32 [0.10-1.05],0.0608439671006388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNX9,Sorting nexin-9,27132,49,0.94 [0.65-1.37],0.7600802748368436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SOD1,Superoxide dismutase [Cu-Zn],26564,47,1.27 [0.76-2.11],0.357936996283925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SOD2,"Superoxide dismutase [Mn], mitochondrial",27137,49,1.51 [0.84-2.73],0.1726104430020333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SOD3,Extracellular superoxide dismutase,23663,40,0.77 [0.39-1.49],0.4317253792379002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SORBS1,Sorbin and SH3 domain-containing protein 1,23614,39,0.94 [0.42-2.11],0.8869525355297708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SORCS2,VPS10 domain-containing receptor SorCS2,26496,46,1.21 [0.59-2.46],0.6042206052193728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SORD,Sorbitol dehydrogenase,27234,49,0.94 [0.64-1.36],0.725160995106974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SORT1,Sortilin,27087,49,0.93 [0.46-1.87],0.8443944256053739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SOST,Sclerostin,27087,49,0.72 [0.38-1.37],0.3200834452730337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,22992,41,1.35 [0.91-2.00],0.1326303787318909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SOX2,Transcription factor SOX-2,23574,39,1.00 [0.26-3.80],0.9993218877600196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SOX9,Transcription factor SOX-9,22992,41,0.62 [0.21-1.86],0.3967103018901404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,23614,39,1.33 [0.54-3.29],0.5299958508525444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPAG1,Sperm-associated antigen 1,23614,39,0.92 [0.52-1.62],0.7728809119205127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPARC,SPARC,27225,47,0.76 [0.54-1.06],0.1086366312233745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPARCL1,SPARC-like protein 1,27136,49,0.93 [0.37-2.33],0.8729070663068568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPART,Spartin,23153,40,0.90 [0.60-1.34],0.5946043870556669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPESP1,Sperm equatorial segment protein 1,23652,40,1.43 [0.51-3.98],0.4927192688049737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINK1,Serine protease inhibitor Kazal-type 1,27137,49,1.00 [0.56-1.79],0.9983625341461309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINK2,Serine protease inhibitor Kazal-type 2,23153,40,1.20 [0.58-2.48],0.619003964341413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINK4,Serine protease inhibitor Kazal-type 4,27084,49,0.95 [0.65-1.38],0.7720802098217727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINK5,Serine protease inhibitor Kazal-type 5,27137,49,0.38 [0.17-0.85],0.0185668027362688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINK6,Serine protease inhibitor Kazal-type 6,27363,49,0.77 [0.48-1.23],0.2700469962531774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINK8,Serine protease inhibitor Kazal-type 8,22889,39,0.88 [0.36-2.15],0.7827564479422234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINT1,Kunitz-type protease inhibitor 1,27059,49,0.64 [0.22-1.86],0.4112342512623792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINT2,Kunitz-type protease inhibitor 2,27269,49,1.05 [0.57-1.93],0.8685865562548885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINT3,Kunitz-type protease inhibitor 3,23528,40,0.96 [0.76-1.21],0.7237771589548775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPOCK1,Testican-1,26950,48,0.73 [0.26-2.02],0.5468861352326024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPON1,Spondin-1,27187,49,1.33 [0.64-2.77],0.4447610015414686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPON2,Spondin-2,27003,49,1.37 [0.67-2.80],0.3858545939700514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPP1,Osteopontin,27417,47,1.84 [1.10-3.07],0.0203921390009139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",22978,40,0.60 [0.27-1.31],0.2000533987454081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPRING1,SREBP regulating gene protein,22790,39,0.85 [0.46-1.58],0.6054576128334388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPRR1B,Cornifin-B,23202,40,1.21 [0.91-1.61],0.1985003099306788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPRR3,Small proline-rich protein 3,23597,41,0.74 [0.48-1.13],0.1593690897911375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPRY2,Protein sprouty homolog 2,26592,46,0.87 [0.65-1.16],0.3322961550917636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",22880,37,0.87 [0.32-2.37],0.7926453056757516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPTLC1,Serine palmitoyltransferase 1,23597,41,1.24 [0.61-2.50],0.55446949419781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SRC,Proto-oncogene tyrosine-protein kinase Src,27178,47,0.90 [0.73-1.11],0.3170038400094631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SRP14,Signal recognition particle 14 kDa protein,27009,48,1.27 [0.85-1.89],0.2348951269966467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SRPK2,SRSF protein kinase 2,27084,49,0.91 [0.67-1.25],0.5615779607223306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SRPX,Sushi repeat-containing protein SRPX,23652,40,1.77 [0.71-4.42],0.2246624434524974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SSB,Lupus La protein,26470,44,0.83 [0.49-1.41],0.4914593273779682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",22978,40,1.13 [0.51-2.53],0.7627592899471338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,27087,49,0.81 [0.63-1.05],0.1160072346208434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,27224,49,0.65 [0.36-1.19],0.1613833196999527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SSH3,Protein phosphatase Slingshot homolog 3,22790,39,0.74 [0.44-1.27],0.2758042049096738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SSNA1,Sjoegren syndrome nuclear autoantigen 1,23528,40,0.92 [0.51-1.64],0.767534182579339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ST13,Hsc70-interacting protein,23153,40,0.98 [0.58-1.66],0.9439398920986392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",27009,48,1.13 [0.62-2.06],0.685009680099719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",27462,47,1.77 [0.75-4.18],0.1909774683701811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",22978,40,1.20 [0.67-2.12],0.5389873345972034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STAB2,Stabilin-2,23649,41,2.16 [0.81-5.71],0.1218914979813926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STAM,Signal transducing adapter molecule 1,23514,40,1.23 [0.60-2.52],0.5803910755650188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STAMBP,STAM-binding protein,26900,48,0.87 [0.58-1.29],0.4783995711356857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STAT2,Signal transducer and activator of transcription 2,22978,40,0.90 [0.60-1.35],0.6081992471251056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STAT5B,Signal transducer and activator of transcription 5B,27009,48,0.93 [0.77-1.11],0.4147875484980529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,22790,39,0.76 [0.43-1.34],0.3407662333265693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STC1,Stanniocalcin-1,27371,49,1.18 [0.65-2.13],0.5825161376482383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STC2,Stanniocalcin-2,27099,49,2.69 [0.98-7.36],0.0543178695932419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STEAP4,Metalloreductase STEAP4,22880,37,0.67 [0.38-1.19],0.1687629543904351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STIP1,Stress-induced-phosphoprotein 1,27099,49,0.89 [0.61-1.31],0.5678012501831843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STK11,Serine/threonine-protein kinase STK11,26637,46,0.94 [0.66-1.35],0.7492357429748919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STK24,Serine/threonine-protein kinase 24,26470,44,0.86 [0.55-1.33],0.4958913988700033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STK4,Serine/threonine-protein kinase 4,27132,49,0.92 [0.69-1.23],0.576042252836242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STOML2,"Stomatin-like protein 2, mitochondrial",22790,39,0.75 [0.51-1.11],0.148970197642708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX16,Syntaxin-16,26496,46,0.54 [0.31-0.94],0.0285749012185194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX1B,Syntaxin-1B,22992,41,0.62 [0.25-1.55],0.3030280050994093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX3,Syntaxin-3,23597,41,0.92 [0.42-2.05],0.8430632478232685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX4,Syntaxin-4,27009,48,0.83 [0.52-1.32],0.438097151942001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX5,Syntaxin-5,22978,40,0.86 [0.37-1.98],0.7152783309429827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX6,Syntaxin-6,26496,46,0.69 [0.43-1.11],0.1308616089257486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX7,Syntaxin-7,22978,40,1.06 [0.58-1.94],0.842439035571103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX8,Syntaxin-8,27084,49,0.65 [0.37-1.13],0.1286817257566384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STXBP1,Syntaxin-binding protein 1,23614,39,0.86 [0.58-1.27],0.4431617410735758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STXBP3,Syntaxin-binding protein 3,26496,46,0.73 [0.37-1.41],0.3458272649219691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUGP1,SURP and G-patch domain-containing protein 1,23528,40,0.78 [0.35-1.73],0.5361902998688406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUGT1,Protein SGT1 homolog,26496,46,0.89 [0.64-1.22],0.4616874209805117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SULT1A1,Sulfotransferase 1A1,27371,49,0.91 [0.75-1.10],0.3177459955095996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SULT2A1,Bile salt sulfotransferase,27084,49,1.12 [0.73-1.72],0.6047699977645273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUMF1,Formylglycine-generating enzyme,22978,40,0.84 [0.47-1.49],0.5456314281581851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,27371,49,1.08 [0.67-1.74],0.7623549935883669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUOX,"Sulfite oxidase, mitochondrial",23614,39,1.08 [0.67-1.73],0.752341704033135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUSD1,Sushi domain-containing protein 1,26637,46,0.75 [0.44-1.27],0.2889552654489826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUSD2,Sushi domain-containing protein 2,27137,49,0.73 [0.30-1.78],0.4885231335962494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUSD4,Sushi domain-containing protein 4,23514,40,1.23 [0.65-2.35],0.5275844491674404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUSD5,Sushi domain-containing protein 5,23012,39,2.35 [0.96-5.75],0.0616836413176968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SV2A,Synaptic vesicle glycoprotein 2A,22992,41,0.89 [0.53-1.49],0.6578772577619492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SWAP70,Switch-associated protein 70,23528,40,1.15 [0.51-2.60],0.7370408873595475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SYAP1,Synapse-associated protein 1,23153,40,0.69 [0.39-1.22],0.202061645410663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,22880,37,0.67 [0.33-1.33],0.253261519646776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SYT1,Synaptotagmin-1,23597,41,0.95 [0.44-2.09],0.9048050920013496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SYTL4,Synaptotagmin-like protein 4,23652,40,0.68 [0.43-1.07],0.0968480283768135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,23202,40,0.88 [0.66-1.17],0.3779051570008102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TACC3,Transforming acidic coiled-coil-containing protein 3,27009,48,0.89 [0.71-1.10],0.2717668812850025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TACSTD2,Tumor-associated calcium signal transducer 2,24037,45,0.51 [0.20-1.27],0.1485358997558958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TADA3,Transcriptional adapter 3,23514,40,0.85 [0.39-1.85],0.6822453843836536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TAFA5,Chemokine-like protein TAFA-5,27009,48,0.63 [0.30-1.31],0.2157047495499705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TAGLN3,Transgelin-3,22790,39,1.10 [0.69-1.75],0.6960117762987054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TALDO1,Transaldolase,23554,41,1.03 [0.53-2.00],0.923475682581446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TANK,TRAF family member-associated NF-kappa-B activator,26592,46,0.89 [0.60-1.31],0.5457987419894743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TAP1,Antigen peptide transporter 1,23202,40,1.26 [0.87-1.81],0.2198646998943016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TARBP2,RISC-loading complex subunit TARBP2,26470,44,0.83 [0.59-1.17],0.2807023734766665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",22992,41,0.95 [0.64-1.41],0.7929477494797749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",23514,40,0.53 [0.22-1.27],0.1543708949571066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TAX1BP1,Tax1-binding protein 1,23597,41,0.85 [0.53-1.37],0.4996106955412013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBC1D17,TBC1 domain family member 17,26470,44,1.37 [0.86-2.17],0.1826182490129027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBC1D23,TBC1 domain family member 23,27009,48,0.81 [0.60-1.07],0.1407390864086203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBC1D5,TBC1 domain family member 5,27084,49,0.97 [0.71-1.33],0.846053142042627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBCA,Tubulin-specific chaperone A,23153,40,0.89 [0.63-1.27],0.5153742034349524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBCB,Tubulin-folding cofactor B,26950,48,0.93 [0.73-1.20],0.5781534088814704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBCC,Tubulin-specific chaperone C,26950,48,0.89 [0.65-1.22],0.4837191173018207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBL1X,F-box-like/WD repeat-containing protein TBL1X,26496,46,0.92 [0.67-1.24],0.572008113940542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBR1,T-box brain protein 1,22992,41,0.62 [0.27-1.46],0.2767689110130155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TCL1A,T-cell leukemia/lymphoma protein 1A,26904,47,1.13 [0.87-1.47],0.3552596995142245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TCL1B,T-cell leukemia/lymphoma protein 1B,26637,46,0.54 [0.32-0.91],0.0204289685762439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TCN1,Transcobalamin-1,23168,37,0.76 [0.30-1.92],0.5595835603483703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TCN2,Transcobalamin-2,27417,47,1.07 [0.47-2.41],0.8775819530414006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TCOF1,Treacle protein,23652,40,1.36 [0.58-3.20],0.4808899023339746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TCP11,T-complex protein 11 homolog,23202,40,0.85 [0.47-1.55],0.6056992750292595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TCTN3,Tectonic-3,23652,40,0.79 [0.28-2.22],0.6567911227926053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TDGF1,Teratocarcinoma-derived growth factor 1,26470,44,1.06 [0.88-1.27],0.5343921115512346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TDO2,"Tryptophan 2,3-dioxygenase",22992,41,1.36 [0.73-2.51],0.3307264257305652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TDP1,Tyrosyl-DNA phosphodiesterase 1,23514,40,0.98 [0.63-1.54],0.9447857012369564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TDRKH,Tudor and KH domain-containing protein,26470,44,0.87 [0.63-1.21],0.4161555921832524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TEF,Thyrotroph embryonic factor,22889,39,1.71 [1.08-2.68],0.0208116272672938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TEK,Angiopoietin-1 receptor,27225,47,2.98 [0.94-9.45],0.0634282863648166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TERF1,Telomeric repeat-binding factor 1,22978,40,0.85 [0.30-2.39],0.7523602065039052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TET2,Methylcytosine dioxygenase TET2,23157,39,0.94 [0.67-1.30],0.6916759962644181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TEX101,Testis-expressed protein 101,22992,41,1.22 [0.58-2.60],0.5969045239662332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TEX33,Testis-expressed protein 33,23202,40,0.39 [0.13-1.13],0.081527595083557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TF,Serotransferrin,23695,41,2.10 [0.54-8.15],0.2833804753579114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFAP2A,Transcription factor AP-2-alpha,22880,37,0.90 [0.50-1.61],0.7129449464136972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFF1,Trefoil factor 1,26998,49,1.17 [0.88-1.55],0.2794508819339251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFF2,Trefoil factor 2,27224,49,1.51 [1.01-2.26],0.0451955152616652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFF3,Trefoil factor 3,27090,49,0.94 [0.53-1.68],0.8426138840550135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFPI,Tissue factor pathway inhibitor,27044,49,0.60 [0.26-1.42],0.2467598181478644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFPI2,Tissue factor pathway inhibitor 2,27135,47,1.41 [0.87-2.27],0.1588214339645282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFRC,Transferrin receptor protein 1,27232,49,1.61 [0.86-3.00],0.1347463203746145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TG,Thyroglobulin,23514,40,1.10 [0.88-1.39],0.3991219612420333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGFA,Protransforming growth factor alpha,27084,49,0.97 [0.56-1.66],0.8994799733781115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGFB1,Transforming growth factor beta-1 proprotein,27369,48,1.05 [0.54-2.05],0.875638137274337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGFB2,Transforming growth factor beta-2 proprotein,23514,40,1.26 [0.75-2.11],0.3912751058616004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGFBI,Transforming growth factor-beta-induced protein ig-h3,26955,49,1.32 [0.52-3.33],0.5601303934467055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGFBR1,TGF-beta receptor type-1,22978,40,0.56 [0.13-2.51],0.4486496164869111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGFBR2,TGF-beta receptor type-2,27225,47,1.08 [0.49-2.39],0.8539118829814073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGFBR3,Transforming growth factor beta receptor type 3,27462,47,0.84 [0.40-1.75],0.6381424576920226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGM2,Protein-glutamine gamma-glutamyltransferase 2,27091,49,1.33 [0.96-1.84],0.0833213859956984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGOLN2,Trans-Golgi network integral membrane protein 2,23663,40,1.30 [0.41-4.06],0.6569399411029848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THAP12,52 kDa repressor of the inhibitor of the protein kinase,22748,39,1.19 [0.90-1.56],0.2200506168280104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THBD,Thrombomodulin,27132,49,0.86 [0.34-2.16],0.7442957684309981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THBS2,Thrombospondin-2,27137,49,1.59 [0.86-2.94],0.1426968224411526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THBS4,Thrombospondin-4,27133,49,1.72 [0.99-2.99],0.0533600695457248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THOP1,Thimet oligopeptidase,27002,48,0.99 [0.43-2.26],0.982299791655496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THPO,Thrombopoietin,26637,46,0.50 [0.25-1.00],0.0513283917102012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THRAP3,Thyroid hormone receptor-associated protein 3,22889,39,1.21 [0.99-1.48],0.0664103198546062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THSD1,Thrombospondin type-1 domain-containing protein 1,22794,40,1.90 [0.95-3.82],0.0700495343027986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THTPA,Thiamine-triphosphatase,23478,40,0.85 [0.60-1.19],0.3355400746509535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THY1,Thy-1 membrane glycoprotein,27371,49,1.07 [0.44-2.62],0.8741945767244637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIA1,Nucleolysin TIA-1 isoform p40,26337,44,0.92 [0.73-1.15],0.4559276374832158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIE1,Tyrosine-protein kinase receptor Tie-1,27462,47,1.21 [0.62-2.37],0.5732475270205892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",26420,44,0.74 [0.41-1.35],0.3293961833198272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,23202,40,0.66 [0.26-1.64],0.3708922521229233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,27224,49,1.18 [0.67-2.06],0.5641835814410536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,23652,40,0.58 [0.26-1.31],0.1884414760606222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,23597,41,0.82 [0.58-1.17],0.2767368084637119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMP1,Metalloproteinase inhibitor 1,26816,49,1.56 [0.67-3.66],0.30280031798647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMP2,Metalloproteinase inhibitor 2,23652,40,0.68 [0.17-2.79],0.5940662965630057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMP3,Metalloproteinase inhibitor 3,27269,49,1.02 [0.84-1.23],0.8603579002859599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMP4,Metalloproteinase inhibitor 4,27137,49,0.89 [0.48-1.65],0.702112706599545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TINAGL1,Tubulointerstitial nephritis antigen-like,27041,49,2.94 [0.97-8.87],0.0556704716331983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TJAP1,Tight junction-associated protein 1,27225,47,0.92 [0.67-1.26],0.6058048712183783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TJP3,Tight junction protein ZO-3,22880,37,1.54 [0.89-2.66],0.1224595390486815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TK1,"Thymidine kinase, cytosolic",23202,40,1.05 [0.53-2.06],0.8985315393074187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TLR1,Toll-like receptor 1,22978,40,1.90 [0.72-5.04],0.1951631151809081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TLR2,Toll-like receptor 2,23202,40,0.58 [0.16-2.12],0.4076403759825688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TLR3,Toll-like receptor 3,27414,49,1.18 [0.76-1.83],0.4507389152659679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TLR4,Toll-like receptor 4,22978,40,0.61 [0.20-1.84],0.3821752432569046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,22992,41,1.26 [0.76-2.08],0.3685083997563623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMED1,Transmembrane emp24 domain-containing protein 1,23202,40,1.18 [0.74-1.89],0.495934534890301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMED10,Transmembrane emp24 domain-containing protein 10,22889,39,0.32 [0.09-1.07],0.0646476195539074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMED4,Transmembrane emp24 domain-containing protein 4,22889,39,1.00 [0.58-1.71],0.9874573667301408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMED8,Protein TMED8,23528,40,0.89 [0.67-1.19],0.4394348528795935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMEM106A,Transmembrane protein 106A,23514,40,0.95 [0.62-1.46],0.81711386676053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMEM132A,Transmembrane protein 132A,23041,41,1.32 [0.84-2.08],0.2228566354841095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMEM25,Transmembrane protein 25,23614,39,1.18 [0.63-2.22],0.6102786448871085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMOD4,Tropomodulin-4,22790,39,0.64 [0.29-1.42],0.2748957279278395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMPRSS11B,Transmembrane protease serine 11B,22880,37,0.52 [0.28-0.97],0.040336297470874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMPRSS11D,Transmembrane protease serine 11D,23551,41,1.04 [0.49-2.18],0.9249161833914824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMPRSS15,Enteropeptidase,27009,48,1.20 [0.91-1.59],0.1879261633749392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMPRSS5,Transmembrane protease serine 5,26820,47,0.81 [0.42-1.56],0.5257147783860601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMSB10,Thymosin beta-10,27137,49,0.76 [0.54-1.08],0.1263423879785779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNC,Tenascin,27224,49,1.90 [1.15-3.12],0.0117821849149362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNF,Tumor necrosis factor,26591,46,1.37 [0.86-2.16],0.1819879389282565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,23528,40,0.76 [0.38-1.54],0.4508730022688937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,26592,46,1.02 [0.51-2.06],0.946079290063742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,23153,40,0.61 [0.36-1.03],0.0647326978557002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,26950,48,1.39 [0.67-2.87],0.3793637799732632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,26950,48,1.15 [0.70-1.88],0.5915740320972781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,27186,46,0.78 [0.47-1.31],0.3512067568945966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,27414,49,1.06 [0.55-2.04],0.8593627015428428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,27139,49,0.60 [0.24-1.50],0.2760015947732717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,27225,47,0.73 [0.33-1.60],0.4353807945248735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,27187,49,1.05 [0.50-2.22],0.8985951387292159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,26592,46,0.87 [0.46-1.64],0.6705761072798289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,27187,49,0.75 [0.31-1.78],0.510878203423852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,23153,40,1.13 [0.55-2.32],0.7446770182354943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,27363,49,1.02 [0.45-2.28],0.9691762975981928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,27137,49,1.30 [0.57-3.00],0.5338235382737225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,27137,49,1.60 [1.09-2.33],0.0154623872780241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,27371,49,0.68 [0.27-1.71],0.4087619865041431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,27369,48,1.42 [0.76-2.63],0.269449316530424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,26950,48,1.41 [0.95-2.09],0.0897635619728044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,27371,49,1.50 [0.92-2.46],0.1070736284769886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,26950,48,1.23 [0.68-2.21],0.4877612644118259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFSF10,Tumor necrosis factor ligand superfamily member 10,27414,49,0.48 [0.18-1.24],0.1275582083537096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFSF11,Tumor necrosis factor ligand superfamily member 11,27084,49,1.05 [0.69-1.60],0.8158041229247444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFSF12,Tumor necrosis factor ligand superfamily member 12,27414,49,0.44 [0.18-1.07],0.0702762540964985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFSF13,Tumor necrosis factor ligand superfamily member 13,27269,49,1.83 [0.72-4.65],0.2038070569008641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,27415,47,1.98 [0.98-4.03],0.0578112832298639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFSF14,Tumor necrosis factor ligand superfamily member 14,26950,48,0.85 [0.54-1.33],0.4685170646616434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFSF8,Tumor necrosis factor ligand superfamily member 8,23649,41,1.98 [0.92-4.26],0.0805664772016789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNIP1,TNFAIP3-interacting protein 1,23597,41,0.95 [0.68-1.33],0.7690367709626997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNN,Tenascin-N,23649,41,2.03 [1.06-3.89],0.032170417929733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNNI3,"Troponin I, cardiac muscle",26637,46,1.08 [0.78-1.50],0.6282370566256796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNPO1,Transportin-1,23202,40,0.72 [0.29-1.79],0.4829620432169526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNR,Tenascin-R,26950,48,0.69 [0.38-1.24],0.2138771859383525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNXB,Tenascin-X,27137,49,1.41 [0.52-3.78],0.4964175077228289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,23652,40,0.82 [0.55-1.23],0.3486420910446346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TOP1,DNA topoisomerase 1,23528,40,1.09 [0.81-1.45],0.5783955901556905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TOP1MT,"DNA topoisomerase I, mitochondrial",22790,39,0.73 [0.35-1.51],0.3957520299494633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TOP2B,DNA topoisomerase 2-beta,22978,40,0.94 [0.64-1.39],0.7664395481814363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TOR1AIP1,Torsin-1A-interacting protein 1,23041,41,0.88 [0.48-1.62],0.6772290971550627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TP53,Cellular tumor antigen p53,26496,46,0.89 [0.48-1.68],0.7285820132452874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TP53BP1,TP53-binding protein 1,22978,40,1.05 [0.74-1.49],0.7741105125138802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TP53I3,Quinone oxidoreductase PIG3,22648,39,1.13 [0.64-2.00],0.6715210328354667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TP53INP1,Tumor protein p53-inducible nuclear protein 1,26637,46,0.89 [0.37-2.11],0.7865242772926322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TP73,Tumor protein p73,22992,41,0.87 [0.36-2.09],0.7571715702720769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPBGL,Trophoblast glycoprotein-like,22992,41,0.66 [0.28-1.56],0.344527564132725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPD52L2,Tumor protein D54,23153,40,0.92 [0.69-1.21],0.5342078893037507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPK1,Thiamin pyrophosphokinase 1,23652,40,0.74 [0.24-2.25],0.5924815376823196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPM3,Tropomyosin alpha-3 chain,22889,39,0.68 [0.29-1.61],0.3800200265159057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPMT,Thiopurine S-methyltransferase,26496,46,1.20 [0.87-1.67],0.2665070931342016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPP1,Tripeptidyl-peptidase 1,26959,49,1.57 [1.02-2.43],0.0422580116785347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPPP2,Tubulin polymerization-promoting protein family member 2,23202,40,1.03 [0.71-1.48],0.8940812901913665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPPP3,Tubulin polymerization-promoting protein family member 3,26470,44,1.32 [0.78-2.23],0.3063043779204221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPR,Nucleoprotein TPR,22889,39,1.03 [0.56-1.89],0.9293373945280878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPRKB,EKC/KEOPS complex subunit TPRKB,22790,39,0.71 [0.38-1.33],0.2818528465412676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPSAB1,Tryptase alpha/beta-1,27369,49,0.81 [0.50-1.29],0.3713017420992602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPSD1,Tryptase delta,23614,39,0.85 [0.35-2.04],0.7096897752589648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPSG1,Tryptase gamma,22978,40,0.61 [0.18-2.07],0.4278898414951584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPT1,Translationally-controlled tumor protein,26592,46,0.81 [0.49-1.32],0.3954550990615063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRAF2,TNF receptor-associated factor 2,27084,49,1.00 [0.70-1.42],0.9819832816381624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRAF3,"TNF receptor-associated factor 3, Isoform 2",22978,40,0.91 [0.38-2.19],0.8411697839512515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,22889,39,0.38 [0.14-1.00],0.0508978001245115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,23202,40,0.77 [0.52-1.14],0.1938996673087221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TREH,Trehalase,23649,41,0.69 [0.47-1.02],0.060773520412288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TREM2,Triggering receptor expressed on myeloid cells 2,27139,49,0.89 [0.55-1.45],0.6424733101105922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TREML1,Trem-like transcript 1 protein,23663,40,0.69 [0.38-1.24],0.2137209339697734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TREML2,Trem-like transcript 2 protein,27137,49,0.62 [0.29-1.32],0.2167720860267868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIAP1,TP53-regulated inhibitor of apoptosis 1,27363,49,0.82 [0.54-1.23],0.3393197439458737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIM21,E3 ubiquitin-protein ligase TRIM21,27084,49,0.68 [0.54-0.86],0.0012893595244953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIM24,Transcription intermediary factor 1-alpha,23155,40,0.66 [0.39-1.11],0.1140313381057358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,23528,40,0.96 [0.73-1.27],0.7730058858158846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIM26,Tripartite motif-containing protein 26,22790,39,0.75 [0.40-1.42],0.3748909815242649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIM40,E3 ubiquitin ligase TRIM40,22992,41,0.76 [0.49-1.18],0.2229886345824495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIM5,Tripartite motif-containing protein 5,27084,49,0.99 [0.74-1.34],0.9642265198921472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIM58,E3 ubiquitin-protein ligase TRIM58,23514,40,0.78 [0.55-1.10],0.1513369336731734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRPV3,Transient receptor potential cation channel subfamily V member 3,22889,39,0.55 [0.25-1.22],0.1401798385401415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSC1,Hamartin,22978,40,0.93 [0.58-1.48],0.7521175904660483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSC22D1,TSC22 domain family protein 1,23614,39,0.78 [0.48-1.28],0.3321685610343038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSHB,Thyrotropin subunit beta,27132,49,0.90 [0.68-1.21],0.4900488927520278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSLP,Thymic stromal lymphopoietin,26637,46,1.11 [0.77-1.61],0.56850542013227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSNAX,Translin-associated protein X,22889,39,0.96 [0.44-2.09],0.9251197396043324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSPAN1,Tetraspanin-1,26637,46,0.84 [0.31-2.27],0.7372226345062751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSPAN15,Tetraspanin-15,22889,39,0.55 [0.24-1.25],0.1538124498179352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSPAN7,Tetraspanin-7,22880,37,0.89 [0.59-1.34],0.569021470471976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSPAN8,Tetraspanin-8,23528,40,1.29 [0.98-1.68],0.0657008638750635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSPYL1,Testis-specific Y-encoded-like protein 1,22978,40,0.66 [0.30-1.47],0.3115554854053636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TST,Thiosulfate sulfurtransferase,26425,44,0.88 [0.61-1.25],0.4730804979159499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TTF2,Transcription termination factor 2,22992,41,0.98 [0.53-1.82],0.9585395947576418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TTN,Titin,22889,39,0.83 [0.48-1.44],0.5031832809945205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TTR,Transthyretin,23429,40,0.72 [0.40-1.30],0.2793493833609091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TUBB3,Tubulin beta-3 chain,22880,37,0.62 [0.19-1.98],0.4174858285628644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TWF2,Twinfilin-2,23649,41,0.83 [0.58-1.20],0.3296491582740787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXK,Tyrosine-protein kinase TXK,23202,40,1.16 [0.83-1.63],0.3712042769852163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXLNA,Alpha-taxilin,26950,48,0.95 [0.71-1.27],0.7325712505236213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXN,Thioredoxin,23262,39,0.85 [0.41-1.76],0.667866635884265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXNDC15,Thioredoxin domain-containing protein 15,27225,47,1.11 [0.44-2.83],0.8275678222815883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXNDC5,Thioredoxin domain-containing protein 5,27371,49,0.92 [0.63-1.35],0.6786847804139053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXNDC9,Thioredoxin domain-containing protein 9,23597,41,0.67 [0.36-1.25],0.2140209386313787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXNL1,Thioredoxin-like protein 1,22833,37,0.91 [0.63-1.32],0.6327553854468424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",27137,49,0.83 [0.47-1.46],0.5199288740464826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TYMP,Thymidine phosphorylase,26952,48,0.88 [0.60-1.30],0.512383991721183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TYRO3,Tyrosine-protein kinase receptor TYRO3,27132,49,0.97 [0.40-2.37],0.942391522763048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",22978,40,1.19 [0.74-1.92],0.4696397937800266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UBAC1,Ubiquitin-associated domain-containing protein 1,27009,48,1.21 [0.60-2.46],0.593606277022537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UBE2B,Ubiquitin-conjugating enzyme E2 B,23514,40,0.74 [0.25-2.22],0.5917388977119862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,23652,40,0.90 [0.55-1.48],0.6866292819139677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,22978,40,0.84 [0.47-1.51],0.5651724506396959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UBQLN3,Ubiquilin-3,22889,39,0.95 [0.47-1.92],0.8963421109115646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UBXN1,UBX domain-containing protein 1,23153,40,0.94 [0.61-1.47],0.7991041233380365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,23528,40,0.92 [0.74-1.14],0.4496102929397758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UGDH,UDP-glucose 6-dehydrogenase,22889,39,0.99 [0.71-1.37],0.9350481151221772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UHRF2,E3 ubiquitin-protein ligase UHRF2,22889,39,0.96 [0.40-2.32],0.9359645837820812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ULBP2,UL16-binding protein 2,26950,48,1.63 [0.87-3.05],0.1233445272178617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UMOD,Uromodulin,27382,47,0.79 [0.51-1.23],0.2964553370399065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UNC5D,Netrin receptor UNC5D,22978,40,0.46 [0.13-1.57],0.2132890150384704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UNC79,Protein unc-79 homolog,22790,39,0.70 [0.38-1.28],0.2425374333713399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UNG,Uracil-DNA glycosylase,23514,40,0.97 [0.40-2.38],0.953789892310907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UPB1,Beta-ureidopropionase,23652,40,1.05 [0.76-1.46],0.7537534891179907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UPK3A,Uroplakin-3a,22880,37,1.36 [0.81-2.30],0.2434928346871431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UPK3BL1,Uroplakin-3b-like protein 1,23161,40,0.87 [0.45-1.68],0.6842428186358037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UROD,Uroporphyrinogen decarboxylase,23153,40,0.91 [0.59-1.39],0.650092721843047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UROS,Uroporphyrinogen-III synthase,22992,41,0.97 [0.62-1.51],0.8855807149676291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,USO1,General vesicular transport factor p115,27009,48,1.03 [0.78-1.36],0.8321629200385567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,USP25,Ubiquitin carboxyl-terminal hydrolase 25,23514,40,0.93 [0.61-1.41],0.7351825842431494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,USP28,Ubiquitin carboxyl-terminal hydrolase 28,23597,41,1.07 [0.49-2.34],0.8624820112801289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,USP47,Ubiquitin carboxyl-terminal hydrolase 47,22889,39,0.97 [0.66-1.42],0.8667702076107751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,USP8,Ubiquitin carboxyl-terminal hydrolase 8,26637,46,0.92 [0.70-1.22],0.5587492740366795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UXS1,UDP-glucuronic acid decarboxylase 1,26496,46,1.04 [0.64-1.68],0.8723888587206332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VAMP5,Vesicle-associated membrane protein 5,26637,46,1.40 [1.00-1.95],0.0501769214653263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VAMP8,Vesicle-associated membrane protein 8,22978,40,0.90 [0.64-1.27],0.5528292779049498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VASH1,Tubulinyl-Tyr carboxypeptidase 1,27084,49,0.89 [0.65-1.22],0.4660313786039969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VASN,Vasorin,26696,49,1.00 [0.39-2.56],0.9972338970270708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VASP,Vasodilator-stimulated phosphoprotein,23663,40,0.84 [0.55-1.28],0.412591901754774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,27009,48,0.48 [0.13-1.76],0.2673700904108294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VAV3,Guanine nucleotide exchange factor VAV3,22880,37,0.90 [0.65-1.23],0.4969602467142845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VCAM1,Vascular cell adhesion protein 1,27177,49,2.62 [1.15-6.01],0.0225704223829956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VCAN,Versican core protein,27371,49,1.76 [0.78-3.94],0.1703393147603335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VCPKMT,Protein-lysine methyltransferase METTL21D,22790,39,0.76 [0.47-1.22],0.2510199277266576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VEGFA,Vascular endothelial growth factor A,27321,49,0.84 [0.54-1.31],0.451116079679173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VEGFB,Vascular endothelial growth factor B,22978,40,0.47 [0.16-1.40],0.1762181246767923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VEGFC,Vascular endothelial growth factor C,27225,47,0.90 [0.57-1.41],0.6367389165019917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VEGFD,Vascular endothelial growth factor D,27363,49,0.85 [0.40-1.79],0.6654128827043505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VGF,Neurosecretory protein VGF,23614,39,0.94 [0.35-2.51],0.9005371777919923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VIM,Vimentin,26637,46,1.22 [0.95-1.56],0.1203211482138662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VIPR1,Vasoactive intestinal polypeptide receptor 1,23041,41,0.62 [0.16-2.32],0.4734161273816436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VIT,Vitrin,23652,40,0.70 [0.31-1.57],0.3817679604695398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VMO1,Vitelline membrane outer layer protein 1 homolog,27009,48,1.05 [0.72-1.53],0.8119599041768516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VNN1,Pantetheinase,23663,40,1.02 [0.67-1.54],0.9297219857167344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VNN2,Vascular non-inflammatory molecule 2,27009,48,1.26 [0.70-2.24],0.4399503037947863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VPS28,Vacuolar protein sorting-associated protein 28 homolog,23202,40,0.77 [0.47-1.25],0.2880029561954075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VPS37A,Vacuolar protein sorting-associated protein 37A,27009,48,0.84 [0.60-1.16],0.2804346442010323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VPS4B,Vacuolar protein sorting-associated protein 4B,23514,40,0.90 [0.65-1.24],0.5098524938212965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VPS53,Vacuolar protein sorting-associated protein 53 homolog,27009,48,0.82 [0.58-1.16],0.2677227011603458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSIG10,V-set and immunoglobulin domain-containing protein 10,23514,40,1.36 [0.69-2.67],0.3719444646987659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,22889,39,1.60 [0.69-3.67],0.2708112940496844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSIG2,V-set and immunoglobulin domain-containing protein 2,23514,40,1.05 [0.65-1.69],0.8568683213428702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSIG4,V-set and immunoglobulin domain-containing protein 4,27099,49,0.95 [0.50-1.80],0.8808180053698579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,27091,49,0.85 [0.56-1.31],0.4648133261631807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSNL1,Visinin-like protein 1,23597,41,1.16 [0.54-2.49],0.6999596906275501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSTM1,V-set and transmembrane domain-containing protein 1,26470,44,1.10 [0.64-1.90],0.7369325321233027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSTM2B,V-set and transmembrane domain-containing protein 2B,23202,40,0.64 [0.25-1.65],0.3546754546957823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,26637,46,0.96 [0.60-1.53],0.8677539830685113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,27371,49,1.02 [0.73-1.44],0.893668569961099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VTCN1,V-set domain-containing T-cell activation inhibitor 1,26496,46,0.59 [0.25-1.40],0.2274348442601617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,23153,40,0.80 [0.47-1.38],0.4288896171943586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VWA1,von Willebrand factor A domain-containing protein 1,27315,49,1.27 [0.69-2.32],0.4374134818573303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VWA5A,von Willebrand factor A domain-containing protein 5A,22790,39,1.11 [0.80-1.56],0.5244308069609762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VWC2,Brorin,26858,48,0.93 [0.49-1.79],0.8329274599851635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VWC2L,von Willebrand factor C domain-containing protein 2-like,23614,39,0.43 [0.15-1.23],0.114845535455289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VWF,von Willebrand factor,27462,47,1.33 [0.94-1.89],0.1076469205806971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WARS,"Tryptophan--tRNA ligase, cytoplasmic",27137,49,1.65 [0.87-3.15],0.1250181807159916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WAS,Wiskott-Aldrich syndrome protein,26592,46,0.75 [0.51-1.10],0.1364015228835962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WASF1,Wiskott-Aldrich syndrome protein family member 1,26637,46,0.88 [0.66-1.17],0.3776007627322288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WASF3,Wiskott-Aldrich syndrome protein family member 3,26470,44,1.00 [0.73-1.38],0.9848652209206032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WASHC3,WASH complex subunit 3,23597,41,0.76 [0.49-1.16],0.1982311546234768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WASL,Neural Wiskott-Aldrich syndrome protein,22978,40,1.13 [0.73-1.75],0.5920577323301459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WDR46,WD repeat-containing protein 46,23514,40,0.75 [0.29-1.90],0.5385310788539186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WFDC1,WAP four-disulfide core domain protein 1,23049,40,0.77 [0.38-1.55],0.4583269213809314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WFDC12,WAP four-disulfide core domain protein 12,27326,49,0.93 [0.63-1.38],0.7240526630258477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WFDC2,WAP four-disulfide core domain protein 2,25738,44,1.14 [0.57-2.28],0.7102733776506067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",26869,48,0.72 [0.38-1.35],0.3053242461824426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",27187,49,0.43 [0.21-0.89],0.0222243901283994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WIF1,Wnt inhibitory factor 1,27363,49,1.59 [0.78-3.26],0.2035651822566911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WNT9A,Protein Wnt-9a,26592,46,1.05 [0.42-2.66],0.9157551560153392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,26950,48,0.90 [0.56-1.44],0.6527683153018942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,XCL1,Lymphotactin,27363,49,1.49 [1.07-2.06],0.0166731625209964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,XG,Glycoprotein Xg,27325,47,0.43 [0.18-1.03],0.0596322811686563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,XIAP,E3 ubiquitin-protein ligase XIAP,22978,40,0.80 [0.46-1.38],0.4180465500582297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,XPNPEP2,Xaa-Pro aminopeptidase 2,27225,47,0.92 [0.69-1.23],0.5826451059170579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,XRCC4,DNA repair protein XRCC4,26470,44,0.68 [0.31-1.47],0.3266556366298717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YAP1,Transcriptional coactivator YAP1,23597,41,2.01 [0.75-5.42],0.1670429086450889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",23528,40,0.96 [0.79-1.18],0.7193939157210094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YES1,Tyrosine-protein kinase Yes,27009,48,0.96 [0.76-1.20],0.6958947364078298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YJU2,Splicing factor YJU2,23514,40,0.55 [0.20-1.49],0.2410296753097565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YOD1,Ubiquitin thioesterase OTU1,22889,39,1.13 [0.70-1.81],0.6168559554342634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YTHDF3,YTH domain-containing family protein 3,26592,46,1.00 [0.73-1.36],0.9979324635952064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YWHAQ,14-3-3 protein theta,23153,40,0.97 [0.64-1.46],0.8747567801979909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YY1,Transcriptional repressor protein YY1,22978,40,0.78 [0.26-2.33],0.6525519898461176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZBP1,Z-DNA-binding protein 1,22978,40,1.08 [0.53-2.22],0.8321957486279937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZBTB16,Zinc finger and BTB domain-containing protein 16,26496,46,0.85 [0.57-1.26],0.4140628739437239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZBTB17,Zinc finger and BTB domain-containing protein 17,26637,46,1.50 [0.94-2.38],0.0883037432713301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZCCHC8,Zinc finger CCHC domain-containing protein 8,22889,39,0.94 [0.56-1.59],0.8246835855199429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZFYVE19,Abscission/NoCut checkpoint regulator,23528,40,0.93 [0.66-1.29],0.6524703319298368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZHX2,Zinc fingers and homeoboxes protein 2,23597,41,1.19 [0.53-2.68],0.6748345551124392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZNF174,Zinc finger protein 174,22978,40,1.31 [0.70-2.42],0.3976967925862669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZNF75D,Zinc finger protein 75D,23202,40,0.78 [0.44-1.38],0.395369723920424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZNF830,Zinc finger protein 830,23514,40,0.83 [0.53-1.31],0.4251851717505246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZNRD2,Protein ZNRD2,23528,40,0.82 [0.52-1.29],0.3870436043353596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,23514,40,0.77 [0.42-1.38],0.3764121253809602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZP3,Zona pellucida sperm-binding protein 3,23041,41,1.05 [0.93-1.18],0.4125311137463433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZP4,Zona pellucida sperm-binding protein 4,22790,39,0.34 [0.09-1.26],0.1069379216355765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZPR1,Zinc finger protein ZPR1,22880,37,1.11 [0.84-1.48],0.4695237484746578
